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Abstract 
 
V(D)J recombination generates a hugely diverse repertoire of antigen receptors through the 
random joining of antigen receptor gene segments. Recombination is catalysed by the RAG 
proteins which bind to and cleave recombination signal sequences (RSSs) that flank each 
coding segment. Since this reaction involves the introduction of double-strand breaks in the 
genome, it poses a major risk to genome stability. Indeed, 35-40% of lymphoid cancers have 
chromosome translocations that bear the hallmarks of mistakes in the production of antigen 
receptor genes. Recently, V(D)J recombination was proposed to trigger genome instability by 
a new mechanism called reintegration, where the by-product of recombination, the excised 
signal circle (ESC), is reinserted back into the genome at an RSS. I examined the cleavage 
step of reintegration and found that an ESC stimulates cleavage of an RSS, but not vice 
versa. For reintegration to occur, simultaneous cleavage at an RSS and ESC is required, so 
this finding suggests that reintegration may not occur as frequently as others have predicted. 
Instead, the ESCs could trigger double-strand breaks at RSSs and cryptic RSSs throughout 
the genome, whilst remaining intact after each cleavage event, in a proposed new 
mechanism called “cut-and-run”. I then investigated the molecular basis of asymmetric 
cleavage, and found that it is most likely caused by RAG proteins binding to both sides of an 
ESC simultaneously and obscuring the cleavage site. Using transfected extrachromosomal 
substrates, I found that RSS-ESC cleavage is also asymmetric in vivo. Finally, analysis of an 
endogenous ESC revealed that it is largely intact in a pro-B cell line, consistent with the cut-
and-run hypothesis. Therefore, cut-and-run could be a potent source of genomic instability in 
developing lymphocytes that creates broken ends for chromosome translocations.  
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Chapter 1 
 
Introduction 
 
A) The adaptive immune system 
 
1.1 Innate and adaptive immunity 
All multicellular organisms are under constant attack from a plethora of different 
pathogens, including viruses, bacteria, fungi and parasites. To defend themselves from 
such attacks, vertebrates have evolved a complex immune system capable of 
recognising and fighting off these pathogens. The first line of defence against infection 
is the innate immune system. Although its complexity can differ greatly between 
species, a form of innate immune system can be found in all classes of plant and 
animal life, including vertebrates and invertebrates. The innate immune system works 
by recognising common features of pathogens and destroys them via non-specific 
mechanisms. For example, specialised cells such as macrophages recognise 
pathogens and infected cells and ingest them by phagocytosis, breaking them down 
into harmless products.  
 
Whilst the innate immune system can be very effective, it offers no protection against 
pathogens that are capable of evolving and adapting to evade the generic, unchanging 
defence mechanisms of the innate immune system. Thus, an adaptive immune system 
has evolved in vertebrates to counteract this, allowing vertebrates to survive and thrive 
in the face of rapidly changing pathogens that the innate immune system cannot 
recognise. The importance of adaptive immunity is evident in children that are born 
without a fully functioning adaptive immune system: their chances of survival are 
vanishingly small unless extraordinary measures are taken to shield them from all 
invading pathogens (Alberts et al., 2002). 
 
1.2 B and T lymphocytes 
Central to the adaptive immune system are the B and T lymphocytes (more commonly 
called B and T cells), which express receptors on their surface that recognise a specific 
part of a pathogen, called an antigen. In B cells these receptors are antibodies, also 
referred to as immunoglobulins (Igs), and in T cells they are known as T cell receptors 
(TCRs).  
 
When a B cell successfully recognises a cognate antigen via its cell-surface Ig, it 
proliferates to generate many identical B cells that secrete huge numbers of the same 
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antibody molecule in a soluble form, which circulate the body and bind to the same 
antigen that originally stimulated its production. These extracellular antibodies can 
neutralise viruses and toxins by completely coating them and preventing them from 
infecting other cells. In addition, antibody binding targets the pathogen for destruction 
by other cells of the immune system such as macrophages and natural killer cells. The 
interaction between an antibody and an antigen is highly specific. Remarkably, 
antibodies are capable of distinguishing between proteins that differ by as little as one 
amino acid. 
 
After binding to a cognate antigen, the response of a T cell depends on whether the 
cell expresses the CD4 or CD8 cell surface marker. CD8+ T cells, also known as 
cytotoxic T cells, are capable of inducing the death of infected cells by releasing 
perforin proteins that form lethal pores in the membrane of the infected cell. The 
majority of CD4+ T cells, also called T helper cells, do not have the capacity to directly 
induce apoptosis. Instead, T helper cells expand the immune response by releasing 
cytokines that direct the functions of other cells of the immune system. However, the 
recent identification of a subset of CD4+ T cells that are directly capable of inducing 
apoptosis shows that cytotoxic effects are not strictly limited to CD8+ T cells (Cheroutre 
and Husain, 2013; Mucida et al., 2013).  
 
T helper cells are classically divided into T helper 1 (TH1) cells and T helper 2 (TH2) 
cells. TH1 cells respond to infections by intracellular bacteria and protozoa by releasing 
interferon-γ to recruit macrophages that engulf the pathogen, whereas TH2 cells are 
mainly involved in the response to extracellular parasites such as helminths (Murphy et 
al., 2007). More recently, the subsets of T helper cells have been expanded to include 
TH17, T follicular helper (TFH), T regulatory (Treg) and TH9 cells (Yamane and Paul, 
2013).  
 
TH17 cells are defined by the expression of IL-17, and help to fight bacteria and fungi 
through recruitment of neutrophils, although aberrant TH17 regulation plays a role in 
autoimmune and inflammatory disorders (Korn et al., 2009). TFH cells interact with B 
cells and help direct the production of antibodies (Ma and Deenick, 2014) and Th9 cells 
are thought to be important in the intestinal response to parasitic worm infection 
(Kaplan, 2013). Unlike all other T helper cell subtypes, which activate the functions of 
other immune cells, Treg cells function by attenuating the activity of other cells of the 
immune system. This functionality includes preventing the recognition of self antigens, 
which is crucial in preventing autoimmune diseases (Vignali et al., 2008). The fact that 
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each T helper subset is equipped with a specific function allows the immune system to 
respond effectively to a variety of different threats. 
  
After a pathogen has been cleared by the immune system, most of the B and T cells 
that were made during the immune response will die, but a small number remain as 
memory B and T cells. In the event of re-infection by the same pathogen, these 
memory B and T cells will recognise the pathogen and rapidly differentiate and 
proliferate into effector cells, dramatically reducing the response time of the immune 
system. It is this immunological memory that forms the basis of vaccinations (Murphy et 
al., 2007). 
  
1.3 Immunoglobulin and TCR structure 
Immunoglobulins are composed of four polypeptide chains linked by disulphide bonds: 
two identical heavy (IgH) chains and two identical light (IgL) chains (Fig. 1.1A). Igs can 
be divided into two distinct domains: a variable region that binds an antigen and a 
constant region that provides a scaffold for the variable region and also signals an 
immune response upon antigen binding. The variable region contains three 
hypervariable or complementarity-determining regions (CDRs), the sequence of which 
varies greatly between B cells, thus enabling recognition of a wide range of pathogens. 
Between the three CDRs are framework regions, which do not vary in sequence but 
provide a necessary scaffold for the CDRs. 
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Figure 1.1 – Immunoglobulin structure. (A) Antibodies consist of four polypeptide chains, two heavy and 
two light, connected by disulphide bonds. Each chain contains variable and constant regions. The variable 
regions of the light and heavy chains form the antigen binding site, and the constant region of the heavy 
chain dictates the effector function of the antibody. The schematic depicts the domain architecture of a 
soluble IgA or IgG antibody, which contain three tandem constant domains and a flexible hinge region. IgD 
also contains three constant domans, but is always membrane-bound, and IgM and IgE both contain four 
tandem constant domains. (B) IgA and IgM antibodies form dimers and pentamers, respectively, of the 
basic antibody structure shown in part (A) via cross-linking with an additional J chain. 
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Humans and mice contain two different types of light chain: kappa (Igκ) and lambda 
(Igλ). The two light chains of each antibody are always identical, being either both κ or 
λ, and never one of each. Each light chain is made of one variable region and one 
constant region. There are also five different types of heavy chain constant region that 
define the five classes of immunoglobulin: IgA, IgD, IgE, IgG, and IgM, with each 
constant region imparting a different functional effect on the antibody. Before binding its 
cognate antigen all antibodies are of the membrane-bound IgD or IgM subtype. Antigen 
binding, followed by TH2 cell interaction, triggers switching to one of the other classes. 
The constant region of an antibody also affects its oligomerisation state: IgD, IgE and 
IgG are monomers, IgA is a dimer and IgM forms a pentamer (Fig. 1.1B). Pentameric 
IgM and IgA contain cysteine residues in the C-terminus of their constant regions that 
form disulphide bridges with an additional polypeptide chain called the joining (J) chain 
(not to be confused with the J gene segment). Crosslinking with the J chain promotes 
multimerisation into pentamers (IgM) and dimers (IgA), which bestows important 
properties upon the Ig molecules (Mestecky et al., 1971; Murphy et al., 2007). In the 
case of IgA, dimerisation is essential for secretion into the mucosal linings, acting as a 
first line of defence against pathogens that enter through the mucous membrane. 
Multimerisation of IgM creates many more antigen binding sites per molecule, thus 
increasing the avidity (binding strength) of the antibody, and enables neutralisation of 
bacteria and viruses through agglutination (Johansen et al., 2000).  
 
TCRs consist of two polypeptides, either an α and a β chain in αβ T cell , or a δ and a γ 
chain in δγ T cells (Fig. 1.2). 95% of T cells in the human body express the αβ form, 
whilst the other 5% express the δγ form (Holtmeier and Kabelitz, 2005). Unlike 
antibodies, TCRs are always membrane-bound, and unlike antibodies, which are 
capable of recognising any form of organic antigen (protein, carbohydrate, lipid, etc.), 
TCRs can only recognise small peptide antigens that are presented on the surface of 
other cells via the major histocompatibility complex (MHC) proteins. Furthermore, the 
affinity and specificity of TCR-antigen interactions is usually much lower than antibody-
antigen interactions. T cells that express the δγ TCR are found mostly in the intestinal 
lining and play an important role in linking the adaptive and innate immune systems 
(Holtmeier and Kabelitz, 2005; Born et al., 2006). Like antibodies, both chains of the 
TCR are joined by a disulphide bond and contain a variable domain and a constant 
domain, followed by a transmembrane domain and a short cytoplasmic tail (Fig. 1.2). 
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Figure 1.2 – T cell receptor structure. TCRs contain two disulphide-linked polypeptide chains, α and β 
(equivalent to light and heavy chains of an antibody, respectively), or δ and γ, and as such possess only 
one antigen binding site. TCRs are always membrane-bound. Each chain contains one variable domain 
and one constant domain, followed by a transmembrane domain and a short intracellular tail. 
 
B) V(D)J recombination 
 
1.4 Generation of antigen receptor diversity 
The number of unique antibodies and TCRs that can be found within the human body 
at any given time is upwards of one billion (Murphy et al., 2007). Given that there are 
only around 20-25,000 protein coding genes in the entire human genome, how is it 
possible to make such a vast repertoire of antibodies? The answer lies in the mixing 
and matching of different gene segments in the genomes of B and T cells, by the 
process of V(D)J recombination. The variable domains of antibodies and TCRs are 
encoded by multiple different variable (V), diversity (D) and joining (J) segments (Fig. 
1.3A). During V(D)J recombination, one of each gene segment is chosen at random 
and recombined to form a complete variable domain coding exon of an antibody or 
TCR. It is the stochastic assembly of coding exons, coupled with the imprecise nature 
with which the gene segments are combined, that is partly responsible for the 
generation of a huge repertoire of antibodies and T cell receptors that are capable of 
recognising a vast range of pathogens. In B cells, after binding to an antigen the 
antibody-antigen interaction is fine-tuned by highly localised point mutations via the 
process of somatic hypermutation (SHM; Section 1.21). SHM does not take place in T 
cells, therefore V(D)J recombination is responsible for the entirety of TCR variation, 
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and also explains why TCR-antigen interactions are of a lower affinity than antibody-
antigen interactions. 
 
For example, the murine IgH locus contains several hundred V gene segments, 13 D 
gene segments and four J gene segments (Fig. 1.3A; Ichihara et al., 1988). The two 
light chain loci, Igλ and Igκ, only contain V and J gene segments, and as a result they 
are less diverse than the heavy chains. In addition to the different V, D and J gene 
segments, the IgH locus contains exons for the five different constant regions. D to J 
rearrangement always takes place first, followed by V to DJ rearrangement, then the 
recombined variable domain exon is joined with the constant region exons by RNA 
splicing (Fig. 1.3A).  
 
Each V(D)J coding segment is flanked by one or two recombination signal sequences 
(RSSs), which are each made up of a conserved heptamer (5’-CACAGTG-3’) and a 
conserved nonamer (5’-ACAAAAACC-3’; Fig. 1.3B). In a 12RSS, the two conserved 
elements are separated by a non-conserved spacer of 12 base-pairs, and in a 23RSS 
the spacer contains 23 non-conserved base-pairs. Efficient recombination only occurs 
between gene segments that are flanked by different length RSSs, a condition referred 
to as the 12/23 rule (Tonegawa, 1983). 12 and 23RSSs are arranged at the antigen 
receptor loci so that only productive combinations (such as D to J) are permitted, and 
non-productive rearrangements are prevented (such as joining a V to another V; Fig. 
1.3A).  
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Figure 1.3 – Recombination of the IgH locus. (A) Schematic representation of an antigen receptor locus 
and the process of V(D)J recombination. Note that a real locus has many more copies of each gene 
segment than shown here. The germline configuration of a hypothetical heavy chain locus is shown at the 
top. D to J recombination always occurs first, followed by V to DJ recombination to generate a complete 
variable region coding exon. Splicing of the mRNA transcript then joins the variable and constant exons to 
create the full heavy chain coding sequence. Light chain loci (Igκ and Igλ) do not contain D segments. 
Open triangle = 12RSS; black triangle = 23RSS. (B) Recombination signal sequences (RSSs) are 
composed of a relatively conserved heptamer and nonamer sequence, separated by a non-conserved 12 
or 23 base pair spacer. Efficient recombination only takes place between a 12 and 23 RSS.  
 
1.5 Overview of V(D)J recombination 
V(D)J recombination can be divided into two distinct phases: a DNA cleavage step and 
a joining step (Fig. 1.4A). The cleavage step is initiated by the lymphoid-specific 
recombinase activating gene (RAG) proteins 1 and 2 (McBlane et al., 1995). The RAG 
proteins bring a 12RSS and a 23RSS together in a synaptic complex and create a 
single-strand nick precisely at the heptamer/coding sequence boundary at each RSS, 
creating a free 3’ hydroxyl group which then attacks the opposite DNA strand in a direct 
transesterification reaction {Fig. 1.4B`; \McBlane, 1995 #20}. This forms a double-
strand break (DSB) at each RSS, where the coding end is a covalently sealed hairpin 
and the signal end terminates in a blunt 5’-phosphorylated end (Fugmann et al., 2000a; 
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Bassing et al., 2002; Gellert, 2002). Following cleavage, the RAG proteins continue to 
hold the coding and signal ends together in a stable postcleavage complex (Agrawal 
and Schatz, 1997; Hiom and Gellert, 1998; Grundy et al., 2009). Proteins of the non-
homologous end joining (NHEJ) pathway are then recruited to repair the broken DNA 
ends. 
 
 
 
Figure 1.4 – The process of V(D)J recombination. (A) Schematic of V(D)J recombination. RAG proteins 
bind to a pair of RSSs, and bring them together in a synaptic complex. Double-strand breaks are made at 
RSS/coding segment boundary, which are then resolved via the NHEJ pathway to form a coding joint and 
signal joint. Blue and red squares are coding segments, triangles are RSSs, and circles are RAG proteins. 
(B) RAG proteins create a single-stranded nick precisely at the boundary of the RSS and the coding 
segment. This leaves a free 3’-OH group, which then attacks the opposing DNA strand via 
transesterification, creating a closed hairpin coding end and a blunt 5’ phosphorylated signal end. 
 
The repair reaction begins with a Ku70-Ku80 dimer binding to a coding or signal end 
(Fig. 1.5; Gu et al., 1997). Ku70-Ku80 then recruits the DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs; Gottlieb and Jackson, 1993), which in turn recruits and 
activates Artemis. Artemis then re-opens the coding end hairpins, predominantly two 
nucleotides 3’ of the hairpin tip, thus creating a four nucleotide overhang of palindromic 
(P) nucleotides (Fig. 1.6; Ma et al., 2002). Further variation is generated by the addition 
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of non-templated (N) nucleotides by terminal deoxynucleotidyl transferase (TdT), a 
lymphoid-specific polymerase, and any gaps are filled in by DNA Pol µ or DNA Pol λ 
(Fig. 1.6). Finally, the two modified coding ends are joined by DNA ligase IV:XRCC4 to 
form a coding joint. Unlike the coding ends, the two signal ends are joined together 
precisely, to form a signal joint (Fig. 1.5; Lieber, 2010). This creates a circular 
extrachromosomal piece of DNA called an excised signal circle (ESC), which is the by-
product of V(D)J recombination. This by-product was previously thought to be inert, but 
as will be discussed below, the ESC can potentially contribute to genomic instability in 
developing lymphocytes by reintegrating back into the genome (Section 1.28). At some 
antigen receptor loci, the orientation of RSSs is such that rearrangement requires an 
inversional recombination, as opposed to deletional recombination. For example, half 
of the V gene segments at the human Igκ locus are arranged in the reverse orientation 
to the J gene segments (Zachau, 1993). This results in both the coding joint and the 
signal joint being retained in the genome, and therefore does not produce an ESC.  
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Figure 1.5 – Non-homologous end joining. A Ku70-Ku80 dimer binds each of the broken DNA ends. At 
the coding ends, Ku70-Ku80 recruits DNA-PKcs:Artemis, which opens the hairpinned ends. TdT, a 
lymphoid-specific polymerase, catalyses the addition of non-templated nucleotides to create further 
variation. Pol µ or Pol λ fill in any remaining gaps, and a complex of DNA ligase IV and XRCC4 ligate the 
modified ends to create a coding joint. Signal ends generally do not undergo further modification; instead, 
they are joined precisely by DNA ligase IV:XRCC4 to form a signal joint on an excised signal circle (ESC; 
adapted from Murphy et al., 2007).  
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Figure 1.6 – Generation of junctional diversity. When DNA-PKcs:Artemis opens a hairpinned coding 
end at a site away from the apex, a short stretch of palindromic (P) nucleotides is created (indicated by 
orange boxes). Non-templated (N) nucleotides are added at random by the lymphoid-specific polymerase 
TdT (indicated by green boxes). The two strands then anneal by complementary base pairing, and any N 
nucleotides that are not complementary are excised by DNA-PKcs:Artemis. Note that the process of NHEJ 
is iterative and very flexible, and the addition and excision of nucleotides can occur in a different order than 
outlined above, or may not occur at all. If the P nucleotides share microhomology, the break can be 
repaired independently of base addition/resection. Therefore, the above scheme is only one example of 
how a break could be repaired.  
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1.6 The RAG proteins 
The RAG1 and RAG2 proteins are the only proteins required to cleave RSSs and 
initiate recombination (McBlane et al., 1995), and are highly conserved in all jawed 
vertebrates. Moreover, they catalyse the only site-specific recombination reaction found 
in higher eukaryotes (Gellert, 2002). Mutations in either RAG1 or RAG2 are associated 
with a spectrum of immunodeficiencies, ranging from severe combined 
immunodeficiency (SCID) to the slightly less severe Omenn syndromes (Jones and 
Simkus, 2009). The RAG1 and RAG2 genes are located next to each other in the 
genome ~20 kb apart in opposite transcriptional directions, and are each encoded by a 
single exon (Oettinger et al., 1990). This close proximity led to the hypothesis that the 
RAG proteins evolved from a transposable element that integrated into the vertebrate 
genome. Indeed, it was later discovered that in vitro the RAG proteins can actually 
catalyse the transposition of DNA ends with a free 3’-OH group in a nonspecific 
manner (Section 1.28; Agrawal et al., 1998). Furthermore, the biochemical mechanism 
of the RAG proteins is very similar to transposases such as the retroviral integrases 
(van Gent et al., 1996b) and the bacterial Tn5 and Tn10 transposases, as will be 
highlighted below. The relation to retroviral integrases is further exemplified by the fact 
that synthetic inhibitors of the HIV integrase can also inhibit RAG activity (Melek et al., 
2002).  
 
Since the full-length RAG proteins are largely insoluble in vitro, the majority of work on 
RAG biochemistry has been done using truncated “core” versions of RAG1 (cRAG1, 
residues 384-1008 of 1040) and RAG2 (cRAG2, residues 1-384 of 527) that are more 
amenable to purification, and are the minimum regions of both proteins that are 
required for RSS cleavage in vitro and in vivo (Fig. 1.7; Sadofsky et al., 1993; Sadofsky 
et al., 1994). RAG1 is the larger of the two RAG proteins, and the core region of RAG1 
contains three structurally distinct domains: a) an N-terminal nonamer binding domain 
that binds to the nonamer of 12 and 23RSSs (Difilippantonio et al., 1996; Spanopoulou 
et al., 1996), b) a central domain that displays nicking activity on single-stranded DNA, 
contacts the heptamer (Peak et al., 2003), and contains a zinc finger domain that 
mediates interactions with RAG2 (Aidinis et al., 2000), and c) a C-terminal domain that 
binds double-stranded DNA non-specifically and cooperatively (Arbuckle et al., 2001). 
The core region of RAG1 also contains a highly conserved catalytic triad of acidic 
residues called a DDE motif (Kim et al., 1999; Landree et al., 1999; Fugmann et al., 
2000b), which co-ordinates a divalent metal cofactor in the RAG1 active site that is 
essential for cleavage. In vivo, this metal cation is most likely Mg2+, since RAG activity 
in the presence of Mg2+ adheres to the 12/23 rule (van Gent et al., 1996c). 
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Figure 1.7 – The RAG proteins. The RAG proteins can be functionally divided into core (grey) and non-
core domains (white). The conserved domains of both RAG1 and RAG2 are shown underneath the 
core/non-core division. RAG1 contains the major DNA binding domains (NBD, central and C-terminus 
domains) and the catalytic DDE motif, whilst RAG2 mainly extends RAG1 contacts with DNA. The C-
terminus of RAG2 contains several highly conserved regions (shown in the lower half) responsible for 
regulating V(D)J recombination, including the inhibition of reintegration. All amino acid numberings are for 
the murine proteins. R = RING (Really Interesting New Gene) domain, ZDD = Zinc-binding Dimerisation 
Domain, NBD = Nonamer Binding Domain, PHD = Plant Homeodomain (Adapted from Swanson and 
Schatz, 2011). 
 
Core RAG2 is comprised of six Kelch-like motifs that are thought to adopt a six-bladed 
propeller conformation, the sixth of which mediates contacts with RAG1 (Callebaut and 
Mornon, 1998; Aidinis et al., 2000), although no formal structure has been solved. In 
isolation, core RAG2 has no inherent DNA-binding activity (Difilippantonio et al., 1996; 
Spanopoulou et al., 1996; Swanson and Desiderio, 1998), so its role in the basic 
cleavage reaction is mainly to increase the affinity and specificity of RAG1 interactions 
with the RSS heptamer (Swanson, 2004).  
 
1.7 RAG non-core regions 
Although the core regions of RAG1 and RAG2 are necessary and sufficient for 
cleavage of RSSs in vitro and in vivo, it is clear that the non-core regions of both 
proteins play major roles in the efficiency, regulation and fidelity of V(D)J recombination 
in vivo (Jones and Simkus, 2009). The non-core N-terminus of RAG1 contains a basic 
motif that mediates interactions with karyopherin alpha 1 (KPNA1), a protein that 
 In t roduct ion  | 15 
 
 
facilitates nuclear localisation of RAG1 (Spanopoulou et al., 1995), and a structurally 
characterised zinc-binding dimerisation domain (ZDD, residues 265-380), which 
contains a RING (Really Interesting New Gene) finger domain (residues 290-328) and 
a classical C2H2 zinc finger domain (355-376) that mediates dimerisation of RAG1 
monomers (Rodgers et al., 1996; Bellon et al., 1997). 
 
The RING domain is the prototypical member of a family of E3 ubiquitin (Ub) ligases, 
and its importance in V(D)J recombination is highlighted by a mutation (C328G) often 
found in Omenn syndrome patients (Simkus et al., 2007). In RAG1, the RING domain 
catalyses autoubiquitination of K233 (Jones and Gellert, 2003) and potentially 
ubiquitinates KPNA1, a protein involved in nuclear localisation (Simkus et al., 2009). 
Moreover, RAG1 has been shown to ubiquitinate histone H3 (Grazini et al., 2010), 
specifically the H3.3 variant (Jones et al., 2011). Recently, the RING domain of RAG1 
was found to recruit a multisubunit E3 Ub ligase complex via Vpr binding protein 
(VprBP), and disruption of VprBP caused developmental arrest of B cells at the pro-B-
to-pre-B transition. Analysis of recombination products in these cells showed a greater 
mutation frequency and an increased number of non-templated nucleotides (Kassmeier 
et al., 2012). Thus, whilst the function of RAG1-mediated ubiquitination remains 
unknown, it may play a role in regulating the joining of RAG cleavage products. 
 
The non-core C-terminus of RAG2 (residues 388-527, Fig. 1.7) is also crucial for 
efficient, correct V(D)J recombination, as evidenced by RAG2 knock-in mice that are 
defective for V to DJ recombination (Akamatsu et al., 2003). The RAG2 C-terminus 
contains several highly conserved features: a flexible acidic hinge that has been 
implicated in maintaining the stability of the RAG postcleavage complex (West et al., 
2005; Coussens et al., 2013), a plant homeodomain (PHD) finger that binds H3K4me3 
and directs the RAG recombinase to active chromatin (Elkin et al., 2005; Matthews et 
al., 2007; Ramon-Maiques et al., 2007), and a threonine residue (T490) that is 
important for the cell cycle-regulated degradation of RAG2 at the G1/S transition (Jiang 
et al., 2005). The far C-terminus of RAG2 (500-527) contains a string of conserved 
residues that potentially binds to phosphoinositides, although the function of this 
remains unclear (Elkin et al., 2005). The acidic hinge, PHD finger and T490 of the 
RAG2 C-terminus residue play crucial, distinct roles in maintaining accurate V(D)J 
recombination, as discussed in greater detail below. 
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1.8 HMG proteins in V(D)J recombination 
The high mobility group (HMG) box proteins are a ubiquitous family of nonspecific DNA 
binding proteins with a wide variety of functions. First discovered over 40 years ago, 
their functions include acting as nonhistone chromosomal proteins that facilitate 
nucleoprotein complex assembly and extracellular cytokines in the inflammatory 
response (Malarkey and Churchill, 2012). The HMGB1/2 proteins contain two HMG box 
domains attached to a basic linker and an acidic tail, and can bind in the minor groove 
of DNA to induce a bend towards the major groove (Weir et al., 1993). Whilst the RAG 
proteins alone are capable of binding and cleaving RSSs, HMGB1 and HMGB2 
function redundantly to stimulate cleavage at a 23RSS and promote formation of a 
12/23 complex in vitro (Sawchuk et al., 1997; van Gent et al., 1997). HMGB1 is 
recruited cooperatively through interactions with RAG1 and DNA (Little et al., 2013), 
and has been shown to induce a large bend in the conserved spacer of the 23RSS 
(Ciubotaru et al., 2013). Since the conserved heptamer and nonamer are further apart 
in a 23RSS, the function of HMGB1 in V(D)J recombination is most likely to be bringing 
the heptamer and nonamer of a 23RSS closer together so that they can be bound 
more efficiently by the RAG proteins. Indeed, footprinting studies found that RAG-
23RSS contacts at the heptamer more closely resemble RAG-12RSS contacts in the 
presence of HMGB1 (Yoshida et al., 2000; Swanson, 2002a). Removal of the acidic tail 
of HMGB1 promotes aggregation of the RAG-RSS complexes, indicating that HMGB1 
might help to maintain the correct oligomeric state of these complexes (Bergeron et al., 
2005). The HMGB proteins do not appear to be critical for V(D)J recombination in vivo, 
since HMGB1 knockout mice perform normal V(D)J recombination (Calogero et al., 
1999). However, a more thorough investigation of the influence of HMGB1 in 
recombination in vivo is precluded by the fact that HMGB1 knockout mice perish from 
unrelated hypoglycaemia within 24 hours of birth (Calogero et al., 1999).  
 
1.9 Assembly of RAG-RSS complexes 
In the absence of RAG2, RAG1 forms a stable dimer (Swanson and Desiderio, 1999) 
that can bind an isolated RSS with a Kd of 29-41 nM (as measured by fluorescence 
anisotropy, Ciubotaru et al., 2003) or 92-114 nM, as measured by electrophoretic 
mobility shift assay (EMSA; Rodgers et al., 1999; Zhao et al., 2009). RAG1-RSS 
contacts are a combination of base-specific and nonspecific interactions with the DNA 
phosphate backbone, which centre on the nonamer region of the RSS and extend 
several base pairs into the spacer region (Swanson and Desiderio, 1998). 
 
Together, RAG1 and RAG2 bind a single RSS with greater specificity and affinity, with 
a Kd of 12-25 nM, as measured by EMSA and fluorescence anisotropy (Zhao et al., 
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2009; Wang et al., 2012). In vitro, the RAG proteins form two major complexes at a 
single RSS, called SC1 and SC2 (single RSS containing complex 1 and 2), as 
observed by EMSA (Swanson, 2002b). Both have been shown to contain two 
molecules of RAG1, and either one (SC1) or two (SC2) molecules of RAG2 that can 
freely re-assort (i.e. RAG2 molecules can exchange without the complex dissociating; 
Swanson, 2002b). Nicking of a 12 or 23RSS can occur in both SC1 and SC2, 
independent of synapsis with a partner RSS (Eastman and Schatz, 1997; Swanson, 
2002b; Swanson, 2002a). When a second RSS is present, it is incorporated into SC2 
to form a paired complex (PC) without the recruitment of any additional RAG molecules 
(Swanson, 2002b). Furthermore, the RAG1 active site is contributed in trans; that is, 
each RAG1 molecule binds to one RSS via the nonamer, but cleaves the heptamer of 
the other RSS (Swanson, 2001; Yin et al., 2009). In the presence of RAG2, RAG-DNA 
contacts are extended to include the entirety of the spacer region and the heptamer-
coding boundary (Swanson and Desiderio, 1998). Studies from other groups indicate 
that a synaptic complex contains three or more RAG1 molecules (Mo et al., 1999; 
Mundy et al., 2002), but this is inconsistent with the studies noted above which show 
that a complex containing just two molecules of RAG1 can cleave a 12/23 RSS pair. 
Furthermore, complexes of this stoichiometry are unique to RAG proteins expressed 
with a GST tag, which is known to promote oligomerisation of its protein conjugates 
(Niedziela-Majka et al., 1998). Therefore, the general consensus in the literature, and 
the conclusion most consistent with the available data, is that the RAG-RSS PC 
contains two molecules of RAG1, two molecules of RAG2, and a 12/23RSS pair 
(Swanson, 2004). 
 
Formation of a paired complex (PC) containing two RSSs could occur via two possible 
pathways: RSS capture, or RAG association. In the RSS capture model, RAG proteins 
bind a single RSS to form SC2, and subsequently bind a second RSS, without the 
addition of any further RAG molecules. In RAG association, two separate SCs form on 
separate RSSs, and then associate via protein-protein interactions (Swanson, 2004). 
Paired complex formation mostly likely occurs via the RSS capture model, for two 
reasons. Firstly, SC2 and PC both contain two molecules each of RAG1 and RAG2 
(Mundy et al., 2002; Swanson, 2002b), and SC2 assembled on a single RSS can be 
converted to PC by addition of a suitable partner RSS (Mundy et al., 2002). Secondly, 
cleavage efficiency is greater when 12 and 23RSS substrates are added in a stepwise 
fashion, than when 12 and 23RSS complexes are formed separately and then mixed 
(Jones and Gellert, 2002). 
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Based on the observations that a) PC formation is more efficient when the first RSS 
bound is a 12RSS (Jones and Gellert, 2002) and b) nicking of endogenous 12RSSs, 
but not 23RSSs, can be detected at the IgH, Igκ and Tcra loci in lymphoid cells (Curry 
et al., 2005), it was previously thought that the RAG proteins preferentially bind a 
12RSS first, then capture a 23RSS. However, it is now considered unlikely that the 
RAG proteins show preference for 12RSSs over 23RSSs. In the first study, truncated 
HMGB1 lacking the acidic C terminus was used (Jones and Gellert, 2002), but the 
acidic tail is known to enhance the DNA-bending activity of HMGB1 (Stros, 1998). 
Since HMGB1 is not needed for efficient 12RSS binding, the lack of acidic tail is 
unlikely to affect subsequent binding to a 23RSS. However, the additional influence of 
the HMGB1 acidic tail might be required to promote a RAG conformation that favours 
capture of a 12RSS partner (Swanson, 2004). In addition, nicking is probably not a 
reliable measure of RAG binding, since the sequence of the RSS and also the coding 
flank sequence can strongly influence the rate of nicking (Yu and Lieber, 1999). 
 
Two recent studies have cast further doubt on the “12 first” model of RSS capture. The 
first study looked at endogenous RSS nicking at the Tcrb locus in developing T cells, 
but also looked at nicking of the same gene segments in vitro. In both cases, 23RSSs 
adjacent to Dβ1 gene segments were nicked more frequently than 12RSSs adjacent to 
Jβ gene segments (Section 1.12; Franchini et al., 2009). This indicates that at the Tcrb 
locus, the RAG proteins bind to the 23RSSs first, before capturing a 12RSS. Whilst this 
study contradicts the findings of Curry et al. (2005) it suffers from the same problem 
that nicking might not be a reliable indicator of RAG binding. 
 
In a more convincing study, chromatin immunoprecipitation sequencing (ChIP-seq) was 
used to directly assess RAG1 and RAG2 binding at the antigen receptor loci in 
developing primary lymphocytes, and it was found that the RAG proteins display no 
preference for either type of RSS (Ji et al., 2010). Instead, the main factor driving RAG 
binding was whether the RSS was found in active chromatin. In these localised 
regions, dubbed recombination centres, RAG binding correlates strongly with high 
levels of RNA polymerase II and H3K4me3, both markers of active chromatin that are 
crucial in regulating V(D)J recombination (Section 1.17). Importantly, this is the only 
study to date that has directly assessed the pattern of RAG-RSS binding in vivo. 
Therefore, the current model of RAG-RSS binding in vivo is that it occurs via a capture 
mechanism and not RAG association, as previously speculated, but the order of 
binding is a combination of the chromatin environment of the RSS, how close the 
heptamer and nonamer sequences are to the ideal consensus, and the sequence of 
the coding flank (Ji et al., 2010; Schatz and Ji, 2011). 
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1.10 RAG cleavage of RSSs 
Following formation of a PC, RAG interactions with the heptamer and adjacent coding 
sequence are more intimate than in the SC, and these interactions are extended even 
further if the substrate is nicked (Nagawa et al., 2002; Nagawa et al., 2004). 
Furthermore, formation of a PC is accompanied by DNA distortion and unwinding at the 
cleavage site (Akamatsu and Oettinger, 1998; Nagawa et al., 1998a). Since the central 
domain of RAG1 preferentially recognises single-stranded heptamer sequence, it is 
thought that the RAG proteins bind to an RSS, create a nick at the heptamer/coding 
sequence boundary and induce localised base-pair melting at the heptamer/coding 
sequence region, although not necessarily in that order (Schatz and Swanson, 2011). 
This is supported by observations that RAG cleavage is stimulated by base-pair 
mismatches or abasic residues in the coding flank (Cuomo et al., 1996; Ramsden et 
al., 1996; Grundy et al., 2007).  
 
A key step in hairpin formation by the related Tn5 transposase is the stabilisation of a 
“flipped” thymidine residue that extrudes from the DNA helix, via stacking interactions 
with a conserved tryptophan residue (Davies et al., 2000). This alignment enables 
nucleophilic attack by the opposing DNA strand to form a closed hairpin loop. A 
similarly flipped thymidine residue has been found in the RAG PC (Nishihara et al., 
2008; Bischerour et al., 2009), and mutational studies have identified four candidate 
aromatic residues capable of stabilising a flipped thymidine: W893, W956, Y935 and 
F971 (Lu et al., 2006; Grundy et al., 2007; Bischerour et al., 2009). However, there is 
no single residue that completely fulfils all the requirements of base flipping, so it is 
suspected that all four residues play an indirect role in base stacking (Bischerour et al., 
2009). 
 
1.11 Basis of the 12/23 rule 
In vivo, recombination between two different length RSSs is 30 times more efficient 
than recombination between either a 12/12 or 23/23 pair (Tonegawa, 1983), but the 
exact mechanism of the 12/23 rule remains unknown. What is known is that the 12/23 
rule is established by the RAG proteins, possibly with assistance from HMGB1, at a 
very early stage of the V(D)J recombination, most likely during synapsis and again at 
double hairpin formation (Fugmann et al., 2000a). As noted above, the RAG proteins 
display a strong preference for binding a 12/23 pair in vitro over a 12/12 pair or a 23/23 
pair (Jones and Gellert, 2002). Furthermore, hairpin formation at an RSS is greatly 
stimulated by the presence of an appropriate partner RSS (Steen et al., 1996; van Gent 
et al., 1996c; Hiom and Gellert, 1998; West and Lieber, 1998). The fact that the RAG1 
active site is contributed in trans (Swanson, 2001) partly explains why hairpin formation 
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can only occur in the context of a paired complex, since each RAG1 subunit cannot 
cleave the RSS bound by its NBD, but it does not explain why the two RSSs must be a 
12/23 pair. 
 
One possible scenario that was proposed by the Gellert group is that upon capture of 
the first RSS, the RAG1-RAG2 dimer bound to the RSS is locked into an isomeric 
conformation, either a 12RSS-like or 23RSS-like conformation, depending on which 
RSS is bound first (Jones and Gellert, 2002). If a RAG heterotetramer binds to a 
12RSS and creates a nick (as in SC2), the free RAG1 NBD has to seek out an 
accessible 23RSS partner against a background of other 12RSSs and nonspecific 
DNA. Since the major RAG-RSS interactions occur at the nonamer, it is possible that 
the free RAG1 subunit in the 12RSS SC2 samples incoming DNA for a nonamer 
sequence. Once a second nonamer is bound, the adjacent sequence is scanned for a 
heptamer. Since this RAG1/RAG2 heterodimer is locked in a 23RSS-binding 
conformation by virtue of the bound 12RSS, the heptamer sequence must be 23 base-
pairs from the nonamer in order for the RAG1 active site to tightly associate. Thus, a 
PC containing two nicked substrates is only possible if it contains a 12/23 pair 
(Swanson et al., 2009). The decision to then convert a nick to a hairpin is likely a 
critical checkpoint in the 12/23 rule, since a flipped-out base is only detected at a pre-
nicked 12RSS in the presence of 23RSS (Nishihara et al., 2008). 
 
Binding of the second nicked RSS must then be transmitted to the active site of the 
RAG1 subunit bound at the heptamer of the first RSS, by an as-yet unknown 
conformational change. This could involve either the correct alignment of one or more 
of the aromatic residues suspected of stabilising a flipped base, or the alignment of one 
or more residues in the DDE, or both. Two gain-of-function RAG1 mutants have been 
described that can catalyse efficient hairpin formation in Mg2+ in the absence of a 
partner (Kriatchko et al., 2006; Nishihara et al., 2008). Furthermore, the presence of a 
partner does not increase cleavage efficiency, indicating that they are defective in 
sensing synapsis of a 12/23 pair. Notably, both mutations are proximal to the DDE 
motif, indicating that the conformational change that signals synaptic complex 
formation is likely to involve these residues. 
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1.12 The “beyond 12/23” rule 
Whilst it is true that only different length RSSs are efficiently recombined in vivo, this 
does not mean that all 12 and 23RSSs are recombined with equal efficiency. At the 
Tcrb locus, the 23RSSs of the Vβ gene segments and the Jβ 12RSSs are arranged in a 
way that permits recombination. Despite this, Vβ-to-Dβ recombination almost never 
occurs, a phenomenon known as the “beyond 12/23 rule”. A straightforward 
explanation would be that the chromatin structure of different regions of the Tcrb locus 
is activated at different development stages, thus enabling RAG access to the Dβ gene 
segments before the Vβ segments (see RSS accessibility, Section 1.15). However, this 
prediction was not borne out by experiments which showed that the Vβ and DJβ regions 
are both active at the same developmental stage (Mathieu et al., 2000; Jackson and 
Krangel, 2006). Furthermore, the beyond 12/23 rule has been recapitulated using 
extrachromosomal substrates in non-lymphoid cells. Therefore, restriction is not 
imposed either by lymphoid-specific factors or the nuclear environment of the Tcrb 
locus. The beyond 12/23 rule could be a result of the RAG proteins binding Dβ 12RSSs 
more efficiently than Jβ 12RSSs, but EMSA studies have shown that they are bound 
with roughly the same efficiency (Drejer-Teel et al., 2007), and the ChIP experiments 
discussed above (Section 1.9) did not indicate a RAG binding preference (Ji et al., 
2010).  
 
A possible explanation lies in the observation that the Dβ 23RSSs contain a binding site 
for the AP1 transcription factor (Wang et al., 2008). c-Fos, a component of AP1, binds 
the Dβ 23RSSs and promotes RAG association with these RSSs, thus enhancing Dβ-to-
Jβ rearrangement. Mutation of the AP1 site abolished this effect (Wang et al., 2008). In 
addition, a separate in vitro study carried out in the absence of c-Fos found that 
synapsis and nicking of Jβ 12RSSs is more efficient with Dβ 23RSSs than Vβ 23RSSs 
(Drejer-Teel et al., 2007). Therefore, the beyond 12/23 rule is most likely enforced by a 
combination of RAG interactions with c-Fos/AP1, and by intrinsic features of the Tcrb 
RSSs. 
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C) Regulation of V(D)J recombination 
 
Despite the huge payoff of having a diverse adaptive immune system, V(D)J 
recombination is an inherently dangerous process in that it creates double-strand 
breaks (DSBs) in the genome of developing B and T cells, which can potentially 
undergo translocation (Section 1.24). Therefore, recombination is a tightly controlled 
process with strict regulations imposed at a number of different levels. Firstly, it is 
regulated in a lineage-dependent manner, such that the RAG proteins are only 
expressed in B and T cells, and only the Ig loci are rearranged in B cells and only the 
Tcr loci are rearranged in T cells. Secondly, recombination is regulated at the cell 
development level, so that certain loci are arranged at specific cell development 
stages. Finally, rearrangement of the gene segments at each locus always occurs in 
the same order.  
 
1.13 B and T cell development 
Like all blood cells, B and T cells arise from haematopoietic stem cells (HSCs) in the 
bone marrow. Commitment of an HSC to either the B or T lineages is regulated by a 
complex transcription factor network. Pax5 is the guardian of B cell identity and 
promotes commitment to the B cell lineage (Nutt et al., 1999); the equivalent 
transcription factor in T cell precursors is Notch1 (Pui et al., 1999; Radtke et al., 1999), 
although this is a greatly simplified overview. 
 
Commitment to the B cell lineage gives rise to the progenitor (pro-B) cell population. 
Further development at this stage is dependent on V(D)J recombination of the IgH 
locus, firstly by DH to JH gene recombination, then VH to DJH joining. Once a productive 
VDJH rearrangement has occurred, the resulting µ chain is expressed on the cell 
surface, in a complex with the surrogate light chains, λ5 and VpreB (Bassing et al., 
2002). Expression of this complex, termed the pre-B cell receptor (pre-BCR), causes a 
cascade of signalling events that triggers proliferation of the large pre-B cell population, 
followed by development to the small pre-B cell stage (Geier and Schlissel, 2006). In 
these cells, light chain recombination is initiated at one of the two light chain isotypes, 
Igκ or Igλ (Gorman and Alt, 1998) where recombination occurs between V and J gene 
segments only. The rearranged light chain product is then expressed with the 
rearranged heavy chain to form the B cell receptor molecule, IgM. Once the IgM binds 
to a cognate antigen in the presence of T cell help, differentiation to the mature B cell 
stage occurs, accompanied by somatic hypermutation (Section 1.21) and class switch 
recombination (Section 1.22). 
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Rearrangement of TCR loci also occurs at distinct developmental stages, in a fashion 
that mirrors B cell development. In TCRαβ cells, the TCRβ locus is rearranged at the 
CD4-/CD8- double negative stage (equivalent to pro-B stage), with Dβ to Jβ 
rearrangement preceding Vβ to DJβ. Once a productive VDJβ chain has been made, it is 
expressed on the cell surface as a pre-T cell receptor with CD3 and the surrogate pre-
Tα chain. Pre-TCR signalling triggers differentiation to the CD4+/CD8+ double positive 
stage where TCRα rearrangement occurs. 
 
1.14 Regulation of RAG expression 
The first level of V(D)J recombination regulation is the expression of the RAG proteins 
themselves. RAG expression is restricted to the B and T cell lineages, and is also 
restricted to specific B and T cell developmental stages (Wilson et al., 1994; 
Grawunder et al., 1995). Under the control of a combination of lymphocyte-specific 
transcription factors including Pax5, Ikaros and E2A, RAG1 and RAG2 expression is 
upregulated at the pro-B and CD4-/CD8- double negative stages, to enable IgH and 
TCRβ chain recombination. Following successful expression of a pre-BCR or pre-TCR, 
RAG expression is downregulated to allow for rapid proliferation (Grawunder et al., 
1995). RAG expression is then upregulated once more for recombination of the IgL and 
TCRα loci at the pre-B and CD4+/CD8+ double positive stages (Wilson et al., 1994). 
Once a complete IgM molecule is expressed on the surface of a B cell, or a TCR 
undergoes positive selection by binding to an MHC molecule, expression of the RAG 
proteins is then sharply downregulated to prevent further rearrangements (Brandle et 
al., 1992). In addition to lineage- and stage-specific regulation, the expression of RAG2 
is restricted to the G1 phase of the cell cycle to prevent recombination during DNA 
replication and cell division (Section 1.27). 
 
The RAG proteins can also be re-expressed in mature B cells in the lymph nodes. The 
purpose of this for receptor editing: if the BCR recognises a self-antigen, the RAG 
proteins are upregulated to allow for continuing rearrangement of the light chain loci. 
Thus, receptor editing has the potential to rescue a self-reactive B cell by producing a 
BCR with a slightly altered specificity (Gay et al., 1993; Tiegs et al., 1993).  
 
1.15 RSS accessibility  
As noted above, recombination of the Ig and Tcr loci is restricted to B and T cells, 
respectively, despite being catalysed by the same RAG proteins and using the same 
signal sequences. Furthermore, rearrangement of gene segments always occurs in a 
specific order (D to J followed by V to DJ at the heavy chain loci). This strict regulation 
can be explained by specific changes in chromatin structure that increase accessibility 
 In t roduct ion  | 24 
 
 
of the antigen receptor loci to allow the RAG proteins to initiate rearrangement only in 
the correct cell type and at the correct stage of development (Alt et al., 1984; 
Yancopoulos and Alt, 1985). Packaging of RSSs into nucleosomes renders them 
inaccessible to RAG binding and consequently inhibits V(D)J recombination (Kwon et 
al., 1998; Golding et al., 1999; McBlane and Boyes, 2000). Furthermore, nucleosomes 
are preferentially positioned over RSSs (Baumann et al., 2003), implying that they must 
be remodelled before V(D)J recombination can be initiated. In addition, a number of 
studies have highlighted specific histone modifications and other changes in chromatin 
that correlate with increased V(D)J recombination.  
 
1.16 Histone acetylation  
Acetylation of histone H3 and H4 is highly correlated with the developmental regulation 
of V(D)J recombination (Roth and Roth, 2000; Huang and Muegge, 2001; Maes et al., 
2001; Ye et al., 2001; Espinoza and Feeney, 2005). Indeed, McMurry and Krangel 
provided a striking association between histone acetylation, accessibility and V(D)J 
recombination at the TCRα/δ loci (McMurry and Krangel, 2000). Further analyses 
spanning the entire IgH locus demonstrated that histone acetylation was regulated both 
globally and locally. Large active domains were acetylated, but within these regions 
peaks of acetylation were localised to the recombination signal sequences (Johnson et 
al., 2003; Morshead et al., 2003). Histone acetylation neutralises positive charges on 
the nucleosome, thus reducing inter-nucleosomal contacts and increasing RSS 
accessibility by RAG proteins (Nightingale et al., 2007). Despite the strong correlation 
between histone acetylation and the initiation of V(D)J recombination, this mark alone 
is insufficient for full locus activation (Sikes et al., 2002; Tripathi et al., 2002; Hesslein 
et al., 2003).  
 
1.17 Histone methylation 
Histone H3 trimethlyated at lysine 4 (H3K4me3) is critical for efficient V(D)J 
recombination. Increased H3K4me3 was first observed at the IgH and Tcrb loci in 
peaks at the ends of regions undergoing recombination (Morshead et al., 2003). More 
comprehensive studies at the Igκ locus, performed in inducible cell lines, primary B 
cells and in cell lines representing distinct developmental stages, uncovered a 
correlation between increased levels of this modification and the initiation of V(D)J 
recombination (Perkins et al., 2004; Goldmit et al., 2005; Fitzsimmons et al., 2007; Xu 
and Feeney, 2009). Discovery of the RAG2 PHD finger explained the molecular basis 
for this correlation (Fig. 1.7; Matthews et al., 2007; Ramon-Maiques et al., 2007), and 
as discussed above, in vivo RAG2 binding correlates highly with H3K4me3 in 
recombination centres (Ji et al., 2010).  
 In t roduct ion  | 25 
 
 
Mutation of crucial aromatic residues in the PHD finger (Y415, M443 and W453) 
eliminates RAG2 binding to an H3K4me3 peptide, and drastically reduces 
recombination in cell-based assays (Liu et al., 2007b; Matthews et al., 2007). 
Furthermore, several PHD finger mutations are implicated in Omenn syndrome 
(Sobacchi et al., 2006). The possible explanations for how the RAG2 PHD finger 
regulates efficient recombination are two-fold. First, binding of H3K4me3 at 
transcriptionally active Ig loci by the RAG2 PHD finger tethers the RAG recombinase to 
“active” RSSs (Liu et al., 2007b; Matthews et al., 2007). Second, H3K4me3 binding 
was found to enhance RAG cleavage efficiency (Matthews et al., 2007; Ramon-
Maiques et al., 2007). A possible explanation for this is that in the absence of 
H3K4me3 binding, the PHD domain binds a self-peptide of RAG2, which forces RAG2 
into a repressed configuration. Binding of H3K4me3 would then relieve this inhibition 
(Ramon-Maiques et al., 2007). This model is consistent with recent kinetic data 
showing that binding of H3K4me3 stimulates RAG-RSS complex formation, nicking and 
hairpin formation (Shimazaki et al., 2009; Grundy et al., 2010).  
 
1.18 Non-coding transcription  
Notably, Ji et al. (2010) demonstrated that the best correlation between RAG1 binding 
and the initiation of recombination occurs at transcriptionally active antigen receptor. 
Sterile, or non-coding, transcripts of the unrearranged antigen receptor loci were first 
identified in the mid 1980s (Lennon and Perry, 1985; Yancopoulos and Alt, 1985; 
Blackwell et al., 1986; Schlissel and Baltimore, 1989). Subsequently, these transcripts 
were found to be up-regulated at the same stage at which V(D)J recombination was 
initiated (Engel et al., 1999; Duber et al., 2003) suggesting that transcription could play 
a role in regulating V(D)J recombination. More recently, the Krangel laboratory 
demonstrated that transcription plays a critical role in regulating V(D)J recombination of 
TCR genes. Transcription through specific RSSs at the Tcra locus was blocked by the 
insertion of a transcriptional terminator downstream of the T early α (TEA) promoter 
(Abarrategui and Krangel, 2006; Abarrategui and Krangel, 2007); this suppressed Vα 
to Jα recombination and greatly diminished levels of H3K4me2, H3K4me3, H3K36me3 
and H3 acetylation at the downstream Jα gene segments. Thus, these studies imply 
that non-coding transcription controls chromatin structure by activating immediately 
downstream RSSs and regulating the addition of histone modifications. Consistent with 
this, transcription is known to regulate chromatin changes associated with gene 
activation, such as histone acetylation, H2B ubiquitination (Workman, 2006) and 
notably H3K4me3. The latter occurs via association of the histone methyltransferase, 
Set1, with RNA polymerase II; this results in deposition of H3K4me3 during 
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transcription initiation (Ng et al., 2003; Bernstein et al., 2005; Pokholok et al., 2005), 
thereby helping to recruit RAG2. 
 
As is the case for RAG binding to RSSs, the nucleosome poses a considerable barrier 
to passage of the polymerase. However, a number of studies have established that 
during the transcription of chromatin templates, H2A/H2B dimers are transiently evicted 
from nucleosomes to enable the passage of the RNA polymerase (Orphanides et al., 
1999; Belotserkovskaya et al., 2003). Notably, a recent study found that even when all 
histone modifications previously associated with recombination are present, 
recombination is not fully activated. Instead, a strong correlation was found between 
the level of recombination and RSS accessibility; this accessibility was found to rely on 
the transcription-mediated eviction of H2A-H2B dimers at RSSs (Bevington and Boyes, 
2013). This therefore answered the long-standing question of how nucleosomes are 
remodelled for the initiation of recombination. Moreover, the authors argue that by 
making the RSSs available only transiently, this may play an important role in reducing 
the number of RAG-mediated double stranded DNA breaks, thereby helping to 
maintain genomic stability.  
 
1.19 Enhancers and transcription factors at the immunoglobulin loci 
The above studies build a picture of non-coding transcription leading to activation of Ig 
and TCR loci in a cell- and stage-specific manner, modulating the necessary chromatin 
changes to allow RAG access to RSSs. However, a crucial question is how non-coding 
transcription itself is regulated. Notably, each antigen receptor locus contains at least 
one recombination enhancer and in some cases these elements share redundant 
functions, maintaining efficient V(D)J recombination when another element is removed 
or compromised, as demonstrated in mouse knockout studies (Takeda et al., 1993; 
Gorman et al., 1996; Xu et al., 1996; Inlay et al., 2002; Chowdhury and Sen, 2004; 
Schlissel, 2004). The function of the enhancers is to regulate the key changes required 
for V(D)J recombination, including stimulating non-coding transcription, increasing the 
level of activating histone modifications and opening up the chromatin to increase 
accessibility. Moreover, the enhancers of the antigen receptor loci are able to stimulate 
these changes over large distances. Indeed, some of the immunoglobulin enhancers 
are located hundreds of kilobases from the gene segments that are targeted for 
rearrangement. Analysis of these enhancers identified several transcription factors that 
appear to play a key role in the regulation of antigen receptor rearrangement, including 
E2A (Sakamoto et al., 2012), interferon regulatory factor 4 (IRF4; Johnson et al., 2008; 
Bevington and Boyes, 2013), and PU.1 (Nelsen et al., 1993; Rivera et al., 1993). The 
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cell- and stage-specific regulation of these transcription factors is thus central to the 
correct regulation of V(D)J recombination.  
 
1.20 Long-range interactions between regulatory elements 
Rearrangements at the antigen receptor loci occur over huge distances of up to 3 Mb. 
In order for this to occur, the antigen receptor loci must undergo substantial large-scale 
genomic reorganisation during lymphocyte development. Fluorescence in situ 
hybridisation (FISH) studies demonstrated that the IgH and Igκ loci are in an extended 
configuration in T cells but they become contracted in pro-B cells and pre-B cells, 
respectively (Kosak et al., 2002; Roldan et al., 2005; Sayegh et al., 2005; Skok et al., 
2007). IgH locus contraction and distal VH to DJH rearrangements are facilitated by the 
transcription factors, Pax5 and YY1, and loss of Pax5 increases the distance between 
the VH and CH regions, thus reducing the use of distal VH gene segments (Hesslein et 
al., 2003; Fuxa et al., 2004; Liu et al., 2007a). In YY1-deficient mice, development is 
blocked prior to the onset of IgH recombination (Gordon et al., 2003; Liu et al., 2007a). 
Similar to the absence of Pax5, loss of YY1 mainly affects recombination of the distal 
VH gene segments and increases the distance between VH and CH gene segments. 
 
More recently, a key role for CTCF in facilitating long range interactions and 
chromosomal loops at the immunoglobulin loci has been uncovered. Developmentally 
regulated binding of CTCF and the cofactor cohesin was demonstrated at sites within 
the IgH and Igκ loci (Degner et al., 2011), which provide an anchor for long range 
interactions and the formation of chromosomal loops. Notably, YY1 binding sites were 
also found at the base of these looped structures (Guo et al., 2011a). Deletion of two 
conserved CTCF binding sites at the IgH locus enabled aberrant VH to DH 
recombination before DH to JH, and also enabled VH to DJH recombination in developing 
T cells (Featherstone et al., 2010; Guo et al., 2011b). These observations highlight the 
importance of CTCF in regulating the stage and lineage specificity of recombination, 
and also indicate that CTCF sites act as a physical barrier that dictates the order of 
rearrangements.  
 
  
 In t roduct ion  | 28 
 
 
D) Somatic hypermutation and class switch recombination in B cell 
maturation 
 
After successfully expressing a functional cell-surface IgM, B cells circulate the body 
until they encounter a cognate antigen. These naïve B cells internalise the antibody-
antigen complex, and in the presence of T cell help, form germinal centres in 
secondary lymphoid organs such the lymph nodes (Kelsoe, 1996; MacLennan, 2005). 
Here, B cells undergo rapid clonal expansion, producing a large number of cells that 
express the same immunoglobulin. The affinity of the B cell receptor-antigen interaction 
is then fine-tuned by the process of somatic hypermutation (SHM), where an extremely 
high rate of localised point mutation occurs at IgH and IgL variable exons (Peled et al., 
2008b). These mutations are clustered around specific nucleotides corresponding to 
the CDR1 and CDR2 of the receptor, thus creating a huge number of B cells that 
express subtle variations of the same immunoglobulin. Some of these antibodies bind 
to the antigen with greater affinity and are subjected to positive selection and proliferate 
further, whereas those cells containing mutations that weaken the interaction will be 
lost (Li et al., 2004; Casali et al., 2006; Di Noia and Neuberger, 2007; Teng and 
Papavasiliou, 2007).  
 
1.21 Somatic hypermutation 
Activation of B cells by an antigen triggers the upregulation of activation-induced 
cytidine deaminase (AID) expression by Pax5 and E2A. AID initiates SHM by 
deaminating deoxycytidine (dC) residues in single-stranded DNA (ssDNA) to 
deoxyuridine (dU), thus creating a uracil:guanine (U:G) mismatch (Fig. 1.8). AID can 
only act on ssDNA, therefore transcription through the Ig locus is essential to create 
single-stranded transcription bubbles before somatic hypermutation can occur (Peled 
et al., 2008b). 
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Figure 1.8 – Somatic hypermutation. AID deaminates cytidine to uridine, which is then processed in one 
of three ways: replication, base excision repair (BER) or mismatch repair (MMR). During replication, U is 
simply recognised as a T, resulting in a C to T point mutation. In BER, uracil DNA glycosylase (UNG) 
removes the uracil residue, leaving an abasic site, which is then repaired incorrectly by an error-prone 
polymerase. In BER only one residue is mutated, whereas in MMR, bases surrounding the lesion are also 
mutated. The BER and MMR pathways usually repair breaks correctly, but during SHM, error-prone 
polymerases are recruited, such as REV1 or Pol µ, resulting in mutations at sites of AID activity.  
 
Since dU is not normally found in DNA, these residues are repaired in one of three 
ways: DNA replication, base-excision repair, or mismatch repair. Repair by DNA 
replication simply involves interpretation of the uracil residue as deoxythymidine, 
resulting in a C-to-T mutation, or a G-to-A mutation in the opposite strand. In base 
excision repair (BER), uracil DNA glycosylase (UNG) excises the uracil residue to 
create an abasic site. The abasic site is converted to a single-strand DNA break by 
apurinic/apyrimidinic endonuclease 1 (APE1), which can then be filled in with any of the 
four bases by a translesional error-prone DNA polymerases such as REV1 or Pol µ 
(Peled et al., 2008b). In mismatch repair, the U:G mismatch is recognised by a different 
set of proteins, but also results in the mutation of residues surrounding the U:G 
mismatch. Either the Msh2-Msh3 or Msh2-Msh6 heterodimer recognizes the U:G 
mismatch, which then recruit (amongst others) MLH1 and PMS2 leading to a single-
strand nick near the mismatch. Exonuclease 1 excises a stretch of the surrounding 
DNA strand, and PCNA recruits error-prone polymerases to repair the gap, resulting in 
several new mutations surrounding the site of the original U:G mismatch (Peled et al., 
2008a). Intriguingly, mismatch repair and base excision repair are normally benevolent 
repair pathways, but in somatic hypermutation they are hijacked and made to introduce 
mutations in the V region. In both cases it is thought that mono-ubiquitinylated PCNA is 
responsible for recruiting the error-prone polymerases (Poltoratsky et al., 2000). 
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1.22 Class switch recombination 
Before stimulation by a complementary antigen, naïve B cells express either the IgM or 
IgD isotypes by alternative splicing of the D or M constant exons onto the variable gene 
exon. Changing to any of the other isotypes (IgG, IgA or IgE) is mediated by class 
switch recombination (CSR, also known as isotype switching). CSR is an 
intrachromosomal deletion recombination reaction that occurs between G-rich tandem-
repeated DNA sequences called switch (S) regions that are located upstream of all 
heavy chain constant CH regions except IgD (Fig. 1.9). Each naïve B cell has the 
potential to switch to any isotype, although the switch is directed by various cytokines 
that activate non-coding transcription through specific switch regions (Stavnezer, 
1996). 
 
The initial steps of CSR are similar to SHM. However, instead of generating a mutation, 
a double-stranded DNA break is made, which is subsequently repaired by the NHEJ 
pathway. First, non-coding transcription through the CH locus creates localised regions 
of ssDNA at S regions, and AID introduces several dU residues in the S regions on 
both strands of DNA. UNG recognises the U:G mismatch and removes the deoxyuracil 
to create an apyrimidinic ribose residue, which is excised by APE1 or APE2, thus 
forming a single-stranded nick. These single-stranded breaks can spontaneously form 
a DSB if two are created close to each other on opposite strands. If not, it is possible 
that proteins from the MMR pathway can convert single-strand breaks that are not near 
each other into DSBs. The NHEJ pathway then joins DSBs at donor and acceptor 
switch regions via the same mechanism as in V(D)J recombination, and the intervening 
DNA is excised (Stavnezer et al., 2008). 
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Figure 1.9 – Class switch recombination. AID creates double strand breaks at switch regions (black 
ovals labelled “s”). Recombination occurs between the two double strand breaks, bringing the alternative 
constant region adjacent to the rearranged variable region. A complete heavy chain transcript is made by 
mRNA splicing.  
 
1.23 Terminal differentiation to plasma cells 
Terminal differentiation of B cells into antibody-secreting plasma cells is regulated by 
BLIMP1 (B lymphocyte induced maturation protein 1), a zinc-finger transcription factor, 
considered to be the primary trigger for plasma cell differentiation. BLIMP1 
orchestrates this transition by repression of Pax5, which has two major effects. The first 
is the repression of the germinal centre programme (i.e. the network of transcriptional 
regulation that drives the proliferation of B cells as well as SHM and CSR) by removing 
the positive regulation of Aicda and Bcl6 by Pax5 (Shaffer et al., 2002; Sciammas and 
Davis, 2004), and the second is the derepression of Xbp1. Xbp1 expression results in a 
dramatic expansion of the endoplasmic reticulum and activation of genes involved in 
the protein secretion pathway, thus allowing the production and secretion of large 
amounts of antibody (Shaffer et al., 2004). In addition, BLIMP1 regulates the differential 
3’ end processing of the immunoglobulin heavy chain pre-mRNA, leading to increased 
levels of antibody secretion (Shapiro-Shelef et al., 2003; Sciammas and Davis, 2004). 
Together, these processes produce plasma cells that are highly efficient, 
immunoglobulin-secreting machines. 
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In addition to its role in regulating recombination (Section 1.19), IRF4 plays a central 
role in coordinating exit from the GC programme. Whilst downregulated throughout the 
GC reaction, IRF4 is upregulated during exit from the germinal centres, and 
coordinates plasma cell development by terminating the GC programme (De Silva et 
al., 2012). This is achieved by derepression of BLIMP1 expression and downregulation 
of Bcl6 expression, which is the master regulator of the GC programme (De Silva et al., 
2012). The central role of IRF4 in regulating plasma cell development is exemplified by 
the fact that deregulation of IRF4 alone can trigger multiple myeloma in plasma cells 
(Shaffer et al., 2008). 
 
E) Mistakes in antigen receptor production cause leukaemia and lymphoma 
 
Normal lymphocyte development involves the programmed formation of multiple 
genomic DSBs and mutations, through the mechanism of V(D)J recombination, and in 
the case of B cells, somatic hypermutation and class switch recombination. Whilst 
these processes are fundamental to the generation of a diverse immune system, the 
formation of DSBs presents a major threat to the genomic integrity of developing 
lymphocytes. Indeed, chromosome translocations arising from aberrant recombination 
are a hallmark of lymphoid malignancies, although these aberrations alone are 
generally not enough to fully trigger carcinogenesis (Kuppers, 2005). For instance, the 
BCL2-IgH translocation can be found in circulating pre-leukaemic blood cells of healthy 
individuals (Limpens et al., 1991; Janz et al., 2003). However, they are a defining 
feature of many lymphoid malignancies, and are thought to be the critical initiating 
event (Kuppers, 2005). Full progression of these malignancies requires additional 
genetic mutations that further deregulate the transcriptional programmes that direct B 
and T cell development. The following section discusses the sources of aberrant 
lymphocyte development and how they trigger malignancy, with a focus on B cells. 
 
1.24 Chromosome translocations  
There are three general mechanisms by which the recurrent translocations found in 
lymhoid tumours are thought to promote malignancy (Nussenzweig and Nussenzweig, 
2010). The first involves upregulation of a proto-oncogene or down-regulation of a 
tumour suppressor gene by the juxtaposition of one of these genes with a strong 
regulator element from one of the immunoglobulin loci (Adams et al., 1985; Vanasse et 
al., 1999). For example, the t(14;18) translocation, found in nearly all follicular 
lymphomas (Raghavan et al., 2001), brings a strong enhancer from the JH locus on 
chromosome 14 within range of the BCL2 promoter on chromosome 18. In a normal 
physiological setting, the role of BCL2 is to prevent caspase 9 and 3-mediated 
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apoptosis by inhibiting the release of mitochondrial cytochrome c (Kridel et al., 2012). 
Therefore, upregulation of BCL2 expression by the JH enhancer promotes survival of 
these cells by reducing their capacity to undergo apoptosis. Another classic example is 
the c-myc/IgH translocation, which is found nearly all cases of Burkitt’s lymphoma 
(Section 1.26; Robbiani and Nussenzweig, 2013). 
 
The second mechanism by which translocations can promote B cell leukaemogenesis 
is via formation of a fusion protein. A classic example is the t(9;22)(q34;q11) 
Philadelphia chromosome, which encodes the BCR-ABL kinase, and whilst being a 
hallmark of chronic myeloid leukaemia, it is also found in 20-40% of adults with B cell 
acute lymphoblastic leukaemia (ALL). The BCR-ABL kinase is a constitutively-active 
kinase that promotes transformation by aberrantly enhancing the RAS-MAPK, JAK-
STAT, and PI3K-AKT pathways (Teitell and Pandolfi, 2009). The final mechanism 
involves the deregulation of microRNA expression. This is a relatively recent discovery 
that is less well characterised than the first two mechanisms, but includes the 
microRNA families miR-15 and miR-16 which act as tumour suppressors by down-
regulating BCL2 (Calin et al., 2004; Calin and Croce, 2007).  
 
The first step in a chromosomal translocation typically involves the formation of two 
DSBs. The majority of B cell translocations that deregulate a proto-oncogene involve a 
break at an immunoglobulin locus, caused by V(D)J recombinase or AID activity. There 
are several possible sources of the second break, including the mis-targeting of RAG 
activity through the recognition of cryptic RSSs (cRSSs; Papaemmanuil et al., 2014) 
and non-standard DNA structures, mis-targeted AID activity, or another process such 
as collapse of a replication fork or exposure to ionising radiation (Tsai and Lieber, 
2010).  
 
Translocations that create a fusion protein, such as BCR-ABL and t(12;21) ETV6-
RUNX1 (previously known as TEL-AML1) do not involve antigen receptor loci, 
therefore they are not the result of aberrant RAG activity. The sources of these breaks 
are less well-defined and potentially more diverse, with similar mechanisms operating 
widely in non-lymphoid cancers. There is some evidence that the cause of 
translocations involving the Bcr and Abl1 breakpoint cluster regions involves Alu 
elements (Elliott et al., 2005), which are short repetitive retrotransposon sequences 
characterised by cleavage by the AluI (Athrobacter luteus) restriction endonuclease 
(Kramerov and Vassetzky, 2005). Other possible causes of translocations that do not 
display evidence of RAG activity include palindromic-mediated genomic instability 
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(Kurahashi et al., 2006), and an imbalance of metabolic pathways, based on 
epidemiological evidence in infant leukaemias (Rabkin and Janz, 2008). 
 
The ETV6-RUNX1 translocation is present in 25% of children with ALL, making it the 
most common genetic lesion in childhood ALL (Shurtleff et al., 1995). Expression of 
this fusion protein is thought to promote transformation by overexpression of the 
erythropoietin receptor and downstream activation of the JAK-STAT signalling pathway 
(Torrano et al., 2011). Furthermore, B cell development is stalled at a stage where the 
RAG proteins are constitutively expressed, leading to an accumulation of translocations 
that can eventually trigger malignant transformation (Papaemmanuil et al., 2014). 
 
1.25 Mistargeted AID activity 
Many human lymphomas involve mature B cells, which have already undergone V(D)J 
recombination and therefore no longer express RAG proteins. Nevertheless, these 
cancers are usually associated with translocations involving immunoglobulin genes, 
such as the Bcl2/IgH translocation in follicular lymphoma and the c-myc/IgH 
translocation in sporadic Burkitt’s lymphoma (Kuppers, 2005). In contrast, mature T cell 
lymphomas are very rare, probably because these cells do not undergo further genetic 
alteration or double-strand break generation. Analysis of the translocations in mature B 
cells indicates that most of the immunoglobulin locus breakpoints are in the V 
(indicating SHM error) or switch (indicating CSR error) regions. Thus, it appears that 
AID activity plays a central role in many of these translocations (Robbiani and 
Nussenzweig, 2013). 
 
Two mouse plasmacytoma models have been used to test the possibility that 
translocations involving switch regions are the result of mis-targeted AID activity. 
Plasmacytomas with c-myc-IgH translocations can be induced by injection of mineral 
oil or by overexpression of interleukin-6 (Potter and Wiener, 1992; Kovalchuk et al., 
2002), and most of the translocations are between the 5’ UTR of the c-myc gene and 
switch regions at the IgH locus. AID-deficient mice do not acquire c-myc-IgH 
translocations, suggesting that AID is essential to initiate the process (Unniraman et al., 
2004; Ramiro et al., 2006). Uracil DNA glycosylase (UNG) is also necessary to create 
the DSB for these translocations (Ramiro et al., 2006), and since UNG creates DSBs in 
the initial steps of CSR, it appears that the source of the c-myc/IgH translocation is 
aberrant CSR and not SHM. 
 
The cause of the c-myc locus break remained elusive for some time with the favoured 
hypothesis being that AID activity was responsible for this break as well, based on the 
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observations that cleavage at both loci occurs at the same stage of B cell development 
and that transcription through the c-myc locus generates G-loops that can be bound by 
AID (Duquette et al., 2005). This prediction was borne out by experiments by Robbiani 
et al. (2008), who showed that when an artificial DSB is made at the IgH locus, the c-
myc/IgH translocation is detected only in AID-proficient cells, thus demonstrating the 
necessity of AID in creating the break at c-myc (Robbiani et al., 2008).  
 
In addition to initiating translocations, AID can introduce mutations at a number of non-
immunoglobulin loci in a hypermutation-like manner, including the proto-oncogenes 
BCL6, PIM1, myc, RhoH/TTF (ARHH) and Pax5 (Pasqualucci et al., 1998; Pasqualucci 
et al., 2001). Mutations in these four oncogenes can be found in 50% of diffuse large B 
cell lymphomas, but not in normal germinal centre B cells, indicating that mistargeted 
AID activity can promote malignancy development not only by translocation-mediated 
mechanisms, but also by a hypermutation-mediated mechanism (Pasqualucci et al., 
2001). 
 
1.26 Mistargeted RAG activity 
 
i) Substrate selection errors 
The first indication that V(D)J recombination might be involved in chromosome 
translocations arose through analysis of translocation breakpoints in B and T cell 
malignancies, which revealed that many of them contain cryptic RSSs, which are 
sequences that bear homology to true RSSs (Dalla-Favera et al., 1982; Kirsch et al., 
1982). This led to the idea that the majority of translocations in developing lymphocytes 
take place because the RAG complex mistakenly identifies these cryptic RSSs as 
suitable recombination partners, but otherwise carries out normal V(D)J recombination 
(Fig. 1.10). There are predicted to be over 10 million cryptic RSSs scattered throughout 
the human genome (roughly one every 1-2 kb), thus creating huge scope for 
translocations by this process (Lewis et al., 1997).  
 
However, accumulating evidence suggests that errors in substrate selection are not the 
major cause of translocations in developing lymphocytes (Brandt and Roth, 2009). 
Firstly, in vivo recombination experiments using extra-chromosomal plasmid substrates 
indicated that whilst some cryptic RSSs are utilised by the RAG proteins very 
efficiently, such as the LMO2, TAL1 and TAL2 cryptic RSSs, others are used very 
inefficiently, if at all, including those found at common translocation breakpoints such 
as the BCL1 and BCL2 loci (Raghavan et al., 2001; Marculescu et al., 2002). Secondly, 
many translocation breakpoints do not occur at the candidate cryptic RSS heptamer 
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boundary of the candidate cryptic RSS, which is inconsistent with RAG cleavage 
activity. Finally, some of the breakpoints contain short direct repeats, indicating that 
cleavage produced a single-stranded overhang, which again is inconsistent with RAG 
activity (Bakhshi et al., 1987; Kuppers and Dalla-Favera, 2001).  
 
 
 
Figure 1.10 – Substrate selection error. RAG proteins carry out normal recombination but mistakenly 
recognise a cryptic RSS or non-standard DNA structure. If the cryptic RSS is adjacent to an oncogene, 
enhancers from the antigen receptor locus can upregulate the expression of the oncogene and contribute 
to leukaemogenesis. End donation occurs in the same way, except that the non-antigen receptor break is 
formed by an unrelated process, such as ionising radiation or a collapsed replication fork. Yellow circle = 
RAG proteins, spotted triangle = cryptic RSS, E = immunoglobulin locus enhancer, V = variable gene 
segment. 
 
ii) Structure-specific RAG binding 
If the BCL2 major breakpoint region (Mbr) does not contain a suitable cryptic RSS, then 
why is the t(14;18) translocation so prevalent? One possible explanation lies in the 
ability of the RAG proteins to bind and cleave non-B form DNA. Analysis of the Mbr 
revealed that it reacts with bisulphite, a chemical probe for ssDNA, suggesting that the 
Mbr forms a stable region of single-stranded, non-B form DNA, which is consistent with 
the preference of the RAG central domain to bind single-stranded DNA. Furthermore, 
the BCL2 Mbr is efficiently bound and cleaved by the RAG complex in transfected cell 
lines, and importantly, the BCL2-IgH translocation can be recapitulated in transfected 
lymphoid cells (Raghavan et al., 2004a; Raghavan et al., 2004b; Raghavan et al., 
2005; Nambiar and Raghavan, 2012), Intriguingly, this occurs independently of a 
discernible nonamer sequence. 
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iii) End Donation 
In some translocations, the non-immunoglobulin partner does not bear the hallmarks of 
either RAG or AID activity, and is thought to arise via another unrelated process, such 
as the collapse of a replication fork, or a random DNA break caused by ionising 
radiation or oxidative free radicals (Tycko and Sklar, 1990; Lewis, 1994; Kuppers and 
Dalla-Favera, 2001). In this “end donation” model of chromosome translocation, a 
break from one of the Ig loci is aberrantly joined with a break formed by one of these 
different processes (Fig. 1.10). End donation-style translocations are estimated to be 
responsible for 30-40% of the translocations found in follicular and mantle cell 
lymphomas (Jager et al., 2000; Welzel et al., 2001). However, it is unclear how RAG-
mediated breaks become available for translocation, as they should be held together in 
a post-cleavage complex until they are resolved by the NHEJ pathway. One possibility 
put forward in a recent study is that certain non-consensus heptamer sequences 
destabilise the RAG postcleavage complex (Arnal et al., 2010), thus making the ends 
available for repair by the error-prone alternative NHEJ pathway. 
  
1.27 RAG-mediated protection against translocations 
Despite the fact that many translocations can arise from aberrant RAG activity, it is 
becoming clear that many aspects of RAG proteins, especially the non-core RAG2 C-
terminus, actively protect against these deleterious reactions.  
 
The cell has two general mechanisms by which DSBs can be repaired: homologous 
recombination and the classical NHEJ (cNHEJ) pathway. More recently, an error-prone 
form of the NHEJ pathway has been discovered, called alternative NHEJ (aNHEJ; 
Deriano and Roth, 2013). As described above, RAG cleavage products are repaired via 
the cNHEJ pathway (Section 1.5). Moreover, use of the homologous recombination 
and aNHEJ pathways is completely blocked by wild-type RAG proteins, indicating that 
the RAG proteins themselves guide the cleavage products to the classical NHEJ 
pathway (Lee et al., 2004). Why is it important that the broken ends are shepherded 
away from the aNHEJ machinery? With the exception of nontemplated nucleotide 
addition by TdT in lymphocytes, repair of DSBs in general by the cNHEJ pathway is 
highly accurate and efficient (Lieber, 2010). Whilst relatively little is known about the 
aNHEJ pathway at the molecular, it is clear that it is more error-prone than classical 
NHEJ, leading to large deletions and short repetitive stretches (Deriano and Roth, 
2013). More importantly, the aNHEJ machinery has a propensity to catalyse 
chromosome translocations (Brandt and Roth, 2009). Therefore, it is crucial that repair 
of RAG-mediated DSBs occurs via the cNHEJ pathway. 
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What are the factors that guide the broken ends to the cNHEJ pathway, and 
simultaneously prevent repair by homologous recombination and aNHEJ? Firstly, 
certain RAG1 mutants (K980A and R838A/K839A/R840A) enable repair of coding and 
signal ends by homologous recombination and alternative NHEJ, (Huye et al., 2002; 
Lee et al., 2004). Secondly, a frameshift mutation in the C-terminus of RAG2 (RAG2-
361fs) allows proteins from the homologous recombination and alternative NHEJ 
pathways to access the coding and signal ends (Corneo et al., 2007). Unlike wild-type 
RAG proteins, the RAG2-361fs mutant enables efficient repair of coding and signal 
ends in cells deficient for classical NHEJ. However, these joints contained short 
sequence homologies and large deletions, indicative of repair by the alternative NHEJ 
pathway (Corneo et al., 2007). Therefore, the alternative NHEJ pathway is capable of 
robustly repairing RAG cleavage products, but this is prevented by the wild-type RAG 
proteins. Remarkably, fusing RAG2 to an unrelated endonuclease (I-Sce1) prevents 
repair of I-Sce1 breaks by any other repair pathway than classical NHEJ. This effect is 
only seen with a pair of breaks containing four ends (as in V(D)J recombination), but 
not a single break (Cui and Meek, 2007).  
 
Mice expressing core RAG2 display a highly increased rate of lymphoma formation on 
a p53-deficient background, caused by translocations at the Tcra/Tcrd and IgH loci 
(Deriano et al., 2011). The authors also show that the post-cleavage complex is less 
stable with core RAG2, suggesting that core RAG2 destabilises the postcleavage 
complex, allowing for repair by the translocation-prone alternative NHEJ pathway, 
consistent with the study discussed above (Corneo et al., 2007). The translocations 
seen in core RAG2/p35-/- are very similar to those seen in mice deficient in ATM (ataxia 
telangiectasia mutated). Since ATM is known to be important in the stability of RAG 
postcleavage complexes in vivo (Bredemeyer et al., 2006), it is possible that a 
destabilised postcleavage complex is responsible for the translocations seen in both 
core RAG2/p53-/- and ATM-/- mice. More recently, the region of the RAG2 C-terminus 
responsible for directing broken ends away from the alternative NHEJ pathway has 
been narrowed down to the acidic hinge region (Fig. 1.7; Chaumeil et al., 2013). 
Mutations in the acidic hinge which neutralised its negative charge reduced the stability 
of the postcleavage complex, promoted repair by alternative NHEJ, and also reduced 
the flexibility of the acidic hinge, implying that the acidic hinge region plays an 
important role in maintaining postcleavage complex stability (Chaumeil et al., 2013). 
Overall then, it is clear that the RAG proteins themselves play a key role in 
shepherding cleavage products towards the classical NHEJ pathway. However, the 
exact mechanism of this transfer remains unknown.  
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The RAG2 C-terminus contains a conserved threonine residue T490 (Fig. 1.7) that 
plays a key role in the cell cycle-dependent degradation of RAG2 (Li et al., 1996; Jiang 
et al., 2005). Cyclin-dependent kinase cyclin A/Cdk2 phosphorylates the T490 residue 
at G0/S phase transition, which leads to ubiquitination of RAG2 by Skp2-SCF and 
degradation via the ubiquitin-proteasomal pathway (Jiang et al., 2005). Thus, RAG2 
expression is tightly limited to the G0/G1 phases of the cell cycle. The degradation of 
RAG2 on entry into the S phase ensures that RAG-mediated DSBs are not generated 
during DNA synthesis, and also limits recombination to a phase where the expression 
of the NHEJ proteins is highest, thus preventing repair by alternative pathways. 
Consistent with this, enforced expression of RAG2 throughout the cell cycle leads to 
the accumulation of aberrant recombination products (Jiang et al., 2004). Since 
removal of the RAG2 C-terminus would also disrupt cell cycle regulation of RAG2, this 
could partly explain the accelerated rate of lymphoma in core RAG2 mice in the cRAG2 
mice described above (Deriano et al., 2011). Consistent with this, mice expressing the 
RAG2 T490A mutant develop lymphomas with a similar genotype to the core RAG2 
mice (Zhang et al., 2011). However, RAG2 T490A/p53-/- mice do not die more rapidly 
than p53-/- mice, indicating that the cell cycle-dependent regulation of RAG2 expression 
cannot fully account for the phenotype of core RAG2/p53-/- mice (Deriano et al., 2011; 
Zhang et al., 2011).  
 
In addition to stabilising of the postcleavage complex and limiting the expression of 
RAG2, a recent study showed that the RAG2 C-terminus actively discriminates 
between optimal and suboptimal cryptic RSSs by increasing the rate of RAG 
dissociation, so that dissociation occurs before nicking can take place (Shimazaki et 
al., 2012). Furthermore, the H3K4me3 binding activity of the RAG2 PHD finger might 
prevent selection of potentially efficient cryptic RSS sites, substrates that do contain 
sites of H3K4me3 modification. Therefore, the RAG proteins themselves safeguard 
genome stability through a combination of stabilising the postcleavage complex (thus 
protecting the broken ends from translocation-prone repair pathways), restricting the 
expression of RAG2 expression to the G1 phase of the cell cycle, and reducing the 
efficiency of cryptic RSS cleavage.  
 
1.28 Reintegration of V(D)J recombination by-products 
In addition to gross chromosome translocations, RAG proteins can also mediate the 
reinsertion of the recombination by-product, the excised signal circle (ESC), via two 
possible reactions, namely transposition and reintegration.  
 
 In t roduct ion  | 40 
 
 
In transposition, the reactive 3’ hydroxyl group from a signal end attacks the 
phosphodiester backbone at any location, leading to random insertion of the ESC in a 
joining reaction that is independent of NHEJ factors (Fig. 1.11A). Many studies have 
highlighted the similarity between V(D)J recombination and viral transposition. Indeed, 
the RAG complex catalyses transposition in vitro with a high efficiency (Agrawal et al., 
1998; Hiom et al., 1998). However, there have been surprisingly few cases reported in 
vivo. One study in a human T cell line found an excised signal end fragment from the T 
cell receptor locus which had integrated into an intron of the HPRT gene (Messier et 
al., 2006), but importantly, there have been no known cases of leukaemia or lymphoma 
where RAG-mediated transposition has been identified as a causal factor. A likely 
explanation for this is that the RAG2 C-terminus almost entirely inhibits the 
transposition reaction (Elkin et al., 2003), thus making transposition an unlikely route 
for reinsertion of ESC by-products. 
 
More recently, two studies have discovered a new way in which the ESC could be 
reinserted back into the genome, in a reaction termed reintegration (Curry et al., 2007; 
Vanura et al., 2007). Reintegration is distinct from transposition in that a transposition 
reaction shows no target specificity, whereas reintegration recombines ESCs with a 
genomic RSS through the same biochemistry as standard V(D)J recombination (Fig. 
1.11B). This could be an authentic RSS or one of the 10 million cryptic RSSs littered 
throughout the human genome. 
 
In the first study, a genome-wide assessment of signal end integrations in developing 
thymocytes (T cell precursors) found that half of the insertions out of a total of 43 
observations were caused by reintegration of an ESC (Curry et al., 2007). Furthermore, 
no obvious translocations or transpositions were detected. Importantly, the number of 
reintegration events was 7-fold higher in mice expressing core RAG2, indicating that 
the RAG2 C-terminus inhibits reintegration of ESCs, possibly via one of the 
mechanisms described above. In the second study, mouse fibroblast cells were 
transfected with extrachromosomal RSS and ESC substrates and RAG expression 
vectors, and it was found that the ESC could efficiently recombine with the RSS-
containing plasmid (Vanura et al., 2007). Furthermore, ESCs could efficiently 
reintegrate with the cryptic RSSs adjacent to the TAL2 and LMO2 oncogenes (Vanura 
et al., 2007). 
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Figure 1.11 – Transposition and reintegration. (A) In transposition, the 3’-OH group of a cleaved signal 
end attacks the phosphodiester backbone at a random genomic locus. (B) In reintegration, RAG proteins 
catalyse normal recombination, albeit between an excised signal circle and a genomic RSS. If this occurs 
at a cryptic RSS adjacent to an oncogene, promoters from the antigen receptor locus can upregulate 
oncogene expression. P = antigen receptor locus promoter. Spotted triangle = cryptic RSS.  
 
Gene profiling studies have shown that a substantial number of leukaemia and 
lymphoma cases display oncogene activation in the absence of any detectable 
cytogenetic abnormalities (Ferrando et al., 2002). The relatively small size of ESCs 
means that their reinsertion could go undetected using traditional cytogenetic methods. 
The occurrence of ESC reintegration in vivo is reinforced by a study which found an 
ESC that had reintegrated at the cryptic RSS in HPRT exon 1, a region that is 
commonly involved in V(D)J recombination errors (Messier et al., 2006). Together with 
estimates that reintegration of ESCs could represent 0.01-1% of V(D)J-mediated 
recombination reactions, with around 5000 reintegration events per human per day 
(Vanura et al., 2007), these studies indicate that reintegration of ESCs is a significant 
threat to genomic stability.  
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F) Aims 
 
The newly discovered reintegration reaction is a potentially significant cause of 
lymphoid cancers, and initial evidence suggests that the RAG2 C-terminus can inhibit 
reintegration by 7-fold (Curry et al., 2007). Whilst the mechanism of inhibition is 
unclear, it is also not sufficient to prevent reintegration entirely, as reintegration 
products are still detected with full-length RAG proteins (Curry et al., 2007). Complete 
prevention of this reaction is of paramount importance. If a mechanistic difference 
between recombination and reintegration exists, a small molecule inhibitor could be 
developed to exploit this difference, which could be used to bolster the natural inhibition 
of reintegration by RAG2 in people at risk, such as infants and the elderly. Therefore, 
the original questions I aimed to address in this project were: 
 
1. Do RAG-ESC interactions differ from RAG-RSS interactions? If so, how? 
2. Which part of the RAG2 C-terminus inhibits reintegration? 
3. By what mechanism does the RAG2 C-terminus inhibit reintegration? 
 
However, whilst optimising the in vitro RAG assays intended to answer these 
questions, I discovered that when an RSS is paired with an ESC, cleavage of the RSS 
is more efficient than cleavage of the ESC, a phenomenon I refer to as asymmetric 
cleavage. Since a low level of ESC cleavage was detected, this does not completely 
preclude reintegration. However, the asymmetric cleavage within an RSS-ESC 
complex indicates that the majority of ESC-RSS pairings do not result in the cleavage 
of the ESC, which is a prerequisite for reintegration. Instead, I put forward an 
alternative outcome, named cut-and-run. In cut-and-run, an ESC stimulates the 
cleavage of an RSS, but the ESC remains intact. The ESC could then repeat this 
process, potentially creating multiple double-strand breaks in the genome of a 
developing B or T cell. Therefore, the aims of the project became: 
 
1. To verify that cut-and-run occurs in vitro with core and full-length RAG proteins 
2. To investigate the molecular basis of asymmetric cleavage 
3. To assess whether asymmetric cleavage occurs in vivo and whether cut-and-
run is likely to occur in B and T cells. 
 
These aims are addressed in turn in the following results chapters. In the first results 
chapter, further optimisation of in vitro cleavage conditions was carried out to ensure 
that asymmetric cleavage of an RSS-ESC pair was not the result of unsuitable or 
unphysiological conditions. In the second results chapter, these in vitro analyses were 
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extended to determine the molecular basis of asymmetric cleavage. Finally, I tested 
whether cleavage of extrachromosomal substrates is asymmetric in vivo, and thus 
whether cut-and-run is likely to occur in B and T cells.  
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Chapter 2 
 
Materials and Methods 
 
(A) Solutions  
 
2.1 Common Buffers 
Unless stated otherwise, all reagents were from Sigma-Aldrich (Poole, UK), and all 
recipes are from Sambrook et al. (1989). 
 
Alkaline lysis buffer I 
50 mM Glucose 
25 mM Tris-HCl (pH 8.0) 
10 mM EDTA (pH 8.0) 
 
Alkaline lysis buffer II 
0.2 M NaOH 
1% (w/v) SDS 
 
Alkaline lysis buffer III 
3 M KOAc 
5 M Acetic acid 
 
DNA loading buffer (6x) 
15% (w/v) Ficoll 
10 mM  Tris (pH 8.0) 
1 mM EDTA (pH 8.0) 
0.01% (w/v) Bromophenol blue 
0.01% (w/v) Xylene cyanol   
 
Formamide loading buffer 
95% (v/v) Formamide 
1 mM EDTA (pH 8.0) 
0.01% (w/v) Bromophenol blue 
0.01% (w/v) Xylene cyanol   
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Lysogeny Broth (LB) 
1% (w/v) Tryptone 
0.5% (w/v) NaCl 
0.5% (w/v)  Yeast Extract 
 
LB-Agar  
1% (w/v) Tryptone 
0.5% (w/v)  NaCl 
0.5% (w/v)  Yeast Extract 
1.5% (w/v)  Agar 
 
Phosphate-buffered saline (PBS) 
137 mM NaCl 
2.7 mM KCl 
4.3 mM Na2HPO4 
1.47 mM KH2PO4 
Adjusted pH to 7.4 with HCl  
 
Protein loading buffer (2x) 
20% Glycerol 
100 mM Tris-HCl (pH 6.8) 
284 mM βMe 
2% SDS 
0.2% (w/v) Bromophenol Blue   
 
SDS-PAGE running buffer 
25 mM  Tris-HCl (pH 8.5) 
192 mM Glycine 
0.1% (w/v) SDS 
 
Sodium phosphate buffer (NaPi) pH 7.2 
68.4 ml 1 M Na2HPO4 
31.6 ml 1 M NaH2PO4 
Final adjustments to pH were made using NaH2PO4 (acid) and Na2HPO4 (base).   
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Super Optimal Broth (SOB) 
2% (w/v) Tryptone 
0.5% (w/v) Yeast extract 
10 mM  NaCl 
2.5 mM KCl 
10 mM  MgCl2 
  
TAE (Tris-acetate-EDTA) buffer 
40 mM  Tris-acetate 
1 mM EDTA (pH 8.0) 
 
TBE (Tris-borate-EDTA) buffer 
90 mM  Tris Base  
90 mM  Boric acid 
2 mM  EDTA (pH 8.0) 
 
TE (Tris-EDTA) buffer 
10 mM Tris-HCl (pH 8.0) 
1 mM EDTA (pH 8.0) 
 
TBS (Tris-buffered saline) buffer 
50 mM  Tris-HCl (pH 7.4) 
150 mM NaCl 
2 mM KCl 
 
2.2 Tissue culture media and solutions 
 
DMEM-complete 
500 ml  Dulbecco’s modified Eagle’s medium (DMEM) 
10% (v/v) Foetal calf serum (FCS) 
120 mM  L-glutamine 
2 ml Penicillin/streptomycin (pen/strep; 100 µg/ml final concentration for both, 
Sigma #P4333) 
DMEM-2 or DMEM-10 was made by adding FCS to 2% or 10%, respectively, and 
omitting pen/strep. 
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MEME-complete 
500 ml  Minimum essential medium Eagle’s (MEME) 
10% (v/v) FCS 
120 mM  L-glutamine 
2 ml  P/S  
MEME-2.5 or MEME-10 was made by adding FCS to 2.5% or 10%, respectively, and 
omitting pen/strep. 
 
Crystal Violet stain (0.1% w/v) 
2.3% (w/v) Crystal violet solution 
Diluted to 0.1% (w/v) with 20% ethanol before use 
 
Polyethyleneimine (PEI, 1 mg/ml) 
Linear PEI (25 kDa, Alfa Aesar #043896.01) was dissolved in water heated to ~80°C 
then cooled to room temperature. The pH was adjusted to 7.0 with HCl, and the 
solution was filter-sterilised and stored in aliquots at -80°C. Working aliquots were kept 
at 4°C for up to 1 month. 
 
(B) Manipulation of DNA 
 
2.3 DNA restriction digest 
All restriction enzymes were purchased from New England Biolabs (NEB), and reaction 
conditions were as specified in the manufacturer’s instructions. A typical restriction 
digest contained 10 units of restriction enzyme/µg DNA and was carried out for 1 h in 
the case of diagnostic digests, or 3-16 h when creating a fragment for cloning. Typical 
volumes were 10 µl for diagnostic digests and 200 µl for preparative digests. 
 
2.4 Electrophoresis of DNA 
Digested plasmid DNA was separated by agarose gel electrophoresis through an 
agarose gel cast in 1x TAE and 5 µg/ml ethidium bromide. 1/6 volume of 6x DNA 
loading buffer was added before loading. The concentration of agarose was dependent 
on the size of fragments being separated, in accordance with the recommendations in 
Sambrook et al. (1989). 
 
2.5 Routine PCR 
A typical PCR reaction contained 1x ThermoPol Reaction Buffer, 200 µM each dNTP, 
0.2 µM forward and reverse primers, 1 ng plasmid DNA template, and 2.5 units Taq 
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DNA polymerase (NEB #M0273) in a 50 µl reaction volume. Cycling conditions were as 
follows: 
 
95°C  2 min 
95°C  30 s 
Tm  30 s          x 30 
72°C  1 min/kb 
72°C  10 min 
 
Some primers contained nontemplated restriction sites at the 5’ end for cloning 
purposes. In these cases, thermal cycling conditions used 15 cycles at the Tm of the 
primer without the additional restriction site, followed by 25 cycles using the Tm of the 
whole primer. The annealing temperature (Tm) of oligonucleotides was calculated using 
the OligoCalc oligonucleotide properties calculator (Kibbe, 2007), available at: 
http://www.basic.northwestern.edu/biotools/OligoCalc.html 
 
2.6 Gel purification of DNA 
DNA was separated by agarose gel electrophoresis (Section 2.4) and visualised by 
ultraviolet light for a minimal amount of time to minimise nicking of DNA. Desired 
fragments were excised from the gel using a sterile scalpel blade and transferred to 
dialysis tubing (8 kDa molecular weight cut-off) with a minimal amount of 1 x TAE (~1 
ml). Fragments were electroeluted at 100 V for 1 h. Polarity of the current was reversed 
for ~20 s to recover DNA that had stuck to the interior surface of the dialysis tubing. 
DNA-containing TAE buffer was transferred to 1.5 ml tubes, and the DNA was purified 
by phenol-chloroform extraction/ethanol precipitation (Section 2.7) and resuspended in 
TE. 
 
2.7 Phenol-chloroform extraction and ethanol precipitation of DNA 
An equal volume of phenol-chloroform (1:1) was added to DNA solutions and the 
mixture was vortexed vigorously for ~5 sec. The aqueous and organic phases were 
then separated by centrifugation at 16,000 x g for 1 minute at room temperature (RT). 
This process was generally repeated once more. If the downstream application of the 
DNA was particularly sensitive (e.g. ligation), residual phenol was removed with an 
equal volume of 100% chloroform followed by vortexing and centrifugation as above. 
The aqueous phase was then transferred to a new 1.5 ml centrifuge tube and DNA was 
precipitated by the adding 1/10th volume of 3 M sodium acetate (pH 5.2) and 2 volumes 
of 100% ethanol. If a particularly small amount of DNA was to be precipitated, 20 µg 
glycogen was added to aid in precipitation and visualisation of the DNA pellet. Samples 
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were mixed and incubated on dry ice for 10 min before centrifugation at 20,000 x g for 
10 min at 4°C. The DNA pellet was washed 1-2 times by adding 1 ml 70% ethanol and 
centrifuging at top speed for 5 min. Pellets were then air-dried for ~5 min, or until all 
visible traces of ethanol had evaporated, and resuspended in a suitable volume of 
either dH2O or TE (depending on the downstream application of the DNA). 
 
2.8 Quantification of DNA 
DNA concentration was calculated using a NanoDrop spectrophotometer, according to 
the Beer-Lambert law: 
 
A = ε x c x l 
 
Where A = absorbance at 260 nm, ε is the extinction coefficient (M-1 cm-1), and l is the 
pathlength of the spectrophotometer, which is usually 1 cm. 
  
2.9 DNA ligation 
Prior to ligation, digested vector was dephosphorylated using calf intestinal 
phosphatase (CIP) to minimise recircularisation. A typical reaction contained 1 x 
NEBuffer 4 and 1 unit of CIP (NEB #P0757), and was incubated at 37°C for 1 h, then 
purified by phenol-chloroform extraction. A typical ligation reaction contained 1 x T4 
DNA Ligase Buffer (50 mM Tris-HCl [pH 7.5], 10 mM MgCl2, 10 mM DTT, 1 mM ATP; 
NEB #B0202S), 1 unit of T4 DNA Ligase (NEB #M0202S), ~50 ng digested and 
dephosphorylated vector, and a 3-fold molar excess of digested insert in a 10 µl 
reaction volume. Ligation of overhanging “sticky” ends was either done for 20 min at 
room temperature (RT) or at 16°C for 16 h. Ligation of blunt DNA ends was done at RT 
for 2 h or 16°C for 16 h. A vector-only control ligation was carried out alongside each 
ligation reaction so that the vector background could be estimated following 
transformation of E. coli. Ligation reactions were stopped by heat inactivation at 65°C 
for 10 min before transformation of E. coli (Section 2.10).  
 
2.10 Transformation of E. coli  
A 50 µl aliquot of chemically competent DH5α cells was thawed on ice. Immediately 
after the aliquot had fully thawed, DNA was added and the sample was mixed gently 
and incubated on ice for 30 min. When transforming E. coli with plasmid DNA from a 
purified stock, 2 ng of DNA was added to cells, and when transforming ligation 
reactions (Section 2.9) half of the reaction (5 µl) was added. Cells were transformed by 
heat shock in a 42°C water bath for 90 sec, followed by a 2 min recovery on ice. 300 µl 
 Mater ia ls  and Methods  | 50 
 
 
SOB, pre-warmed to RT, was added and the cells were incubated at 37°C for 45-60 
min (generally 60 min for ligations, 45 min for stock plasmids). Cells were then plated 
on LB-agar plates containing the appropriate selective antibiotic. For transformation of 
a purified plasmid stock, 10 µl was plated, and for ligation reactions, 150 µl was spread 
onto each of two plates. These plates were then incubated at 37°C for 16 h.  
 
2.11 Small scale preparation of plasmid DNA (miniprep) 
Small scale preparation of plasmid DNA was carried out according to Sambrook et al. 
(1989). A single colony of E. coli was picked from an LB-agar plate with a sterile pipette 
tip and used to inoculate 2 ml of LB with appropriate antibiotic (working concentrations 
taken from Sambrook et al., 1989). Cultures were incubated for 16 h at 37°C with 
shaking (250 rpm). 1.5 ml of the culture was transferred to a 1.5 ml centrifuge tube, and 
the remaining 0.5 ml was stored at 4°C to inoculate cultures for subsequent large scale 
plasmid preparation. Cultures were spun at 16,000 x g for 30 sec to pellet the bacteria, 
and the supernatant was discarded. Pellets were thoroughly resupended in 100 µl 
alkaline lysis buffer I by vortexing. 200 µl alkaline lysis buffer II was added, mixed 
gently by inverting several times, and incubated on ice for 5 min. 150 µl alkaline lysis 
buffer III was added and mixed vigorously by vortexing, then tubes were incubated on 
ice for 5 min. Cellular debris was removed by centrifugation at 16,000 x g for 2 min, 
and the plasmid-containing supernatant was transferred to a new 1.5 ml tube. Samples 
were cleaned by phenol-chloroform extraction/ethanol precipitation (Section 2.7) 
without sodium acetate. Pellets were washed once with 1 ml 70% ethanol, air-dried 
briefly and resuspended in 50 µl TE. Typically, purified samples were tested by 
diagnostic restriction digest (Section 2.3) to check for successful ligation of a DNA 
fragment or to confirm the identity of a plasmid. RNase A (10 ng/µl) was also added to 
simultaneously degrade RNA during the restriction digest. 
 
2.12 Large scale preparation of supercoiled plasmid DNA (maxiprep) 
10 ml LB containing the appropriate selective antibiotic was inoculated with the 0.5 ml 
of culture left over from small-scale plasmid preparation (Section 2.11) or with a single 
colony from a streaked out glycerol stock (Section 2.13). The 10 ml culture was 
incubated at 37°C with shaking (250 rpm) for ~8 h, then used to inoculate 500 ml LB 
plus antibiotic, which was then incubated for 16 h at 37°C with shaking (250 rpm). Cells 
were harvested by centrifugation at 4,000 x g for 20 min (4°C). Plasmid DNA was then 
purified using a Qiagen Plasmid Maxi Kit (Qiagen #12162) according to the 
manufacturer’s instructions. Purified DNA was resuspended in 0.5 ml TE and the 
concentration was measured using a NanoDrop spectrophotometer.  
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2.13 Preparation of glycerol stocks for long-term storage of plasmid DNA 
For long-term storage of plasmids, glycerol stocks were made by transferring 625 µl of 
cells cultured for 16 h for large scale plasmid purification (Section 2.12), to a sterile 1.5 
ml screw-cap tube, adding 375 µl sterile 40% glycerol and snap-freezing on dry ice. 
Glycerol stocks were stored at -80°C.  
 
(B) Purification of core RAG proteins using the baculovirus/Sf9 expression 
system 
 
2.14 Maintenance of suspension Sf9 cells 
Suspension Sf9 cells were cultured in Sf-900 II serum-free medium (SFM; Life 
Technologies #10902-096) at 28°C with moderate shaking (140 rpm). Cells were grown 
to a density of 1.5-2.0 x 106 cells/ml, at which point they were diluted to 0.5 x 106 
cells/ml. Proliferation from 0.5 to 2.0 x 106 cells/ml usually took ~ 48 h. 
 
2.15 Calculation of baculovirus titer by plaque assay 
The titer of baculovirus stocks was calculated according to the protocol in the Bac-to-
Bac® Baculovirus Expression System manual (Life Technologies Publication Number 
MAN0000414). Before beginning, plaquing medium was prepared by melting 4% low-
melting point agarose (Life Technologies #18300-012) in a 70°C water bath for 30 min; 
this was then combined with 1.3 x Sf-900 Medium (Life Technologies #10967-032) at a 
1:3 ratio (i.e. 30 ml medium and 10 ml melted 4% agarose per plaque assay). The 
prepared plaquing medium was kept in a 40°C water bath until use to prevent the 
agarose from setting.   
 
2 ml of Sf9 cells at 0.5 x 106 cells/ml was added to each well of two 6-well plates and 
incubated at 28°C for 1 h to allow cells to attach. In the meantime, a dilution range of 
eight 10-fold serial dilutions of baculovirus carrying RAG1 or RAG2 cDNA was made by 
adding 0.5 ml of virus stock (or the previous dilution) to 4.5 ml of Sf-900 II SFM. Once 
cells were attached, the medium was removed and immediately replaced with 1 ml of 
virus dilution. The dilutions 10-4 to 10-8 were used in duplicate, and a no virus negative 
control in duplicate (i.e. 1 ml of SFM), for a total of 12 wells. Cells were incubated at 
28°C for 1 h to allow for infection. The virus dilutions were then removed and replaced 
with 2 ml of plaquing medium, which was left to set at RT for 1 h. The plates were then 
transferred to a humid box (a sterilised Tupperware box with tissues soaked in sterile 
dH2O in the bottom to prevent desiccation of the agarose overlay) and incubated at 
28°C for 7-10 days until viral plaques were visible to the naked eye. At this point, to 
improve visualisation of the plaques, 0.5 ml of neutral red solution (1 mg/ml) prepared 
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in dH2O was added to each well and incubated for 1-2 h at RT. Excess stain was then 
removed with a pipette and the viral plaques were counted.  
 
The viral titer (plaque forming units (pfu)/ml) was calculated according to the formula: 
 
Titer (pfu/ml) = number of plaques x dilution factor x 
 
                
 
 
2.16 Plaque purification of recombinant baculoviruses 
Serial passage of baculovirus stocks leads to an accumulation of defective interfering 
particles (DIPs; Pijlman et al., 2001; Pijlman et al., 2003). These viral particles often 
lack some or all of the foreign gene of interest or other genes involved in very late gene 
expression and compete with growth of the desired recombinant virus, thus drastically 
reducing recombinant protein yield. Therefore, core RAG1 and core RAG2 
baculoviruses (AcD26 and AcD25, respectively; McBlane et al., 1995) were plaque-
purified twice to ensure that stocks were clonally pure and free from DIPs, following the 
protocol outlined in the Bac-to-Bac® Baculovirus Expression System manual 
(Publication Number MAN0000414).  
 
The first part of the protocol is identical to a plaque assay (Section 2.15). This is 
followed by an intermediate amplification of individual plaques, then a second round of 
plaque purification. Once viral plaques were visible to the naked eye, two well-isolated 
plaques of each baculovirus were picked using a sterile pipette tip and transferred to 
0.5 ml SFM in a 1.5 ml tube, and mixed well by vortexing. 2 ml of 0.5x106/ml Sf9 cells 
was seeded in each well of two 6-well plates and incubated at 28°C for 1 h. Sf9 cells 
were then infected with 100 µl of each plaque isolate in duplicate, alongside a mock-
infection of 100 µl SFM. Infected cells were incubated in a humid box at 28°C for 72 h, 
until cells showed signs of infection. Next, a second plaque assay was set up, as 
described in Section 2.15. Individual plaques were picked with a sterile pipette tip, 
transferred to 0.5 ml SFM, vortexed, and stored at 4°C until amplification. 
 
This new plaque isolate (0.5 ml) was now double-plaque-purified, and required 
amplification. Ideally, baculovirus should be amplified by infecting Sf9 cells at a 
multiplicity of infection (MOI; the ratio of pfu:cells) ranging from 0.05-0.1. However, 
infecting at the ideal MOI was not possible since the viral titer of the plaque isolates 
was not known, and there was not enough stock for a plaque assay. Instead, the 0.5 ml 
of double-purified baculovirus plaque was split between 5 wells of a 6-well plate 
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seeded with 1 x 106 Sf9 cells/well and incubated for 4 days in a humid box at 28°C. 
This is the P1 stock. 
 
Assuming a P1 titer of 1x106 cells/ml (as suggested in the Bac-to-Bac manual), the P1 
stock was used to infect 50 ml of Sf9 cells (2 x 106 cells/ml), using an MOI of 0.1. 
Infections were incubated at 28°C with moderate shaking (140 rpm). After 48 h, cells 
were removed by centrifugation at 1000 x g for 5 min, and the baculovirus-containing 
supernatant was transferred to fresh 50 ml tubes. These P2 baculoviral stocks were 
stored at 4°C, protected from light. Tissue culture-grade FCS was added to 2% to 
minimise loss of infectivity from degradation by residual proteases. The viral titer of the 
P2 stocks was estimated by plaque assay (Section 2.15) to be 1.2 x 108 pfu/ml for the 
RAG 1 baculovirus, and 1x108 pfu/ml for RAG2. Several 1 ml aliquots of the P2 viral 
stocks were snap-frozen on dry ice and stored at -80°C for long-term storage.  
 
Since the P2 amplification only yielded 50 ml, large volume high-titer P3 stocks were 
made by infecting large Sf9 cultures (>250 ml) at an MOI of 0.1. Infected cells were 
incubated at 28°C for 48 h with moderate shaking (140 rpm), and baculovirus was 
harvested and stored as above. If subsequent amplifications of baculovirus were 
required, these were done using the 1 ml aliquots of P2 stored at -80°C, and not by 
serial passage of the P3 stocks.  
 
2.17 Expression and purification of core RAG proteins from Sf9 cells  
Suspension Sf9 cells were grown to a density of 1.5 x 106 cells/ml and co-infected with 
recombinant baculoviruses that express His- and MBP-tagged core RAG1 and core 
RAG2 (AcD26 and AcD25, respectively; McBlane et al., 1995) at an MOI of 3 for both 
viruses. Infected cells were incubated at 28°C with shaking (140 rpm) for 60-72 h. Cells 
were then harvested by centrifugation at 1000 x g for 20 min, washed twice with ice-
cold PBS, snap-frozen in a dry ice/ethanol bath and stored at -80°C until purification. 
 
All subsequent steps were carried out at 4°C unless stated otherwise. Infected cell 
pellets were thawed on ice and resuspended in 20 ml of lysis buffer (20 mM Tris-HCl 
[pH 7.9], 0.5 M NaCl, 5 mM imidazole, 2 mM β-mercaptoethanol (βME), 1 mM 
benzamidine, 1 mM phenylmethylsulphonyl fluoride (PMSF), 2X Complete Protease 
Inhibitor Cocktail (Roche #11697498001). Cells were mechanically lysed by ten strokes 
in a glass Dounce homogeniser with a tight-fitting pestle and then subjected to 3 cycles 
of sonication at 10 microns for 30 sec using an MSE Soniprep 150, followed by cooling 
on ice for 30 sec. The lysate was then cleared by centrifugation at 10,000 x g for 30 
min, and loaded onto a 1 ml Ni-NTA column (Qiagen Superflow #1018611) equilibrated 
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with buffer A (20 mM Tris-HCl [pH 7.9], 0.5 M NaCl, 5 mM imidazole) connected to an 
ÄKTA Explorer (GE Healthcare). The column was washed with 5 column volumes (CV) 
of buffer A, followed by 5 CV of buffer B (20 mM Tris [pH 7.9], 0.5 M NaCl, 20 mM 
imidazole). Core RAG proteins were eluted with 10 CV of elution buffer (20 mM Tris-
HCl [pH 7.9], 0.5 M NaCl, 0.5 M imidazole).  
 
The RAG-containing fractions (identified by a peak on the chromatogram) were pooled 
together and mixed with 2 volumes of amylose column buffer (NaPi [pH 7.2], 0.5 M 
NaCl, 0.25% Tween 20®), then loaded onto a 1 ml amylose column (NEB #E8022S) 
equilibrated with amylose column buffer. The column was washed with 5 CV of 
amylose column buffer, followed by 3 CV of amylose column buffer without Tween. 
Purified RAG proteins were eluted with 15 CV of amylose column buffer without Tween 
and with 10 mM maltose. 
 
RAG-containing fractions were analysed by SDS-PAGE (Section 2.19) and fractions 
containing similar concentrations of protein were pooled. Protein was then 
concentrated 4-fold using centrifugal filter units with a molecular weight cut off of 30 
kDa (Millipore #UFC803024). This procedure is also convenient for desalting samples, 
as the protein samples are in a solution containing salt at a high concentration (0.5 M 
NaCl) after elution from the amylose column. Therefore, after each spin cycle, 
concentrated protein was diluted with storage buffer (25 mM Tris-HCl [pH 8.0], 150 mM 
KCl, 2 mM DTT, 10% glycerol). Four spin cycles were carried, concentrated protein 
was aliquoted, snap-frozen in a dry ice-ethanol bath and stored at -80°C. 
 
2.18 Expression and purification of HMGB1 
The full-length rat HMGB1 expression plasmid pETM11-HMGB1 was a kind gift from 
Prof Marco Bianchi (Vita-Salute San Raffaele University, Milan, Italy). This plasmid 
contains the full-length protein coding sequence of rat HMGB1 (UniProt #B4F758) with 
an N-terminal 6xHis tag that can be removed by Tobacco Etch Virus (TEV) protease. 
Purification of full-length HMGB1 was carried out according to a protocol provided by 
Prof Bianchi. BL21(DE3) cells were transformed with pETM11-HMGB1, plated on 
LB/kanamycin agar plates and grown at 37°C for 16 h. A single colony was picked and 
used to inoculate 10 ml of LB/kanamycin and grown at 37°C for 16 h. The following day 
the entire 10 ml culture was transferred to 1 litre of LB/kanamycin and incubated at 
37°C (250 rpm) until the OD600 = 0.6-0.8. Expression of HMGB1 was then induced with 
IPTG at 0.5 mM, and incubated at 25°C with shaking (250 rpm) for 16 h.  
 
 Mater ia ls  and Methods  | 55 
 
 
Cells were harvested for 20 min at 4,000 x g, washed once in ice-cold PBS, and the 
pellet was snap-frozen in a dry ice/ethanol bath and stored at -80°C until purification. 
The following was carried out at 4°C unless stated otherwise. The pellet was thawed on 
ice and resuspended in 20 ml lysis buffer (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 10 
mM imidazole, 2 mM βME, 0.2% Igepal CA630, 1x EDTA-free protease inhibitor 
cocktail (Roche #11873580001), 1 mM benzamidine, 1 mM PMSF). The resuspended 
cells were sonicated for 4 cycles of 2 min at 10 microns, 2 min on ice, and the lysate 
was clarified by centrifugation at 16,000 x g for 30 min. The cleared lysate was then 
filtered through a 0.2 μm syringe filter unit. The filtered lysate was bound to 5 ml Ni-
NTA resin (Qiagen) in an Econo-Pac® chromatography column (Biorad #732-1010) on 
a rotating shaker for 30 min. The flowthrough was collected and applied to 2.5 ml of Ni-
NTA resin in a second Econo-Pac® column for 30 min to maximise recovery of His-
tagged HMGB1. The flowthrough was collected and both columns were washed with 
10 CVs of lysis buffer, 5 CVs of lysis buffer without Igepal CA 630 or protease 
inhibitors, 5 CVs of wash buffer 1 (20 mM Tris-HCl [pH 8.0], 1 M NaCl, 10 mM 
imidazole, 2 mM βMe) and 5 CVs of wash buffer 2 (20 mM Tris-HCl [pH 8.0], 150 mM 
NaCl, 30 mM imidazole, 2 mM βMe). HMGB1 was eluted with elution buffer (Tris-HCl 
[pH 8.0], 150 mM NaCl, 300 mM imidazole, 2 mM βMe). 
 
HMGB1 from the Ni-NTA column was loaded onto a 1 ml HiTrap SP XL column (GE 
Healthcare) equilibrated with buffer A (20 mM Tris-HCl [pH 8.0], 1 mM DTT, 80 mM 
NaCl). The column was washed with 9 column volumes of buffer at 80 mM NaCl and 
HMGB1 was eluted with a gradient of 80-650 mM NaCl (20 mM Tris-HCl [pH 8.0], 1 
mM DTT) over 25 CVs. HMGB1-containing fractions were dialysed against 100 
volumes of storage buffer (25 mM Tris-HCl [pH8.0], 150 mM KCl, 2 mM DTT, 10% 
glycerol) and analysed by SDS-PAGE (Section 2.19). 
 
2.19 SDS-polyacrylamide gel electrophoresis of proteins 
Typically, protein samples were analysed on a 10% (37.5:1 acrylamide:bis-acrylamide) 
polyacrylamide gel (8 x 10 x 0.07 cm). For HMGB1, it was found that the best 
resolution is achieved using a 12% gel (19:1 acrylamide:bis-acrylamide). In both cases, 
a 3% (37.5:1 acrylamide:bis-acrylamide) stacking gel was used. Running and stacking 
gel solutions were prepared as per the protocol in Sambrook et al. (1989) and cast 
using the BioRad Protean III system. Samples were mixed with an equal volume of 2x 
protein loading buffer by vortexing, then heated in a boiling water bath for 3 min. 
Denatured samples were loaded onto the gel and separated for 1 h at 180 V.  
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2.20 Coomassie staining of polyacrylamide gels 
Polyacrylamide gels were incubated on an orbital shaker at RT in fixing solution (25% 
(v/v) isopropanol, 10% (v/v) acetic acid) for 10 min. Fixing solution was replaced with 
rapid Coomassie staining solution (10% (v/v) acetic acid, 0.006% (w/v) Coomassie 
Brilliant Blue G-250) for a minimum of 1 h. Gels were destained with 10% (v/v) acetic 
acid until the background was clear, which usually took around 20-30 min. 
 
2.21 Estimation of protein concentration by SDS-PAGE and densitometry 
The concentration of purified proteins was estimated by running a range of BSA 
concentrations on an SDS-PAGE gel alongside an aliquot of purified protein. Gels were 
stained with Coomassie (Section 2.20) and photographed using a SynGene white light 
transilluminator. The band densities were measured using AIDA Image Analyser 
software (Raytest, Germany, v.4.14). A BSA standard curve was plotted in Excel 
(2007) and the equation of the line of best fit was used to estimate the amount of 
purified protein in each band.  
 
(C) Expression and purification of full-length RAG proteins using a vaccinia 
virus/HeLa cell expression system 
 
2.22 Maintenance of cell lines used in producing recombinant vaccinia and 
expressing full-length RAG proteins 
Adherent Baby Hamster Kidney 21 (BHK-21) and HeLa cells were maintained in 
DMEM-complete. HuTK- 143B cells were maintained in DMEM-complete with 25 µg/ml 
bromodeoxyuridine (BrdU). In general, adherent cells were cultured in a 75 cm2 flask 
until ~90% confluent, at which point they were split 1:10-1:20. This was done by 
aspirating medium from the cells, adding 1 ml trypsin/EDTA and leaving to detach for 
~5 min at RT. Detached cells were resuspended in 10 ml DMEM-complete to inhibit 
trypsin, then 1-2 ml was added to 20 ml DMEM-complete in a fresh 75 cm2 flask. 
 
Suspension HeLa cells were cultured in MEME supplemented with 5% FCS, 4 mM L-
glutamine and 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid). 
HEPES was included to maintain the pH at pH 7.0, since the incubator set up for 
spinner flasks did not contain CO2. The log phase of suspension HeLa cell growth is 
between 1 and 5 x 105 cells/ml. HeLa cell density was maintained between 5x104 
cells/ml and 5 x 105 cells/ml. Proliferation from 5x104 to 5x105 cell/ml typically took 
around 72 h. 
 
 Mater ia ls  and Methods  | 57 
 
 
In general, complete medium (i.e. medium supplemented with 10% FCS, L-glutamine 
and pen/strep; Section 2.2) was used for routine cell maintenance, and medium 
supplemented with 2% FCS and L-glutamine, but no antibiotic was used during 
infections. A lower concentration of FCS is used during infections because high 
concentrations can inhibit viral infectivity, and antibiotics are omitted because they are 
potentially toxic to cells during infection. 
 
2.23 Cloning full-length RAG proteins into vaccinia transfer vector pTM1 
The pTM1 expression cassette contains (5’ to 3’): a T7 RNA polymerase promoter, the 
encephalomyocarditis virus untranslated leader region (EMCV-UTR) to increase 
transgene expression levels, a multiple cloning site (MCS), and a T7 terminator. The 
expression cassette is flanked by segments of the vaccinia virus thymidine kinase (TK) 
gene. During production of recombinant vaccinia virus the expression cassette is 
inserted into the TK gene of wild-type vaccinia virus by homologous recombination, 
allowing for selection of recombinant vaccinia virus in a TK-deficient (TK-) cell line.  
 
Complementary synthetic oligonucleotides encoding a 9xHis tag and a FLAG tag 
flanked by NcoI and EcoRI sites (FLAG-His Adaptor F and R, Table 2.1) were 
annealed and digested with NcoI and EcoRI, gel-purified and ligated into the 
NcoI/EcoRI sites of pTM1 to make pTM1-FH. The pTM1 vaccinia transfer vector (Moss 
et al., 1990) was a kind gift from Dr Bernard Moss (National Institute of Allergy and 
Infectious Diseases, USA). The coding sequences of full-length RAG1 and full-length 
RAG2 were PCR-amplified from pJH548 and pJH549, respectively (Sadofsky et al., 
1993), using the Q5® high-fidelity DNA polymerase (NEB #M0491). Primers were 
designed so that a SmaI site was added to the N-terminus of the RAG1 coding 
sequence and an EcoRI site was added to the N-terminus of the RAG2 coding 
sequence. RAG1 was amplified with RAG1 SmaI F and RAG1 XhoI R, and RAG2 was 
amplified using RAG2 EcoRI F and RAG2 XhoI R (Table 2.1). Both were amplified to 
include the XhoI site of pJH548/pJH549 located downstream of the RAG1/RAG2 
coding sequence. RAG1 and RAG2 PCR products were gel-purified and ligated into 
the SmaI/XhoI or EcoRI/XhoI sites of pTM1-FH, respectively, to make pTM1-FHR1 and 
pTM1-FHR2. DNA sequencing by GATC Biotech (Konstanz, Germany) confirmed the 
identity of the clones and that no mutations had been introduced. 
 
2.24 Amplification of wild-type and recombinant vaccinia virus 
Stocks of wild-type and recombinant virus were prepared in the same way. Wild-type 
vaccinia virus was a kind gift from Prof Geoffrey Smith (University of Cambridge, UK), 
which was supplied as a crude lysate of infected cells that required trypsination before 
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infection. An aliquot of virus was mixed with an equal volume of trypsin/EDTA and 
incubated at 37°C vortexing at 5-10 min intervals for 30 min, or until no visible cell 
clumps remained. Trypsinised virus was diluted to 12 ml with DMEM-10. Four confluent 
175 cm2 flasks of HeLa cells were infected at an MOI of 1 by adding 3 ml to each flask. 
Virus was evenly distributed by gentle rocking for ~30 s then incubated at 37°C/5% 
CO2 for 2 hours, with gentle shaking every 30 min. After 2 h, 30 ml DMEM-10 was 
added and cells were incubated for 3 days until cytopathic effects were observed. To 
harvest the virus, cells were detached by shaking, centrifuged at 1000 x g for 5 min, 
and resuspended in 2 ml MEME-2. Vaccinia virus remains cell-associated, so cells 
were lysed by freeze-thawing three times to release the virus. Virus stocks were stored 
as a crude lysate in 0.5 ml aliquots at -80°C. 
 
2.25 Calculation of vaccinia virus titer 
All incubations were at 37°C/5% CO2. A 6-well plate was seeded with 3.3 x 10
5 BHK-21 
cells/well in 2 ml MEME-complete and incubated for 8-16 h. Baby hamster kidney 21 
(BHK-21) cells were used because they have a long spindle-like morphology, which 
rounds up dramatically upon infection, making plaques easy to identify. HeLa cells can 
be used, but their round morphology and much faster doubling time makes it harder to 
identify plaques. A 10 µl aliquot of crude virus lysate was thawed and trypsined as in 
Section 2.24 and used to make eight 10-fold serial dilutions of virus in MEME-2. BHK-
21 cells were washed with PBS to remove residual antibiotics, and then infected with 2 
ml of the 10-6, 10-7 and 10-8 dilutions in duplicate. Cells were incubated for 1-2 hours 
with gentle shaking every 15-30 min. 4 ml MEME-complete was then added (without 
removing virus dilutions) and cells were incubated for 24-48 h, until plaques were 
visible under a light microscope. 
 
To stain cells, medium was removed and 1 ml 0.1% crystal violet (which only stains 
viable cells) was added and incubated at RT for a minimum of 5 min. Stain was 
discarded and excess stain washed off with PBS. Viral plaques were counted and 
averaged for each dilution and the titer (pfu/ml) was calculated according to the 
formula: 
 
pfu/ml = 
number of plaques  dilution factor
ml of virus used
 x 2 
 
The final multiplication accounts for dilution with trypsin at the start of the protocol. 
Since 2 ml of virus was used, this cancels the division so the formula can be simplified 
to: 
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pfu/ml = number of plaques x dilution factor 
 
The final titer estimate was calculated by averaging the titers for each dilution.  
 
2.26 Production of recombinant vaccinia virus 
To produce recombinant vaccinia virus, BHK-21 cells were simultaneously infected with 
wild-type vaccinia virus and transfected with vaccinia transfer vector containing the full-
length RAG coding sequences (Section 2.23). Two 25 cm2 flasks were seeded with 
BHK-21 cells and grown to near confluency. Wild-type vaccinia virus was trypsinised as 
in Section 2.22 and diluted to 1.5 x 105 pful/ml in MEME-2. Medium was removed from 
BHK-21 cells and replaced with 1 ml diluted wild-type vaccinia virus (MOI ~0.05). Cells 
were incubated for 2 hours at 37°C/5% CO2.  
 
pTM1-FHR1 and pTM1-FHR2 were transfected using Lipofectamine reagent according 
to the manufacturer’s instructions (Life Technologies). 8 µg of either pTM1-FHR1 or 
pTM1-FHR2 was added to 625 µl Opti-MEM® I medium in separate tubes and mixed 
gently. 25 µl Lipofectamine reagent was added to 625 µl Opti-MEM® I medium and 
incubated at RT for 5 min. The plasmid and Lipofectamine solutions were then mixed 
by vortexing briefly and incubated at RT for 20 min. Virus inoculum was removed from 
the cells, and replaced with 100 µl transfection solution, which was evenly distributed 
by gentle rocking. 5 ml of MEME-complete was added and the cells were incubated for 
48 h at 37°C/5% CO2. Cells were dislodged by gently shaking the flask and vigorously 
pipetting medium over the cells. Virus was harvested by transferring resuspended cells 
to a 50 ml tube and centrifuging at 1000 x g for 3 min, then resuspending in 1 ml of 
MEME-2. Virus was released from cells by freeze-thawing three times and stored at -
80ºC until selection (Section 2.27). 
 
2.27 Selection of recombinant vaccinia virus 
When recombinant vaccinia virus is made using the pTM1 transfer vector, the 
expression cassette is inserted into the non-essential vaccinia virus TK gene. 
Therefore, recombinant vaccinia virus was selected by infecting a TK-deficient cell line. 
Human TK-deficient 143B cells (HuTK- 143B, ATCC #CRL-8303) were a kind gift from 
Prof Geoffrey Smith (University of Cambridge, UK). HuTK- 143B cells were maintained 
in DMEM-complete medium containing 25 µg/ml bromodeoxyuridine (BrdU). BrdU is a 
synthetic nucleoside analogue of thymidine, which must be phosphorylated by TK in 
order to be incorporated into DNA. If HuTK- 143B cells are transfected with wild-type 
vaccinia virus expressing the TK gene, BrdU becomes phosphorylated and lethally 
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incorporated into the viral genome. Therefore, only recombinant vaccinia virus with 
inactivated TK will survive and produce plaques upon infection of HuTK- 143B cells. 
 
3.3 x 105 HuTK- 143B cells/well were seeded in one 6-well plate per virus and 
incubated for 16 h. 100 µl of recombinant viral lysate was trypsinised with an equal 
volume of trypsin/EDTA as in Section 2.24. Four 10-fold serial dilutions (ranging from 
10-1 to 10-4) were made in DMEM-2. Medium was removed from the cells and 1 ml virus 
dilution was added (10-2 to 10-4 dilutions in duplicate wells) and incubated for 1-2 h at 
37°C/5% CO2. An agarose overlay was prepared by mixing equal volumes of 2% low-
melting point agarose (melted and cooled to 45°C) and 2x selective plaquing medium 
(2x plaque medium, Life Technologies #21935028), 5% FCS, 240 mM L-glutamine, 
0.5% (v/v) pen/strep, 50 µg/ml BrdU). The viral inocula were removed and cells were 
overlaid with 3 ml selective agarose per well. Cells were incubated for 48 h (37°C/5% 
CO2). A second overlay, containing neutral red stain, was prepared by mixing equal 
volumes of 2% low melting point agarose and 2x selective plaquing medium + 0.1% 
neutral red. 2 ml of selective agarose was added to each well and incubated for 16 h. 
The following day, ten well-isolated plaques were picked using sterile pipette tips and 
the agarose plugs were transferred to 0.5 ml DMEM-2% (no pen/strep or BrdU). 
Samples were vortexed vigorously and freeze-thawed 3 times, then snap-frozen on dry 
ice and stored at -80°C.  
 
2.28 Screening of recombinant vaccinia virus 
TK- plaques need to be screened by PCR to check for insertion of the transgene, since 
spontaneous TK- virus mutants can arise at a frequency of 1:10,000. Recombinants 
can represent anywhere between 10 to >90% of plaques, depending on the 
transfection efficiency (Earl et al., 2001). Screening required infecting a small culture of 
HuTK- 143B cells, harvesting the virus and using a small amount of infected cell lysate 
in PCR assays.  
 
1.25 x 105 HuTK- 143B cells were seeded in each well of a 24-well plate in 0.5 ml 
complete DMEM-10/BrdU and incubated (37°C/5% CO2) for 16 h until 90% confluent. 
Plaque isolates (Section 2.27) were thawed and mixed, and each well was infected 
with 0.25 ml of one plaque isolate and incubated for 2 h (37°C/5% CO2) with gentle 
shaking at 15 min intervals. 1 ml DMEM-2/BrdU was added and cells were incubated 
for 48 h (37°C/5% CO2). Cells were scraped using the rubber end of a 1 ml syringe 
plunger, transferred to 1.5 ml tubes, and centrifuged for 30 s at top speed to pellet 
infected cells. Cell pellets were washed once with 1 ml PBS (30 s, 16,000 x g) and 
resuspended in 0.5 ml PBS.  
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DNA was extracted from plaque isolates by freeze-thawing three times to lyse the cells. 
100 µl of lysate was transferred to a 1.5 ml tube with 10 µl DNA extraction buffer (20 
mM Tris-HCl [pH 7.5], 20 mM EDTA, 0.5% SDS, 1 mg/ml Proteinase K), mixed gently 
by inversion and incubated at 37°C for 3.5 h. DNA extracted from each isolate was 
purified by phenol-chloroform extraction/ethanol precipitation and resuspended in 20 µl 
TE. 10 µl of each was then tested for insertion of the RAG transgenes by PCR using 
the VacV RAG F and VacV RAG R primers (Table 2.1), followed by agarose gel 
electrophoresis (Section 2.4). To ensure that the recombinant vaccinia virus was 
clonally pure, the processes of selection and screening (Section 2.27 and 2.28) were 
repeated twice more, taking four plaque isolates forward each time. Once recombinant 
viruses had been through three rounds of selection and screening, they were amplified 
by infection of successively larger numbers of cells according to the amplification 
protocol in Section 2.24. The first two stages of amplification (12-well plate then 25 cm2 
flask) were done using selective conditions (i.e. HuTK- 143B cell grown in BrdU). Large 
stocks of full-length RAG1 and full-length RAG2-expressing vaccinia viruses were then 
produced by infection of HeLa cells in 175 cm2 flasks. The viral titer was then estimated 
as in Section 2.25. 
 
2.29 Purification of full-length RAG proteins from vaccinia-infected HeLa 
suspension cells 
Suspension HeLa cells were infected with three viruses: both viruses expressing full-
length RAG1 or full-length RAG2 and a recombinant vaccinia virus that expresses T7 
RNA polymerase (vTF7-3, a kind gift from Dr John Barr, University of Leeds, UK) at an 
MOI of 10 for each virus. All three vaccinia viruses were trypsinised as in Section 2.24, 
added to cells and incubated for 24 h (37°C/5% CO2). Infected cells were harvested by 
centrifugation at 1000 x g for 5 min at 4°C, washed twice with ice-cold PBS, snap-
frozen in a dry ice/ethanol bath and stored at -80°C until purification. 
 
Full-length RAG proteins were purified according to a protocol based on McBlane et al. 
(1995). All steps were carried out at 4°C. An infected cell pellet was thawed on ice and 
resuspended in 10 ml buffer C0 (20 mM Tris-HCl [pH7.5], 500 mM NaCl, 1x complete 
protease inhibitors (Roche), 10% glycerol, 0.1% Triton X-100). Cells were lysed by 20 
strokes in a Dounce homogeniser with a tight-fitting pestle and the lysate was cleared 
by centrifugation for 30 min at 11,000 x g (30,000 rpm), 4°C, using a Beckman SW55 
Ti rotor. 1 ml of anti-FLAG M2 resin in an Econo-Pac® column (BioRad) was washed 
with three column volumes (CV) 0.1 M glycine [pH3.5] and equilibrated with 5 CV of 
buffer C0 without protease inhibitors. Cleared lysate was applied to the column by 
gravity flow, and then re-applied to maximise binding. The column was washed with 10 
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CV Buffer C0 without protease inhibitors, and full-length RAG proteins were eluted with 
10 CV of buffer C0 + 100 µg/ml FLAG peptide. 
βMe and imidazole were added to the eluate at 2 mM and 20 mM, respectively, and 
applied to a 1 ml Ni-NTA column attached to an ÄKTA Explorer and equilibrated with 
buffer A (10 mM Tris-HCl [pH 8.0], 500 mM NaCl, 20 mM imidazole, 2 mM βMe). The 
column was washed with 10 CV buffer A, and His-tagged RAG proteins were eluted 
using a gradient of 20 to 500 mM imidazole. Samples were analysed by SDS-PAGE 
and western-blot (Section 2.30), which indicated that the full-length RAG proteins were 
largely insoluble, since they were detected in the pellet after centrifugation but not in 
any subsequent fraction. 
 
2.30 Western blot of full-length RAG proteins 
Samples were taken at each step of the full-length RAG purification for detection of full-
length RAG proteins by western blot. First, samples were separated by SDS-PAGE 
(Section 2.19). Prior to transfer, polyvinylidene fluoride (PVDF) membrane (Hybond P, 
GE Healthcare #10600023) was soaked in 100% methanol, washed four times with 
dH20, then washed in transfer buffer for 10 min (20 mM Tris-HCl [pH 8.0], 150 mM 
glycine, 20% (v/v) methanol, 0.038% (w/v) SDS). Proteins were transferred from the 
gel to PVDF membrane using a semi-dry blotter for 1 h at 0.68 mA/cm2. Non-specific 
binding sites were blocked for 1 h in 20% horse serum (HS)/PBS on a rocking platform. 
The blocked membrane was then hybridised in 3 ml 1:2000 monoclonal mouse anti-
FLAG antibody (Sigma #F3165) in HS/PBS/1% TWEEN-20 (PBST) solution for 1 h at 
RT on a roller mixer. Unbound primary antibody was removed by washing with PBST, 
changing the PBST every 10 min. The secondary hybridization was with 1:10,000 
horse radish peroxidase (HRP)-conjugated polyclonal anti-mouse antibody in HS/PBST 
for 1 h at RT, followed by washing in PBST for 45 min, replacing the PBST every 10 
min. Chemiluminescent HRP substrate was prepared according to the manufacturer’s 
instructions (ThermoPierce #34077) and added to the membrane for ~3 min. Blots 
were then exposed to photosensitive film and developed in a film processor.  
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(D) Expression and purification of core and full-length RAG proteins from 
HEK-293T cells  
 
2.31 Cloning MBP-tagged core and full-length RAG coding sequences into a 
mammalian expression vector 
The full-length coding sequences of RAG1 and RAG2 were PCR amplified from 
pJH548 and pJH549, respectively, using the Q5 high-fidelity polymerase (NEB 
#M0491) and primers that add NdeI and BamHI sites. Full-length RAG1 was amplified 
using primers RAG1 NdeI F and RAG1 BamHI R, and full-length RAG2 was amplified 
using primers RAG2 NdeI F and RAG2 BamHI R (Table 2.1). Core RAG1 was 
amplified using primers cRAG1 NdeI F and cRAG1 R. The PCR products were blunt-
ligated into pBluescript cut with EcoRV, then subcloned into the MBP-tagging vector 
pET-MBPL (a kind gift from Dr Chris Thomas, University of Leeds) via the NdeI and 
BamHI sites, such that the RAG coding sequences were in-frame and downstream of 
the MBP coding sequence. MBP-tagged RAG sequences were subcloned into pEF-XC 
(a modified version of pEF-BOS; Mizushima and Nagata, 1990) via the XbaI and 
BamHI sites, to make pEF-MfR1, pEF-MfR2 and pEF-McR1 (Fig. 2.1-2.3). MBP-tagged 
core RAG2 in pEF-XC was made by amplifying the MBP-core RAG2 sequence from 
pEF-MfR2 and adding XbaI and BamHI sites, using primers MBP flRAG F and MBP 
cRAG2 (Table 2.1). The MBP-cRAG2 fragment was then inserted into the XbaI/BamHI 
sites of pEF-XC to make pEF-McR2 (Fig. 2.4). DNA sequencing by GATC Biotech 
(Konstanz, Germany) confirmed the identity of the clones and that no mutations were 
introduced during PCR. 
 
2.32 Transfection of HEK-293T cells with full-length RAG expression vectors 
10 cm2 dishes (typically 15 per transfection) were seeded with 2 x 106 HEK-293T 
cells/dish in complete DMEM-10 and incubated at 37°C/5% CO2 for 16 h. Medium was 
replaced with fresh medium and incubated for 3 h at 37°C/5% CO2. HEK-293T cells 
were then co-transfected with pEF-MfRAG1 and pEF-MfRAG2 using polyethylenimine 
(PEI). Transfection solution was prepared in serum- and antibiotic-free DMEM using 5 
µg of each plasmid and 30 µg of PEI per dish in a total volume of 1 ml/dish. The 
DNA/PEI mixture was vortexed briefly and incubated at RT for 10 min. 1 ml of DNA/PEI 
mix was added drop-wise to each dish and distributed evenly by gentle rocking, then 
incubated for 48 h at 37°C/5% CO2. Cells were harvested by scraping and transferring 
to 50 ml tubes, and centrifuging at 1000 x g for 3 min at 4°C. Cells were washed twice 
with ice-cold PBS, snap-frozen in dry ice/ethanol and stored at -80°C. 
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2.33 Purification of full-length RAG proteins from HEK-293T cells 
Core and full-length RAG proteins, expressed in HEK-293T cells, were purified in the 
same way. All steps were performed at 4°C. Cell pellets (typically from two 
transfections per purification i.e. 30 dishes) were thawed on ice and resuspended in a 
total of 10 ml of lysis buffer (10 mM NaPi [pH 7.2], 0.5 M NaCl, 1 mM DTT, 0.25% 
TWEEN-20, 1x protease inhibitors with EDTA (Roche), 1 mM PMSF, 1 mM 
benzamidine). Cells were lysed using a Dounce homogeniser by 20 strokes with a 
tight-fitting pestle, then centrifuged for 40 min at 11,000 x g (30,000 rpm), 4°C, with a 
SW55 Ti rotor (Beckman). The supernatant was loaded (0.5 ml/min) onto a 1 ml 
amylose column (NEB # E8022S) equilibrated with buffer A (10 mM NaPi [pH 7.2], 0.5 
M NaCl, 1 mM DTT, 0.25% TWEEN-20). The column was washed with 10 CV of buffer 
A, followed by 10 CV of buffer B (buffer A without TWEEN-20) and protein was eluted 
with 10 CV buffer C (Buffer A without TWEEN-20, with 10 mM maltose). Fractions were 
analysed by SDS-PAGE, and RAG-containing fractions were pooled and dialysed twice 
for 3 h against dialysis buffer (25 mM Tris-HCl [pH8.0], 150 mM KCl, 2 mM DTT, 10% 
glycerol). Dialysed protein was aliquoted, snap-frozen in a dry ice/ethanol bath and 
stored at -80°C. 
 
(E) In vitro RAG assays 
 
2.34 Gel purification of DNA oligonucleotides 
All synthetic oligonucleotides, purified by desalting, were supplied by Sigma-Aldrich 
(Poole, UK). DNA oligonucleotides that were used as in vitro RAG substrates (Table 
2.2) were gel-purified using the “crush-and-soak” method (Ellington and Pollard, 2001). 
Oligonucleotides were run on a 12% (19:1) polyacrylamide gel containing 7M urea and 
1x TBE for 1 h at 500 V. Gels were wrapped in cling film and oligonucleotides were 
visualised by UV shadowing using a hand-held UV monitor at 254 nm and the 
intensifying screen of a western blot cassette, and excised using a sterile scalpel blade. 
The gel slice was finely chopped on a glass gel plate and transferred to a 1.5 ml tube in 
1 ml TE, 100 mM NaOAc, and 0.5% SDS to prevent nuclease activity during elution. 
Tubes were heated in a boiling water bath for 3 min, then freeze-thawed 3 times in dry 
ice and a 42°C water bath. The oligonucleotide was left to diffuse from the gel matrix 
on a rotating wheel at RT overnight. Polyacrylamide was removed by centrifugation at 
top speed for 2 min, and supernatant was transferred to a fresh 1.5 ml tube. Residual 
polyacrylamide was removed by filtering through a 0.2 µm syringe filter unit. The 
volume of oligonucleotide solution was reduced to 400 µl by butanol extraction, prior to 
purification by phenol-chloroform extraction/ethanol precipitation. DNA pellets were 
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resuspended in TE and the concentration of purified oligonucleotide was measured 
using a NanoDrop spectrophotometer (Section 2.8). 
 
2.35 Preparation of radiolabelled oligonucleotides 
The “top” strand of each RSS-containing oligonucleotide (Table 2.1) was 5’-end 
labelled with [γ-32P]-ATP using T4 polynucleotide kinase (T4 PNK, NEB #M0201S). 
Labelling reactions containing 10 pmol oligonucleotide, 10 units T4 PNK, 1x T4 PNK 
buffer (70 mM Tris-HCl [pH 7.6], 10 mM MgCl2, 10 mM DTT) and 2.5 µl [γ-
32P]-ATP 
(Perkin-Elmer Life Sciences) in a total volume of 15 µl were incubated at 37°C for 30 
min. The volume was increased to 50 µl with TE and unincorporated [γ-32P]-ATP was 
removed using MicroSpinTM G-25 columns (GE Healthcare) for 2 min at 700 x g. 
Purified radiolabelled oligonucleotide was then annealed to its unlabelled reverse 
complement (Section 2.36). 
 
2.36 Annealing oligonucleotides 
Oligonucleotide annealing reactions contained both complementary strands at 100 nM, 
100 mM NaCl, and 0.5x TE in a total volume of 100 µl. Annealing reactions were then 
heated in screw-cap tubes for 3 min in a boiling water bath and left to cool gradually 
overnight. The final concentration of annealed oligonucleotide was 100 nM. 
Radiolabelled and unlabelled oligonucleotides were annealed in the same way.  
 
2.37 In vitro RAG cleavage assays 
A typical RAG cleavage reaction contained 25 mM MOPS pH 7.0, 50 mM potassium 
acetate, 1 mM DTT, 100 μg/ml BSA and 1 mM divalent metal cation chloride salt (either 
CaCl2, MnCl2 or MgCl2) prepared as a 10x concentrated mix, 2 nM radiolabelled 
oligonucleotide, 30 ng (120 nM) HMGB1, and 4 µl of purified RAG proteins (usually ~ 
80 nM) in a total volume of 10 µl. Where indicated, a second unlabelled partner 
oligonucleotide was included. Reactions were incubated at 37°C, usually for 15 min (or 
as indicated in the figure legend), and stopped by addition of 3.3 μl of 4x stop buffer 
(200 mM Tris-HCl [pH 8.0], 0.4% SDS, 20 mM EDTA, 0.7 mg/ml proteinase K, 4x DNA 
loading buffer), followed by incubation at 37°C for 30 min. SDS and proteinase K are 
included in the stop buffer to degrade the RAG proteins. If this step is omitted, a portion 
of the radiolabelled oligonucleotide remains bound by RAG proteins and HMGB1, and 
becomes stuck in the wells of the gel during electrophoresis, thus preventing accurate 
quantification of the level of cleavage. The whole reaction was loaded onto a 12% 
(19:1) polyacrylamide gel in 1x TAE (17 cm x 15 cm x 1.6 mm), and separated for 1.5 h 
at 170 V (constant). Gels were soaked in 70% methanol on an orbital shaker for 20 min 
at RT to prevent them from cracking when drying due to the high percentage of 
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polyacrylamide. Gels were dried on to Whatman® 3MM chromatography paper using a 
Bio-Rad gel drier with an 80°C heated lid for 1 h. The dried gel was exposed to a 
phosphorimager screen and visualised using an FLA-1500 phosphorimager (Fujifilm). 
The percentage of substrate cleaved was quantified using AIDA Image Analyser 
software (Raytest, Germany, v.4.14). 
 
2.38 Analysis of RAG cleavage activity by denaturing gel electrophoresis 
To analyse the nicking and hairpinning activity of RAG proteins, cleavage assays were 
set up as described in Section 2.37. Then, half of the reaction was added to 4x stop 
buffer and run on a native polyacrylamide gel as described in Section 2.37. The 
remaining half of the reaction was purified by phenol-chloroform extraction/ethanol 
precipitation, resuspended in 5 µl formamide loading buffer, and run on a 12% (19:1) 
polyacrylamide gel containing 7 M urea. DNA was electrophoresed for 1 h at 500 V and 
the gel was transferred to Whatman 3 MM paper. Gels were dried and processed as in 
Section 2.37. 
 
2.39 Electrophoretic mobility shift assay (EMSA) 
RAG-RSS binding assays were identical to cleavage reactions, except that they were 
incubated at 37°C for 10 min only in the presence of either MgCl2 or CaCl2, as 
indicated. 1 µg of monomeric streptavidin (Thermo #21125) per reaction was included 
in the streptavidin supershift assay (Section 4.1). After incubation, reactions were 
chilled on ice for 5 min and loaded onto a 4% (19:1) polyacrylamide gel (17 cm x 15 cm 
x 1.6 mm) in 0.5x TBE, pre-chilled to 4°C in a cold room. The gels were run and dried 
as for cleavage assays (Section 2.37), except the 70% methanol soak was omitted. 
Dried gels were exposed to a phosphorimager screen and visualised using an FLA-
1500 phosphorimager (Fujifilm). 
 
2.40 Estimating RAG-RSS and RAG-ESC dissociation constant (Kd) by EMSA 
The affinity of RAG-ESC binding was estimated by EMSA. Binding reactions were set 
up as in Section 2.39, with core RAG concentration ranging from 0-80 nM. The amount 
of dialysis buffer was kept constant by keeping the combined volume of RAG and 
dialysis buffer at 4 µl/reaction. This was to ensure that the concentration of monovalent 
cations and glycerol, which might affect binding efficiency, was the same for each RAG 
concentration. Gels were run and processed as in Section 2.39, and the fraction of 
bound and unbound oligonucleotide was measured by densitometry. The dissociation 
constants (Kd) were estimated by plotting RAG concentration against % bound probe in 
Excel, and calculating the concentration of RAG protein at which 50% of probe was 
bound.  
 Mater ia ls  and Methods  | 67 
 
 
2.41 DNase I footprint analysis of RAG-RSS binding 
The 12RSS footprint probe was prepared by digesting 100 µg pJβ2.7+, a 12RSS-
containing plasmid, with EcoRV and NdeI. The 12RSS containing fragment was gel-
purified, resuspended in dH2O, and radiolabelled by filling in the recessed NdeI end 
with α-32P-dCTP and Klenow polymerase. Labelling reactions, containing the 
EcoRV/NdeI fragment from pJβ2.7+, 5 µl α-32P-dCTP, 1x NEBuffer 2, and 10 units of 
Klenow polymerase, were incubated for 30 min at RT, then supplemented with 5 mM 
dNTP mix to complete the fill-in reaction. The labelled fragment was then purified by 
phenol-chloroform extraction/ethanol precipitation and resuspended in 50 µl TE. The 
ESC footprint probe was prepared in the same way, except that the NheI/ApaI 
fragment from pJδ1+ was used.  
 
Binding reactions containing 1x buffer (25 mM MOPS [pH 7.0], 0.1 mg/ml BSA, 42 mM 
KOAc, 2 mM DTT, 1 mM CaCl2), 12RSS probe or ESC probe (~30 counts per second), 
20% DMSO, 0.2 µg polydI.dC, and 100 nM cRAG proteins, were incubated at 37°C for 
10 min. MgCl2 (5 mM final concentration) and 2 units of DNase I were added and the 
mixture was incubated at RT for 1 min. DNase I reactions were quenched by the 
addition of EDTA at 15 mM, and then purified by phenol-chloroform/ethanol 
precipitation, using GlycoBlue (Life Technologies #AM9516) to aid in the visualisation 
of the small radioactive DNA pellet. DNA was resuspended in 3 µl formamide loading 
buffer, boiled for 3 min and run alongside the appropriate GA marker on a pre-warmed 
6% (19:1) denaturing polyacrylamide gel for 45 min at 38 mA. Gels were transferred to 
Whatman 3MM paper and dried in a BioRad vacuum drier for 45 min with an 80°C 
heated lid. The dried gel was exposed to a phosphorImager screen and scanned using 
an FLA-1500 PhosphorImager (FujiFilm). The relative density of each band was 
measured using ImageJ.  
 
2.42 Preparation of GA ladder  
Preparation of a GA ladder was required for determining the identity of each band in 
the DNase I footprint experiments. The same radiolabelled probe that is used in the 
footprint is partially chemically degraded at only the G and A residues, thus creating a 
radiolabelled ladder where each G and A residue of the probe is seen on a gel. The GA 
ladder was prepared by precipitating a fifth of the labelled probe stock (Section 2.41) 
and resuspending it in 10 µl dH2O. 25 µl 100% formic acid was added and the mixture 
was incubated for 2 min at RT, and quenched by addition of 200 µl stop buffer (300 mM 
NaOAc [pH 5.2], 0.1 mM EDTA [pH 8.0], 0.1 mg/ml yeast tRNA) and 150 µl 100% 
ethanol chilled to -20°C. DNA was precipitated by centrifugation at 14,000 rpm for 10 
min and washed twice with 70% ethanol. The pellet was resuspended in 200 µl dH2O 
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and precipitated once more, washed with 70% ethanol, and dried in a SpeedVac. The 
dried pellet was resuspended in 70 µl 10% (v/v) piperidine, transferred to a screw-cap 
tube and incubated in a 90°C heat block for 30 min. Piperidine was evaporated in a 
SpeedVac, and the pellet was resuspended in 30 µl of dH2O. The DNA was then 
transferred to a fresh tube to minimise piperidine contamination, and dried again in a 
SpeedVac. This was repeated twice more, resuspending in 20 µl dH2O the first time, 
and 10 µl formamide loading buffer the second time.  
 
(F) In vivo RAG activity assays 
 
2.43 Cloning of 23RSS-containing plasmid substrate 
The 23RSS-containing plasmid used in extrachromosomal RAG activity assays 
(Section 2.44-2.47) was made by replacing the 12RSS in pJβ2.7+ (Fig. 2.5). Briefly, 
oligonucleotides containing a consensus 23RSS oligonucleotide with terminal BamHI 
and HindIII sites (23RSSF and 23RSSR, Table 2.1) were annealed and phosphorylated 
using T4 PNK as in Section 2.35, except non-radioactive dATP was used instead of [γ-
32P]-ATP. The phosphorylated 23RSS oligonucleotide was then ligated (Section 2.9) 
with pJβ2.7+ cut with BamHI and HindIII to make p23+ (Fig. 2.6). 
 
2.44 Transfection of NIH/3T3 cells 
NIH/3T3 cells were maintained in DMEM-complete, splitting 1:10 when a confluency of 
~90% was reached. NIH/3T3 cells were plated at 1 x 106 cells/10 cm dish in 10 ml 
DMEM-complete the day before transfection. Cells were transfected with 2 µg of RSS-
containing plasmid and/or an ESC plasmid, and 1 µg each of RAG1 and RAG2 
expression vectors using PEI as in Section 2.32. Cells were harvested by scraping 48 h 
after transfection. Plasmid DNA was extracted using the method described by Hirt 
(1987; Section 2.42), and resuspended in 20 µl of dH2O. 1 µl of each sample was 
analysed by qPCR (Section 2.46). The amount of intact 12RSS plasmid (pJβ2.7+) was 
quantified using primer pair re-int1 and re-int2, and the amount of intact 23RSS 
plasmid (p23+) using 23RSS fwd and 23RSS rev. The total amount of 12RSS 
(pJβ2.7+) or 23RSS plasmid (p23+) was quantified using primers Neo3 fwd and Neo3 
rev. The amount of intact ESC plasmid (pJδ1+) was quantified using primer pair Jdcut 
fwd and Jdcut rev. The total amount of pJδ1+ was quantified using primers Jdnorm fwd 
and Jd norm rev (all primer sequences can be found in Table 2.3). Thermal cycling 
conditions were as follows: 
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95°C 6 min 
95°C 10 s 
Tm 15 s   40 cycles 
72°C 10 s 
 
2.45 Extraction of plasmid DNA from transfected mammalian cells 
Plasmid DNA was extracted from transfected NIH/3T3 cells using the method 
described by Hirt (1967). Transfected cells were washed twice with 3 ml of PBS, and 
lysed directly on the plate by addition of 0.8 ml of buffer 1 (0.6% (w/v) SDS, 0.01 M 
EDTA [pH 7.5]), and incubation at RT for 10 min. 0.2 ml of buffer 2 (5 M NaCl) was 
added and mixed by swirling to neutralize, and left for 2 min, after which the cells were 
scraped into a 1.5 ml tube and stored at 4°C overnight. SDS and protein was removed 
by centrifugation at 14,000 rpm, 4°C, for 40 min. The supernatant was transferred to a 
fresh tube and DNA was cleaned by two rounds of phenol-chloroform 
extraction/ethanol precipitation. 1 ml 100% butanol was added, mixed vigorously, and 
spun at top-speed for 1 min. The butanol layer was removed and DNA was precipitated 
in 100% ethanol and NaOAc, then washed in 1 ml 70% ethanol (Hirt, 1967).  
 
2.46 Quantitative PCR 
A typical quantitative PCR contained 5 µl 2x SensiFAST SYBR® No-ROX mix (Bioline 
#BIO-98080), 400 nM of forward and reverse primers (Table 2.1) and 1 µl of sample in 
a total volume of 10 µl. PCRs were carried out in a Corbett RotorGene 6000 qPCR 
machine, and analysed using the Corbett Rotor-Gene 6000 Series Software (v.1.7, 
build 87). In each case, a standard curve of samples containing the amplified region 
was analysed alongside in order to calculate the relative amount of product in each of 
the unknown samples. A no-template control was included in each run to test for cross-
contamination.  
 
2.47 Ligation-mediated PCR (LM-PCR) of extrachromosomal substrates 
Plasmid DNA extracted from transfected NIH/3T3 cells (Section 2.44) was used in an 
LM-PCR assay to determine whether a decrease in qPCR product (Section 2.46) was 
caused by double-strand breaks at the plasmid RSS, or by nicking of the plasmid RSS, 
since qPCR cannot distinguish between these two possibilities. Only double-strand 
breaks will ligate with a linker oligonucleotide and give an LM-PCR product. 5 ng of 
extracted plasmid DNA digested with EcoRV was used as a positive control and 
processed in the same way as undigested. FM25 and FM11 oligonucleotides (Table 
2.3) were annealed and used in a ligation reaction containing 5 ng extracted plasmid 
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DNA (from Section 2.45), 3 µl 10x T4 DNA ligase buffer and 5 units T4 DNA ligase in a 
final volume of 30 µl. Ligation reactions were incubated at 16°C for 16 h, then purified 
by phenol-chloroform extraction/ethanol precipitation and resuspended in 10 µl dH2O. 
In the first round of PCR, 2 µl resuspended DNA was used in a reaction containing 3 µl 
10x ThermolPol buffer, 1 µl Vent polymerase (NEB #M0254), 0.6 µM each of CMVfwd 
and FM25 primers (Table 2.3), and 300 nM each dNTP in a total of 30 µl. Cycling 
conditions were as follows: 
 
95°C 5 min 
95°C 30 s 
57°C 20 s       25 cycles 
72°C 30 s 
72°C 7 min 
 
In the second round of PCR, 1 µl first round PCR product was used in a reaction 
identical to the first round of PCR, except using the 12RSS fwd and FM25 primers 
(Table 2.3). Cycling conditions were also identical, except the temperature of the 
annealing step was 60°C. Reaction products were then separated by agarose gel 
electrophoresis, dried in a vacuum drier with a heated lid, and visualised using an FLA-
1500 phosphorimager (FujiFilm). 
 
2.48 Quantitative PCR of Vλ1-JCλ1 recombination in mouse pro-B cells 
Purified samples of transgenic (PIP3; Bevington and Boyes, 2013) and non-transgenic 
mouse pro-B cell DNA were a kind gift from James Scott (Boyes laboratory, University 
of Leeds, UK). Amplification of recombined Vλ1-JCλ1 recombined gene segments 
required an initial round of standard PCR (Section 2.5) to improve specificity of the 
quantitative step, using primers V1SacIF and J1StyIR (Table 2.3). The following 
thermal profile was used: 
 
95°C 5 min 
95°C 30 s 
55°C 20 s         15 cycles 
68°C 30s 
68°C 5 min 
 
Products from the first round of PCR were then diluted 1:10 with dH2O, and 1.5 µl was 
used in a nested qPCR assays, using primers V1RSSF and J1RSSR (Section 2.46). 
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Vλ1-Jλ1 ESC was quantified using 1 µl of each DNA sample and primers ESC F and 
ESC V1 R (Table 2.3). To test the specificity of ESC amplification, a portion of each 
sample was digested with ApaLI restriction enzyme (NEB #R0507), which cleaves the 
ESC at the head-to-head RSS junction, for 16 h at 37°C. Digestions were quenched by 
SDS/Proteinase K digestion (0.5% SDS and 0.2 µg/µl proteinase K) at 56°C for 1 h, 
and purified by phenol-chloroform extraction/ethanol precipitation. In all cases, the 
relative amount of DNA in each sample was quantified using primers that amplify the 
GAPDH gene (GAPDH F and GAPDH R2, Table 2.3). Data were then normalised by 
dividing the amount of Vλ1-Jλ1 recombination or Vλ1-Jλ1 ESC product by the amount 
of GAPDH product. 
 
Table 2.1 – Oligonucleotides used for cloning. All oligonucleotides were synthesised then purified by 
desalting by Sigma (Poole, UK).  
 
 
 
 
 
 
 
 
 
Oligonucleotide Sequence (5’-3’) 
FLAG-His adaptor F 
GGATCCCATGGCACATCATCACCATCACCACCATCACCATCCAGA
CTACAAGGACGACGACGACAAACCAGAATTCCTA 
FLAG-His adaptor R 
TAGGAATTCTGGTTTGTCGTCGTCGTCCTTGTAGTCTGGATGGTG
ATGGTGGTGATGGTGATGATGTGCCATGGGATCC 
RAG1 SmaI F CAGACCCGGGATGGCTGCCTCCTTGCCGTCT 
RAG1 XhoI R ACTCCTCGAGGGAGAAGACCTCACTGCAACCC 
RAG2 EcoRI F CCGAATTCATGTCCCTGCAGATGGTAACAGTG 
RAG2 XhoI R GTCCTCGAGGTCCGACGGTATCGATAAGCTTG 
VacV RAG F TCAACAAGGGGCTGAAGGATGC 
VacV RAG R TTTCGGGCTTTGTTAGCAGCCG 
RAG1 NdeI F GACTACCATATGATGGCTGCCTCCTTGCCG 
RAG1 BamHI R TCAGTCGGATCCAAATACCAACTTCTATGTGG 
RAG2 NdeI F GACTACCATATGATGTCCCTGCAGATGGTAAC 
RAG2 BamHI R TCAGTCGGATCCCAATATACCTGAGTCTGAGG 
MBP flRAG F TCGATGTCTAGACCACCATGGAAATCGAAGAAGGTAAAC 
MBP cRAG2 TAGCATGGATCCTTAGTCGACACTGAAACAAAATTCCTCTGAGTC 
cRAG1 F NdeI ATGCTACATATGGTGCATATCAATAAAGGGGGACG 
cRAG R TAGCATGGATCCTTACGCGTTATGAGCATTCATA 
23RSSF AGCTTCCAAAAACATGTCGGTCTGTCACCTCATGATGGTGACACG 
23RSSR GATCCGTGTCACCATCATGAGGTGACAGACCGACATGTTTTTGGA 
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Table 2.2 – Oligonucleotides used as in vitro RAG substrates. Heptamer and nonamer sequences are 
underlined. All oligonucleotides were synthesised and desalted by Sigma, then purified by denaturing 
PAGE (Section 2.34). 
 
 
 Oligonucleotide Sequence (5’-3’) Reference 
DAR39 (12RSS top) 
GATCTGGCCTGTCTTACACAGTGCTACAGACTGGAACAAA
AACCCTGCAG 
McBlane et 
al. (1995) 
DAR40 (12RSS bottom) 
CTGCAGGGTTTTTGTTCCAGTCTGTAGCACTGTGTAAGAC
AGGCCAGATC 
McBlane et 
al. (1995) 
DG61 (23RSS top) 
GATCTGGCCTGTCTTACACAGTGGTAGTACTCCACTGTCT
GGCTGTACAAAAACCCTGCAG 
McBlane et 
al. (1995) 
DG62 (23RSS bottom) 
CTGCAGGGTTTTTGTACAGCCAGACAGTGGAGTACTACC
ACTGTGTAAGACAGGCCAGATC 
McBlane et 
al. (1995) 
MBNSJ top (ESC top) 
CTGCAGGGTTTTTGTTCCAGTCTGTAGCACTGTGCACAGT
GGTAGTACTCCACTGTCTGGCTGTACAAAAACCCTGCAG 
Neiditch et 
al (2002) 
MBNSJ bottom (ESC 
bottom) 
CTGCAGGGTTTTTGTACAGCCAGACAGTGGAGTACTACC
ACTGTGCACAGTGCTACAGACTGGAACAAAAACCCTGCA
G 
Neiditch et 
al. (2002) 
DAR81 (nonspecific top) 
GATCTCGCCTCTCTTAGGTTAATCCTATAGAACTCGTCCC
CGTACCTCGAG 
Ramsden et 
al., 1996 
DAR82 (nonspecific 
bottom) 
CTAGAGCGGAGAGAATCCAATTAGGATATCTTGAGCAGG
GGCATGGAGCTC 
Ramsden et 
al., 1996 
ESC 12d7 top 
CTGCAGGGTTTTTGTTCCAGTCTGTAGCACAGTGGTAGTA
CTCCACTGTCTGGCTGTACAAAAACCCTGCAG 
- 
ESC 12d7 bottom 
GACGTCCCAAAAACAAGGTCAGACATCGTGTCACCATCAT
GAGGTGACAGACCGACATGTTTTTGGGACGTC 
- 
ESC 23d7 top 
CTGCAGGGTTTTTGTTCCAGTCTGTAGCACTGTGGTAGTA
CTCCACTGTCTGGCTGTACAAAAACCCTGCAG 
- 
ESC 23d7 bottom 
GACGTCCCAAAAACAAGGTCAGACATCGTGACACCATCA
TGAGGTGACAGACCGACATGTTTTTGGGACGTC 
- 
ESC 23d9 top 
CTGCAGGGTTTTTGTTCCAGTCTGTCGCACTGTGCACAGT
GGTAGTACTCCACTGTCTGGCTGTCTGCAG 
- 
ESC 23d9 bottom 
CTGCAGACAGCCAGACAGTGGAGTACTACCACTGTGCAC
AGTGCGACAGACTGGAACAAAAACCCTGCAG 
- 
12d7 top 
GATCTGGCCTGTCTTACTACAGACTGGAACAAAAACCCTG
CAG 
- 
12d7 bottom 
CTGCAGGGTTTTTGTTCCAGTCTGTAGCACTGTGTAAGAC
AGGCCAGATC 
- 
23RSSm9 top 
GATCTGGCCTGTCTTACACAGTGGTAGTACTCCACTGTCT
GGCTGTGCGCTTATTCTGCAG 
- 
23RSSm9 bottom 
CTGCAGAATAAGCGCACAGCCAGACAGTGGAGTACTACC
ACTGTGTAAGACAGGCCAGATC 
- 
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Table 2.3 – Primers used for LM-PCR and qPCR assays. All oligonucleotides were synthesised and 
purified by desalting by Sigma (Poole, UK). The Tm used for each primer pair is shown, as calculated using 
the online OligoCalc software (Kibbe, 2007), using the salt-adjusted formula. 
 
Oligonucleotide Sequence (5’-3’) Tm (°C) 
Re-int 1 GAGCTCGGGGAGCCTTAG 
60 
Re-int 2 AATCTCACCTGTGACCGTGAG 
23RSS fwd AAACATGTCGGTCTGTCACC 
60 
23RSS rev TCTGCAGAATTCCACCACAC 
Neo3 fwd TGCTCCTGCCGAGAAAGTATC 
60 
Neo3 rev TTTCGCTTGGTGGTCGAATG 
Jdcut fwd CGGTTTTTGGAACGTCCTCAAG 
60 
Jdcut rev TTTTCCAAAGCGGTCGACAG 
Jdnorm fwd GTCGCCTTCTTGCACATTACTC 
60 
Jdnorm rev AACAACAGATGGCTGGCAAC 
FM25 GCGGTGACTCGGGAGATCTGAAGTG - 
FM11 CACTTCAGATC - 
CMVfwd CGCAAATGGGCGGTAGGCGTG - 
12RSS fwd CTTCCTGTGCTGGGAGACCT - 
V1SacIF GCCAACTGGGTCCAAGAAAAAC 
58 
J1StyIR GCACCTCAAGTCTTGGAGAG 
V1RSSF GGCACAGACTGAGGATGAG 
55 
J1RSSR CAGTCAGTTTGGTTCCTCCA 
ESC F GATGTCACCACCTTGGAAGAA 
58 
ESC V1R GAAGATGGTAGTTATGAGACTGTACCAG 
GAPDH F ACTTTCTTGTGCAGTGCCAGC 
56 
GAPDH R2 GCACACTTCGCACCAGCATC 
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2.49 Plasmid Maps 
 
Maps for all plasmids used in this thesis are provided below. Only the final clones are 
given; cloning intermediates and source vectors are not shown. The complete 
sequence of pETM11-HMGB1 was not provided by Prof Bianchi so a map could not be 
made. Plasmid maps were generated using SnapGene software (v2.5). 
 
 
 
Figure 2.1 – Map of pEF-MfR1. All unique restriction sites with a recognition sequence of 6 bp or more 
are shown. Blunt cutters are shown in green. AmpR = Ampicillin resistance gene, ori = origin of replication, 
SV40 = simian virus 40, MBP = maltose-binding protein, EF-1α intron A = elongation factor-1α promoter. 
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Figure 2.2 – Map of pEF-MfR2. All unique restriction sites with a recognition sequence of 6 bp or more 
are shown. Blunt cutters are shown in green. AmpR = Ampicillin resistance gene, ori = origin of replication, 
SV40 = simian virus 40, EF-1α intron A = elongation factor-1α promoter, MBP = maltose-binding protein. 
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Figure 2.3 – Map of pEF-McR1. All unique restriction sites with a recognition sequence of 6 bp or more 
are shown. Blunt cutters are shown in green. AmpR = Ampicillin resistance gene, ori = origin of replication, 
SV40 = simian virus 40, EF-1α intron A = elongation factor-1α promoter, MBP = maltose-binding protein. 
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Figure 2.4 – Map of pEF-McR2. All unique restriction sites with a recognition sequence of 6 bp or more 
are shown. Blunt cutters are shown in green. AmpR = Ampicillin resistance gene, ori = origin of replication, 
SV40 = simian virus 40, MBP = maltose-binding protein coding sequence, EF-1α intron A = elongation 
factor-1α promoter. 
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Figure 2.5 – Map of pJβ2.7+. pJβ2.7+ contains the CMV promoter upstream of a 12RSS to enable 
transcription through the 12RSS. All unique restriction sites with a recognition sequence of 6 bp or more 
are shown. Blunt cutters are shown in green. AmpR = Ampicillin resistance gene, CMV = human 
cytomegalovirus, ori = origin of replication, SV40 = simian virus 40, NeoR/KanR = neomycin/kanamycin 
resistance gene. 
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Figure 2.6 – Map of p23+. All unique restriction sites with a recognition sequence of 6 bp or more are 
shown. Blunt cutters are shown in green. AmpR = Ampicillin resistance gene, CMV = human 
cytomegalovirus, ori = origin of replication, SV40 = simian virus 40, NeoR/KanR = neomycin/kanamycin 
resistance gene.  
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Figure 2.7 – Map of pJδ1+. All unique restriction sites with a recognition sequence of 6 bp or more are 
shown. Blunt cutters are shown in green. AmpR = Ampicillin resistance gene, CMV = human 
cytomegalovirus, Signal Joint = head-to-head 12RSS-23RSS, ori = origin of replication, SV40 = simian 
virus 40. 
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Chapter 3 
 
Analysis of RAG cleavage in an RSS-ESC complex 
 
A) Introduction 
 
It is well-documented that mistakes in V(D)J recombination trigger leukaemias and 
lymphomas via chromosome translocations, and these translocations seem to be the 
major way in which V(D)J recombination causes cancer (Kuppers, 2005). In the late 
1990s, the idea emerged that the RAG recombinase could trigger leukaemia via a 
process called transposition (van Gent et al., 1996b; Agrawal et al., 1998; Hiom et al., 
1998). In a transposition reaction, the ESC is reinserted back into the genome at any 
location in a non-sequence specific reaction (Hiom et al., 1998). Whilst random 
insertion of broken signal ends has been proven to occur in vitro, to date there is only 
limited evidence that this reaction occurs in vivo (Messier et al., 2003; Messier et al., 
2006). Importantly, no transposition events have been detected in cancer patients. 
 
Two papers published in the same year showed that ESCs could be reinserted into the 
genome in a different way, via a process called reintegration (Curry et al., 2007; 
Vanura et al., 2007). During reintegration, RAG proteins form a complex between an 
ESC and a genomic RSS, catalyse the cleavage of both substrates, and transfer the 
broken ends to the NHEJ proteins so that the ESC is reinserted back into the genome. 
Reintegration differs from transposition in that reintegration is sequence-specific, 
occurring only at a genomic RSS, and proceeds via the same biochemical mechanism 
as standard V(D)J recombination (Vanura et al., 2007). This reaction could occur at a 
legitimate RSS, or perhaps more dangerously, at a cryptic RSS. There are predicted to 
be over 15 million cryptic RSSs scattered throughout the human genome (Lewis et al., 
1997), and a number of these are adjacent to oncogenes (Boehm et al., 1988; Kuppers 
and Dalla-Favera, 2001). Some ESC by-products, depending on their origin, will 
contain strong promoter elements from the antigen receptor loci (Fig. 1.11B). 
Therefore, it is feasible that an ESC containing a promoter could undergo reintegration 
adjacent to an oncogene, thereby upregulating the expression of that oncogene, and 
contribute to leukaemia and lymphoma formation. 
 
One of the studies that reported reintegration of ESCs also found that mice expressing 
core RAG2 gave a higher level of reintegration events, suggesting that the RAG2 C-
terminus can inhibit reintegration (Curry et al., 2007). In order determine whether there 
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are any key differences in RAG-RSS and RAG-ESC interactions that could either 
explain the mechanism by which the RAG2 C-terminus inhibits reintegration, or be 
exploited by small molecule inhibitors to completely inhibit reintegration, I carried out in 
vitro analyses of RAG activity at RSSs versus ESCs.  
 
The first part of this chapter describes the purification of core RAG1 and core RAG2 
(cRAG) and high mobility group B1 (HMGB1) proteins required for the in vitro analyses 
and the optimization of the reaction conditions required to accurately recapitulate in 
vivo recombinase activity. Once I had determined suitable reaction conditions, I found 
that cleavage and stimulation of 12 and 23RSSs is roughly equivalent, but that 
cleavage of the ESC is less efficient, indicating an asymmetry in cleavage between 
RSSs and ESCs. Whilst not entirely at odds with the model of reintegration, I put 
forward an alternative mechanism to describe the outcome of the majority of RAG-
ESC-RSS interactions called cut-and-run. In cut-and-run, an ESC stimulates cleavage 
at an RSS, whilst remaining intact in the majority of interactions. This intact ESC could 
potentially stimulate cleavage at a second RSS, and repeat the process of cleavage 
and running to another RSS until it is lost through cell division or cleaved by RAG 
proteins or other cellular nucleases.  
 
Whilst cRAG proteins are more amenable to purification, they might not accurately 
recapitulate full-length RAG activity, so it was necessary to purify the full-length RAG 
(flRAG) proteins. The second part of this chapter discusses issues surrounding 
successful purification of flRAG proteins and presents the results from their use in 
activity assays. I find that cleavage shows some asymmetry between a 12RSS and 
ESC, albeit with a lower overall asymmetry than with core RAG proteins, but cleavage 
between a 23RSS and ESC is not at all asymmetric. Inaccuracies caused by the 
overall low activity of the flRAG proteins could have influenced these results; 
nevertheless, in vivo data presented in Chapter 5 shows that full-length RAG cleavage 
of RSSs and ESCs is indeed asymmetric. 
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B) Results 
 
3.1 Purification of core RAG proteins and HMGB1  
 
Until recent years, the majority of biochemical analyses of V(D)J recombination and the 
RAG recombinase have been performed using truncated versions of the RAG1 and 
RAG2 proteins. Early work on the RAG proteins identified the minimal core regions of 
RAG1 and RAG2 that are necessary and sufficient to carry out recombination of 
extrachromosomal substrates in vivo (Sadofsky et al., 1993; Silver et al., 1993; Cuomo 
and Oettinger, 1994; Sadofsky et al., 1994; Kirch et al., 1996). For RAG1, this 
encompasses residues 384-1008 of 1040, which contain the nonamer binding domain 
(Difilippantonio et al., 1996; Spanopoulou et al., 1996) and the DDE motif of the active 
site (Kim et al., 1999). The core region of RAG2 includes residues 1-384 out of 527, 
which removes several conserved but non-essential domains including a plant 
homeodomain (PHD) finger which binds to H3K4me3, and an acidic “hinge” region 
(Matthews et al., 2007; Ramon-Maiques et al., 2007), the function of which is less 
clear, but which might be involved in directing the broken ends RSS ends to the 
nonhomologous NHEJ machinery, and away from the alternative NHEJ pathway 
(Chaumeil et al., 2013). Recently, the minimal region of RAG2 has been reduced to 
residues 1-360 (Corneo et al., 2007; Schatz and Swanson, 2011), but the vast majority 
of published data have been made using residues 1-387 of RAG2, and it is this version 
of core RAG2 that is used here. 
 
The core versions of the RAG proteins are considerably easier to express and purify in 
large quantities than the full-length counterparts, and co-expression increases both the 
yield and activity of the RAG proteins compared to when they are expressed separately 
(Swanson, 2004). Therefore, core RAG1 (cRAG1) and core RAG2 (cRAG2) were 
purified from Sf9 cells infected with baculoviruses that express cRAG1 and cRAG2 with 
maltose binding protein (MBP), 9xHis and 3xmyc tags (Fig. 3.1A). To obtain optimal 
cRAG expression, stocks of cRAG1 and cRAG2 baculoviruses were plaque-purified 
and amplified to ensure clonally identical stocks (Section 2.16). Following estimation of 
their titers by plaque assay (Section 2.15), they were then used to infect large 
suspension cultures of Sf9 insect cells. cRAG proteins were co-purified from infected 
cells by Ni2+ affinity chromatography followed by amylose affinity chromatography 
(Section 2.17; Fig. 3.1B). One litre of infected cells typically yields ~150 µg of purified 
RAG proteins that are greater than 95% pure, as judged by SDS-PAGE (Fig. 3.1B). 
The ratio of cRAG1:cRAG2 is usually around 2:1, possibly because RAG2 is more 
 Analys is  o f  RAG c leavage in  an RSS -ESC complex | 84 
 
 
prone to degradation by cellular proteases, or is less efficiently expressed in Sf9 cells 
than RAG1.  
 
 
 
Figure 3.1 – Purified core RAG proteins and HMGB1 (A) Schematic of MBP-, 9xHis- and 3xmyc-tagged 
core RAG fusion proteins. MBP = Maltose binding protein, H = 9xHis tag, M = 3xmyc tag. (B) Purified 
MBP-tagged core RAG1 (118 kDa) and MBP-tagged core RAG2 (90 kDa). The different lanes show 
samples of the 1 ml fractions collected from the amylose column. M = marker, * = contaminant/degradation 
product. (C) Purified full-length HMGB1 (26 kDa) 
 
As described in Section 1.8, HMGB1 is a nonspecific DNA-binding protein that can 
incorporate into the RAG-RSS complex and stimulate RAG cleavage of 23RSSs by 
binding in the spacer and bringing the heptamer and nonamer closer together (van 
Gent et al., 1997; Swanson, 2002a). As a result, HMGB1 is routinely included in in vitro 
RAG activity assays (Swanson, 2004). Therefore, 6xHis-tagged full-length rat HMGB1 
was expressed in the BL21(DE3) strain of E.coli and purified first by Ni2+ affinity 
chromatography and then by anion exchange chromatography (Section 2.18; Fig. 
3.1C). One litre of induced E. coli typically yields ~10 mg of highly pure full-length 
HMGB1 (>98% pure, Fig. 3.1C). 
 
3.2 Establishing in vitro reaction conditions: stimulation of RAG cleavage is 
non-specific in the presence of Mn2+ 
 
Reintegration involves pairing either the 12 or 23RSS from an ESC with an appropriate 
partner RSS. Before investigating this mechanism, it was important to first verify that 
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the purified RAG proteins were behaving in the manner expected when utilising 
standard 12 and 23RSSs. Therefore, well-established reaction conditions were used to 
assess the activity of RAG proteins on radiolabelled oligonucleotides containing the 
sequence of either a 12 or 23RSS (McBlane et al., 1995).  
 
In a typical cleavage assay, a radiolabelled oligonucleotide encoding a 12RSS, 23RSS 
or ESC is incubated with core RAG1, core RAG2, HMGB1, and a non-labelled partner 
RSS. The cleavage products are separated on a native polyacrylamide gel and 
visualised using a PhosphorImager (Section 2.37). The oligonucleotides contain the 
same consensus heptamer and nonamer sequences and differ only in spacer length. 
Heptamer and nonamer sequences that deviate from the consensus can affect the 
efficiency with which RSSs are bound and cleaved (Ramsden et al., 1996); therefore 
identical heptamer and nonamer sequences were used for both 12 and 23RSS 
oligonucleotides. 
 
In vivo, efficient recombination only occurs between two coding segments flanked by 
RSSs of different spacer length, i.e. a 12 and 23 RSS, a requirement known as the 
12/23 rule (Tonegawa, 1983) and this specificity is reflected in vitro (van Gent et al., 
1996c; Hiom and Gellert, 1998). When a radiolabelled 12RSS (DAR39/DAR40, Table 
2.2) is incubated with cRAG proteins, HMGB1 and a less than equimolar amount of 
unlabelled 23RSS, the level of cleavage is low (Fig. 3.2A, lanes 2-7). However, the 
level of cleavage increases up to 40-fold when the unlabelled 23RSS (DG61/DG62, 
Table 2.2) is at equimolar concentrations or higher (Fig. 3.2A, lanes 7-11). The same 
stimulatory effect is also seen when the 23RSS is labelled. The efficiency of cleavage 
is low in the absence of a partner RSS, but addition of unlabelled 12RSS above an 
equimolar amount causes an increase in cleavage (Fig. 3.2B). Overall, the 23RSS is 
cleaved less efficiently than a 12RSS, consistent with previous studies (van Gent et al., 
1996a; Ramsden et al., 1997). 
 
Next, to mimic synaptic complex formation during reintegration, a labelled 12 or 23RSS 
oligonucleotide was paired with an oligonucleotide containing a signal joint where a 12 
and 23RSS are joined at the heptamer sequence (MBNSJ-top/MBNSJ bottom, Table 
2.2), as is the case with an ESC. The level of cleavage at both a 12 and 23RSS is 
stimulated to a similar level, as would be expected since an ESC contains both a 12 
and a 23RSS and therefore could form a synaptic complex with either type of RSS (Fig. 
3.3). However, when the ESC is labelled, the level of cleavage remains relatively low 
regardless of the amount or type of partner RSS present (Fig. 3.4), indicating a 
potential asymmetry in stimulation and cleavage at an RSS-ESC pair.  
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Figure 3.2 – RSSs co-stimulate RAG cleavage in the presence of Mn
2+
. (A) 2 nM radiolabelled 12RSS 
oligonucleotide (DAR39/DAR40) was incubated at 37°C for 1.5 hours with purified cRAG1 and cRAG2, 
HMGB1, and an unlabelled 23RSS oligonucleotide (DG61/DG62), ranging from 0.16- to 8-fold excess of 
unlabelled partner. The cleavage efficiency as a percentage of the total labelled substrate and the molar 
ratio of unlabelled partner is shown below each lane. The substrates used are shown above the gel, with a 
yellow star indicating the location of the radiolabel. (B) As for A, except the 23RSS was radiolabelled and 
an unlabelled 12RSS oligonucleotide was titrated.  
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Figure 3.3 – ESCs stimulate RSS cleavage in Mn
2+
. (A) 2 nM radiolabelled 12RSS oligonucleotide was 
incubated at 37°C for 1.5 hours with purified cRAG1 and cRAG2, HMGB1, and an unlabelled ESC 
oligonucleotide (MBNSJ top/MBNSJ bottom), ranging from 0.16- to 8-fold excess of unlabelled partner. 
The cleavage efficiency as a percentage of the total labelled substrate and the amount of unlabelled 
partner is shown below each lane. The substrates used are shown above the gel, with a yellow star 
indicating the location of the radiolabel. (B) As for A, except the 23RSS (DG61/DG62) was radiolabelled.  
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Figure 3.4 – Cleavage at RSS-ESC complexes in Mn
2+
. (A) 2 nM radiolabelled ESC oligonucleotide was 
incubated at 37°C for 1.5 hours with purified cRAG1 and cRAG2, HMGB1, and an unlabelled 12RSS 
oligonucleotide, ranging in concentration from 0.16- to 8-fold excess. The cleavage efficiency as a 
percentage of the total labelled substrate and the amount of unlabelled partner is shown below each lane. 
The substrates used are shown above the gel, with a yellow star indicating the location of the radiolabel. 
(B) As for A, except an unlabelled 23RSS was titrated. 
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The ESC substrate would more accurately be called a signal joint or excised signal 
joint instead of an ESC, since the two head-to-head RSSs are located on a short linear 
oligonucleotide and not a circular piece of DNA. For the sake of clarity and consistency 
however, the oligonucleotide ESC substrate will be referred to as an ESC for the 
entirety of this thesis. 
 
To test the sequence-specificity of this reaction, I added a non-specific oligonucleotide 
(DAR81/DAR82, Table 2.2) to a labelled 12 or 23RSS. Surprisingly, the non-specific 
oligonucleotide also stimulates cleavage at an RSS by the same amount as an RSS or 
ESC (Fig. 3.5). A likely cause of this non-specific stimulation is the divalent metal 
cation used in the reaction buffer. I initially used Mn2+ as the divalent metal cation 
because higher levels of RAG activity were generally observed with this cation, and at 
first, my purified cRAG proteins were not active in Mg2+. As is the case with many DNA-
processing proteins, including retroviral integrases (Bujacz et al., 1997), T7 DNA 
polymerase and E. coli DNA polymerase I (Tabor and Richardson, 1989), Mn2+ can be 
utilised by RAG proteins in place of Mg2+ (Santagata et al., 1998). In most cases, the 
catalytic activity of DNA processing proteins is more efficient in the presence of Mn2+ 
than Mg2+, but at the expense of greater promiscuity. This is also true of the RAG 
proteins, since Mn2+ has been shown to uncouple the cleavage reaction, allowing 
efficient hairpin formation at a single RSS outside of the 12/23 restriction (McBlane et 
al., 1995; van Gent et al., 1996c; Santagata et al., 1998). A bandshift assay (Section 
2.39) confirmed that the non-specific oligonucleotide is indeed bound by the RAG 
proteins (Fig. 3.6, top panel), as would be expected if it is to stimulate cleavage at an 
RSS. However, a cleavage assay in the same conditions shows that the non-specific 
oligonucleotide is not cut by RAG proteins (Fig. 3.6, bottom), confirming that although 
the RAG proteins can efficiently bind to DNA without a signal sequence, an RSS is 
essential for RAG cleavage of DNA. Since Mn2+ facilitates non-specific stimulation of 
RAG activity outside the 12/23 rule, it is not suitable for use as a cofactor in 
determining the effect of ESCs on RSS cleavage and RAG-ESC interactions. 
Therefore, it was important to repeat these experiments in the presence of Mg2+, as the 
stimulation of RAG activity is expected to be sequence-specific under these conditions.  
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Figure 3.5 – Stimulation of core RAG activity is not sequence-specific in the presence of Mn
2+
. (A) 
Addition of a non-specific 50 bp oligonucleotide to 2 nM 12RSS stimulates cRAG activity by the same 
amount as another RSS, indicating that stimulation is not sequence-specific in the presence of Mn
2+
. (B) 
As for (A) except a labelled 23RSS oligonucleotide was used. NS = non-specific 50mer.
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Figure 3.6 – Non-specific DNA is bound but not cleaved in the presence of Mn
2+
 by core RAG 
proteins. A bandshift assay using a labelled non-specific 50mer indicates that the non-specific 
oligonucleotide is bound by the cRAG proteins, but is not cleaved (bottom panel). The far right lane is a 
positive control showing binding and cleavage at a labelled 12RSS.  
 
3.3 Establishing in vitro reaction conditions: RAG cleavage adheres to the 
12/23 rule in the presence of Mg2+ 
 
Initially, Mg2+ was substituted for Mn2+, keeping all other factors and reaction 
components the same as in previous experiments. However, I did not observe efficient 
hairpin formation under these conditions (Fig. 3.7A, left). Although several studies have 
reported RSS cleavage in these conditions (van Gent et al., 1996c; Eastman and 
Schatz, 1997; Hiom and Gellert, 1998), the Swanson group routinely includes 20% 
dimethyl sulphoxide (DMSO) in their reactions, since they observe that addition of 
DMSO promotes the accurate production of hairpins and without DMSO, RAG 
cleavage in Mg2+ is inefficient and largely off-target (Bergeron et al., 2006). In my 
hands, DMSO is essential for efficient hairpin formation when Mg2+ is the metal 
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cofactor (Fig. 3.7A, right panel). Although several faint bands can be seen in the 
absence of DMSO, one of which is the correct size for a hairpin product (Fig. 3.7A, left 
panel), DMSO appears to be essential for efficient and correct hairpin formation in 
Mg2+-containing buffer (Fig. 3.7A, right panel).  
 
I next examined the stimulation of RAG cleavage by a partner substrate in the 
presence of Mg2+ and DMSO. Other groups have reported that cleavage of a single 
RSS in Mg2+ is inefficient, and efficient cleavage requires the presence of a suitable 
partner RSS. Contrary to this, I observed that after incubation for 2 hours at 37°C, 
addition of a partner reduces the cleavage efficiency (Fig. 3.7A, right panel, and Fig. 
3.7B, top panel). However, co-stimulation is observed if the incubation time is 
shortened to 15 minutes (Fig. 3.7B, bottom panel). 
 
One possible explanation is that in the presence of Mg2+ conditions, cRAG proteins can 
undergo one of two reactions: an initial “fast” coupled reaction, and a slower uncoupled 
reaction. In the initial coupled reaction, RAG proteins form a synaptic complex with two 
RSS substrates, where each substrate stimulates cleavage at the other, as seen after a 
15 minute incubation (Fig. 3.7B, bottom panel). In the uncoupled reaction, RAG 
proteins bind to and cleave a single RSS. The rate of this reaction is slower than the 
coupled reaction, and after longer incubation periods the products from cleavage at a 
single RSS accumulate. At concentrations where the unlabelled partner is in excess, 
single cleavage of the unlabelled partner outcompetes cleavage at the labelled 
substrates, hence the apparent decrease in cleavage at higher concentrations of 
partner. An undesirable side-effect of a short incubation time is that the overall level of 
cleavage (between 1-10%) is much lower than in previous experiments performed for 
1.5 hours in the presence of Mn2+ (e.g. up to 80% cleavage, Fig. 3.2A).  
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Figure 3.7 – DMSO is essential for efficient RAG cleavage in the presence of Mg
2+ 
(A) 2 nM 
radiolabelled 12RSS was incubated for 2.5 hours at 37°C with cRAG proteins, HMGB1, and 0.01 - 4 nM 
unlabelled 23RSS in the presence of Mg
2+
, either without (left) or with (right) 20% (v/v) DMSO. Efficient 
cleavage is only observed in the presence of DMSO (B) Labelled 12RSS oligo was incubated with 
unlabelled 23RSS (left), lanes 3-9) or ESC (lanes 10-16) for either 2 hours or 15 min. Stimulation by a 
partner or an ESC is only observed after a short incubation (lanes 6-9 and 13-16). After longer incubations, 
stimulation is less pronounced.  
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3.4 Core RAG proteins purified from HEK-239T cells are more active than 
those purified from Sf9 cells 
 
cRAG proteins purified from Sf9 cells showed relatively low levels of activity in Mg2+ 
compared to Mn2+, especially in the short incubation periods necessary to observe 
substrate co-stimulation (Fig. 3.7B), which complicated accurate quantification and 
interpretation. It is possible to purify RAG proteins from transfected human embryonic 
kidney 293T (HEK-293T) cells (Bergeron et al., 2006). Using this expression system, I 
found that the cRAG proteins showed a higher level of activity than cRAG proteins 
purified from Sf9 cells. Therefore, cRAG proteins purified from HEK-293T cells (Fig. 
3.8) were used in all relevant experiments described below. 
 
Using the newly optimised reaction conditions (namely, 20% DMSO and 15 min 
incubation time) and cRAG proteins purified from HEK-293T cells, I tested RAG activity 
with different substrate combinations to determine whether or not the 12/23 rule is 
adhered to. As I observed for cRAG proteins in the presence of Mn2+, 12 and 23RSSs 
co-stimulate, with the greatest stimulation observed at a 10-fold excess of unlabelled 
partner (Fig. 3.9A). However, a non-specific oligonucleotide does not stimulate 
cleavage, indicating that stimulation is sequence-specific and that cRAG proteins 
purified from HEK-293T cells adhere to the 12/23 rule under these conditions (Fig. 
3.9B). 
 
The fact that stimulation occurs at a 10:1 ratio of unlabelled:labelled substrate is not 
physiologically accurate. However, a greater concentration of partner relative to 
labelled substrate is needed because cRAG proteins are present in excess. Therefore, 
when both substrates are present at a 1:1 ratio, most of the labelled and unlabelled 
substrates are present in separate complexes, hence the need to add an excess 
amount of unlabelled partner to force the formation of a synaptic complex. A 10-fold 
excess of unlabelled partner appears to be the ideal concentration; at concentrations 
greater than this the unlabelled partner begins to compete with the labelled substrate 
(e.g. Fig. 3.9A, lanes 7 and 8). 
 
It should be noted that under these new conditions there is a diffuse band that runs 
slightly faster than the expected 16 bp product (Fig. 3.9). Titration of a suitable 
unlabelled partner reduces the abundance of this band. The nature of this band is 
unclear, but it is specific to reactions performed in buffer containing DMSO and Mg2+, 
and is not observed in the presence of Mn2+ (Fig. 3.10). There are three possible  
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Figure 3.8 – Core RAG proteins purified from transfected HEK-293T cells. Adherent HEK-293T cells 
were co-transfected with MBP-tagged core RAG1 and core RAG2 expression vectors. Core RAG proteins 
were purified in a single step by amylose affinity chromatography. Each lane is a different fraction eluted 
from an amylose column. McR1 = MBP-tagged core RAG1 (112 kDa); McR2 = MBP-tagged core RAG2 
(86 kDa).
 
 
 
for this. Firstly, small amounts of contaminating nuclease in the RAG prep, that are 
active in Mg2+ but not Mn2+, degrade the labelled oligonucleotide. Addition of a partner 
oligonucleotide then stimulates RAG activity so that nuclease activity is out-competed. 
The second possibility is that in the absence of a partner substrate, RAG proteins 
perform off-target cleavage of the labelled substrate, and addition of a partner 
promotes correct hairpin formation. Finally, it is possible that the diffuse band 
represents the single-stranded 16 bp product caused by RAG nicking, but not 
hairpinning. In the presence of Mg2+, RAG proteins are capable of nicking RSSs in the 
absence of a suitable partner, but a partner is required for efficient hairpin formation 
(van Gent et al., 1997). In the original conditions (i.e. in the absence of DMSO), the 
nicked strand stays annealed to the opposite strand, since the Tm of the 16 base nick 
product (~43°C) is greater than the incubation temperature (37°C). DMSO lowers the 
Tm of DNA by 0.75°C per 1% DMSO (von Ashen et al., 2001), so the presence of 20% 
DMSO in the new conditions will decrease the Tm of the 16 base nick product to ~28°C. 
Furthermore, the smaller diffuse band is more abundant in the presence of Mg2+ than in 
Mn2+ (Fig. 3.10), since a suitable partner is not required for efficient hairpin formation in 
Mn2+ (van Gent et al., 1997). Therefore, the diffuse band is most likely to be nicked 
substrate that has denatured at 37°C in the presence of DMSO, and runs slightly faster 
than the double-stranded 16 bp product caused by hairpinning. Addition of a partner 
RSS allows for the majority of nicks to be converted hairpins, thus reducing the 
abundance of denatured nicked products (Fig. 3.9A). In any case, although this diffuse 
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band can complicate densitometry, it does not affect the overall interpretation or 
conclusions of these data.  
 
 
 
Figure 3.9 – RSSs co-stimulate in a sequence-specific manner in the presence of Mg
2+
. (A) 2 nM 
labelled 12 (left) or 23RSS (right) was incubated in Mg
2+
-containing buffer with cRAGs purified from HEK-
293T cells and an RSS oligonucleotide of different spacer length. (B) As for (A), except unlabelled 
nonspecific 50mer was added instead of RSS.
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Figure 3.10 – A diffuse band is observed in the presence of Mg
2+
. The cleavage of 12 and 23RSSs by 
core or full-length RAG proteins was analysed under different conditions, namely in the presence of Mg
2+
 
or Mn
2+
, and with or without an ESC partner. A diffuse band appears most strongly when in the presence 
of Mg
2+
 and in the absence of an ESC partner (lanes 1 and 7), suggesting that it could be caused either by 
contaminating nucleases or by off-target RAG cleavage.  
 
Next, I examined the effect of an ESC in the presence of Mg2+. As observed in the 
presence of Mn2+, an ESC stimulates cleavage at both a 12RSS and a 23RSS, with the 
greatest level of stimulation (approximately 4-fold in each case) seen when there is a 
10-fold excess of ESC (Fig. 3.11A). However, neither a 12RSS nor a 23RSS stimulates 
cleavage at an ESC (Fig. 3.11B). In fact, addition of a partner causes a decrease in 
ESC cleavage. The difference in cleavage efficiency of 12 and 23RSS (at a 10-fold 
excess of partner) is only 1.2-fold, suggesting that the level of RSS cleavage and 
stimulation is relatively symmetric. By contrast, a 12RSS and ESC have a 4-fold 
difference in cleavage efficiency, and with a 23RSS, the difference is 10-fold. These 
data therefore indicate that cleavage and stimulation within an RSS-ESC complex is 
asymmetric in the presence of Mg2+. 
 
To see whether asymmetric cleavage between ESCs and RSSs is due to limiting RAG 
concentration, labelled 12RSS or ESC oligonucleotides were incubated with a 10-fold 
excess of unlabelled 23RSS (since this is typically the concentration at which maximum 
cleavage is observed), and cRAG proteins at concentrations ranging from 20 to 80 nM 
(Fig. 3.12). At each concentration of RAG proteins, ESC cleavage was less efficient 
than RSS cleavage, on average by a factor of 12. Therefore, asymmetric cleavage is 
independent of cRAG concentration, at least at the concentrations tested.  
 
 
 Analys is  o f  RAG c leavage in  an RSS -ESC complex | 98 
 
 
 
 
Figure 3.11 – ESCs stimulate RSS cleavage in the presence of Mg
2+
, but RSSs do not stimulate ESC 
cleavage (A) 2 nM radiolabelled 12 or 23RSS-containing oligonucleotide was incubated with cRAG 
proteins purified from HEK-293T cells, HMGB1 and 1 to 50-fold excess of unlabelled ESC oligonucleotide. 
Reactions were carried out for 15 min at 37°C. (B) As for (A), except a radiolabelled ESC was used and an 
unlabelled 12 or 23RSS was added.  
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Figure 3.12 – ESC cleavage is less efficient than RSS cleavage over a range of cRAG 
concentrations. 2 nM radiolabelled 12RSS (left) or ESC (right) oligonucleotide was incubated for 30 min 
at 37°C with 20 nM unlabelled 23RSS oligonucleotide and cRAG proteins ranging from 20 to 80 nM. ESC 
cleavage was less efficient than RSS cleavage at each concentration of cRAG proteins. 
 
If an RSS does not stimulate cleavage at ESC, then this is at odds with the proposed 
model of reintegration. In order for reintegration to occur, an ESC must first be cut by 
RAG proteins. Whilst reintegration could occur to an extent, since some ESC cleavage 
does occur (Fig. 3.11), reintegration might occur less frequently than previously 
predicted since the cleavage in RAG-RSS-ESC complexes appears to be asymmetric 
(Fig. 3.13A). Instead, I propose an alternative mechanism by which ESCs could trigger 
genome instability in developing B and T cells, called “cut-and-run” (Fig. 3.13B). In cut-
and-run, when RAG proteins form a synaptic complex with a genomic RSS and an 
ESC, the ESC stimulates cleavage at the RSS, but cleavage at the ESC is not 
stimulated. The data in Fig. 3.11 indicate that in an RSS-ESC complex, the ESC would 
remain intact in three quarters of these interactions. If the ESC remains intact, 
depending on the fate of the post-cleavage complex in these instances, RAG proteins 
could potentially form a complex with this ESC and a second genomic RSS, and 
stimulate cleavage at the RSS. This process of cleavage and “running” to another 
genomic RSS (hence “cut-and-run”) could be repeated until the ESC is cleaved or lost 
through cell division. In the remainder of this thesis, I further investigate this cut-and-
run hypothesis. 
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Figure 3.13 – Asymmetric cleavage and the cut-and-run hypothesis. (A) When two RSSs of different 
spacer length are incubated together with RAG proteins, RAG cleavage is stimulated at both substrates. 
Therefore, both cleavage and stimulation are “symmetric”. However, when one of the RSSs is replaced 
with an ESC, cleavage at the RSS is stimulated, but ESC cleavage is not stimulated, therefore cleavage 
with an ESC-RSS pair is “asymmetric”. (B) If asymmetric cleavage occurs in vivo, it is possible that instead 
of ESCs reintegrating into the genome, the more frequent outcome is that an ESC stimulates cleavage of a 
genomic RSS (either legitimate or cryptic), whilst the ESC itself remains intact. This ESC could potentially 
be re-bound by the RAG proteins, and “run” to another RSS to stimulate further cleavage.
 
 
 
3.5 Expression of full-length RAG proteins using a vaccinia-based system 
 
The data shown up until this point have been produced using truncated versions of the 
RAG1 and RAG2 proteins. The non-core regions, whilst not vital for the basic 
biochemical activity of the RAG proteins, are known to play a number of important roles 
in the regulation of V(D)J recombination. For example, the RAG2 C-terminus contains 
a PHD finger that binds to trimethylated lysine 4 of histone H3 (H3K4me3), thus 
directing the RAG recombinase to actively transcribed regions of the antibody loci 
(Matthews et al., 2007), and also plays a role in reducing the frequency of reintegration 
events (Curry et al., 2007). Since reintegration and cut-and-run both involve RAG-ESC 
interactions, it was of critical importance to test whether the asymmetry in cleavage 
observed with a cRAG-RSS-ESC complex occurs with the full-length RAG proteins. 
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The first approach to obtain purified full-length RAG proteins involved expression in a 
vaccinia-based system, which has previously been shown to produce active full-length 
RAG proteins (McBlane et al., 1995; Elkin et al., 2003). In this expression system, 
vaccinia virus containing the cDNA of the protein of interest under the control of a T7 
promoter is used to infect mammalian cells along with a recombinant vaccinia virus that 
expresses the T7 RNA polymerase (Elroy-Stein and Moss, 2001). Expression of the 
protein of interest is directed by T7 RNA polymerase, leading to very high yields. First, 
the flRAG coding sequences with N-terminal 9xHis and FLAG epitopes were cloned 
into the vaccinia virus transfer vector pTM1 (Section 2.23). Then, to produce 
recombinant vaccinia virus, BHK-21 cells were infected with wild-type vaccinia virus 
and co-transfected with the pTM1-flRAG transfer vectors (Section 2.26). In these 
vectors, the flRAG genes are flanked by sections of the vaccinia virus thymidine kinase 
(TK) gene, so that in infected cells they are inserted into the vaccinia genome by 
homologous recombination, allowing for selection of TK-deficient mutants (Sections 
2.27 and 2.28). Recombinant vaccinia virus was then purified through several rounds of 
plaque purification to ensure a clonally identical stock. Stocks of flRAG1 and flRAG2 
vaccinia viruses and a T7 RNA polymerase-expressing virus, vTF7-3, were made by 
amplification in adherent HeLa cells prior to large-scale infection for protein purification.  
 
An anti-FLAG western blot of the purification process indicated that only trace amounts 
of flRAG proteins were present after the centrifugation step, indicating that although the 
flRAG proteins were expressed using this system, they were largely insoluble in the 
conditions used (Fig. 3.14A). Optimisation of the lysis conditions was carried out in an 
attempt to solubilise the full-length RAG proteins, but unfortunately this approach 
ultimately proved fruitless, and the vaccinia/T7 expression system was abandoned. 
 
I therefore turned to the other main way in which full-length RAG proteins have been 
purified, which is based on plasmid transfection into adherent human embryonic kidney 
HEK-293T cells (Bergeron et al., 2006). In this system, HEK-293T cells are transfected 
with mammalian expression vectors containing the full-length RAG protein coding 
sequences with N-terminal MBP tags. Full-length RAG1 and full-length RAG2 (flRAG 
proteins) were then purified via one-step affinity chromatography on an amylose 
column (Fig. 3.14B). 
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Figure 3.14 – Purification of full-length RAG proteins. (A) Expression via the vaccinia/T7 system did 
not yield soluble flRAG proteins. flRAG proteins can be detected up until the point of clarification by 
centrifugation, after which only a minimal amount can be detected in the supernatant. The schematic at the 
top shows the protein constructs and the tagging scheme. H = 9xHis tag, F = FLAG tag, fR1 = 
9xHis/FLAG-tagged full-length RAG1 (122 kDa), fR2 = His9/FLAG-tagged full-length RAG2 (62 kDa) (B) 
MBP-tagged flRAG proteins purified from transfected HEK-293T cells. The schematic shows the protein 
constructs. MfR1 = MBP-full-length RAG1 (162 kDa), MfR2 = MBP-full-length RAG2 (102 kDA), * = 
contaminant or degradation product. The amount of MfR1 is just at or below the detection limit of 
Coomassie stain. 
 
Full-length RAG activity was first tested with standard 12 and 23RSS substrates, using 
the same conditions determined for core RAG proteins in the presence of Mg2+, to 
verify that the purified full-length RAG proteins adhere to the 12/23 rule. Addition of a 
23RSS to a 12RSS stimulates RAG cleavage, with the greatest stimulation (four-fold) 
seen when the partner concentration is 10-fold greater (Fig. 3.15A, left). A 12RSS also 
stimulates 23RSS cleavage by a maximum of 3.1-fold when the concentration of 
12RSS is 10 times greater (Fig. 3.15A, right). Addition of a non-specific oligonucleotide 
does not stimulate RAG cleavage by any more than 1.5-fold at either a 12 or 23RSS, 
indicating that stimulation of full-length RAG activity by a partner RSS is sequence-
specific and symmetric, and that the purified full-length RAG proteins adhere to the 
12/23 rule in vitro (Fig. 3.15B). 
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Figure 3.15 – Purified full-length RAG proteins adhere to the 12/23 rule in vitro (A) Addition of an 
unlabelled 23RSS oligonucleotide to a radiolabelled 12RSS oligonucleotide stimulates flRAG activity at the 
12RSS. The greatest stimulation is seen when the partner substrate is 10 times more concentrated (lane 
7) (B) A nonspecific 50mer does not significantly stimulate cleavage at either a 12 (left; 1.5-fold difference) 
or 23RSS (right; 1.3-fold difference). Diagrams above each gel indicate the substrates used, and a star 
indicates which substrate is radiolabelled. The percentage of cut substrate and the concentration of 
unlabelled partner is shown beneath each lane. The concentration of labelled oligonucleotide is 2 nM in 
each case.  
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I then tested whether cleavage of an RSS-ESC pair is also asymmetric when using full-
length RAG proteins. Addition of an ESC to a labelled 12RSS causes a maximum 
increase of 1.6-fold, seen at a 5-fold excess of ESC, and addition of an ESC to a 
labelled 23RSS does not stimulate cleavage by a significant amount (Fig. 3.16A). 
Contrary to observations with core RAG proteins, addition of either a 12RSS or 23RSS 
partner to an ESC causes an increase in cleavage of 2.2-fold with a 12RSS and 3.1-
fold with a 23RSS (Fig. 3.16B), but addition of a non-specific oligonucleotide does not 
stimulate cleavage (Fig. 3.17). Furthermore, cleavage and stimulation in a 12RSS-ESC 
complex is roughly equivalent (compare lane 7 in Fig. 3.16A left and 3.16B left), whilst 
an ESC is cut more efficiently in a 23RSS-ESC complex (lane 7 in Fig. 3.16A right and 
Fig. 3.16B right). Therefore, it seems that ESC-RSS cleavage in vitro is not asymmetric 
when using these purified full-length RAG proteins. However, results from qPCR-based 
experiments indicate that ESC-RSS cleavage with full-length RAG proteins is 
asymmetric in vivo (Section 5.1). 
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Figure 3.16 – Full-length RAG cleavage of an ESC-RSS pair is not asymmetric (A) Addition of an 
unlabelled ESC oligonucleotide to a radiolabelled 12RSS oligonucleotide (left) or 23RSS (right) stimulates 
flRAG-mediated cleavage, with the greatest stimulation seen when the ESC is 10 times more 
concentrated. (B) A 12RSS stimulates ESC cleavage by a maximum of 2.2-fold, whereas a 23RSS 
stimulates ESC cleavage by 3-fold. Diagrams above each gel indicate the substrates used, and the star 
indicates which substrate is radiolabelled. The percentage of cut substrate is shown below each lane with 
the concentration of unlabelled partner shown beneath that. The concentration of labelled oligonucleotide 
is 2 nM in each case.  
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Figure 3.17 – Cleavage of an ESC is not stimulated by a nonspecific oligonucleotide. Labelled ESC 
oligonucleotide was incubated for 15 min at 37°C in Mg
2+
-containing buffer with full-length RAG proteins, 
HMGB1 and an unlabelled nonspecific oligonucleotide (concentration shown underneath each lane). NS = 
non-specific oligonucleotide.  
 
3.6 Mechanism of ESC cleavage by RAG proteins 
 
Cleavage of standard 12 or 23RSSs occurs by nicking an RSS precisely between the 
conserved heptamer and the coding segment, creating a free 3’ hydroxyl group which 
then attacks the opposite DNA strand in a direct trans-esterifcation reaction (McBlane 
et al, 1995). Hairpin formation requires base flipping of the nicked strand, catalysed by 
aromatic residues in RAG1, such that it can undergo nucleophilic attack by the 
opposing DNA strand (Lu et al., 2006; Bischerour et al., 2009).  
 
The two papers that have investigated ESC cleavage disagree on the mechanism of its 
cleavage. One group’s data indicate that cleavage of an ESC occurs via the standard 
nick-hairpin mechanism (Vanura et al., 2007), whereas Roth’s group propose an 
alternative “nick-nick” mechanism, whereby the RAG proteins nick one strand of the 
ESC between the two heptamers, and then bind to the other RSS and nick the opposite 
strand, thus creating a double strand break with two blunt ends and no hairpin (Neiditch 
et al., 2002). The different conclusions reached by these two groups could be a result 
of the different experimental approaches. Vanura et al. (2007) detected reintegration 
products on transfected substrates by PCR, and Roth’s group used ligation-mediated 
PCR (LM-PCR) to amplify broken ESC ends. Since the latter is a highly sensitive 
technique, it is possible that the contribution of nicked substrates to overall cleavage 
was overestimated.  
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Nevertheless, since the available information suggests that both scenarios are a 
possibility, I examined whether the cleavage products formed in my experiments are 
the result of the standard nick-hairpin or the alternative nick-nick mechanism. A 
labelled 12RSS, 23RSS or ESC oligonucleotide was incubated for 15 min at 37°C with 
cRAG proteins, HMGB1, and a 10-fold excess of unlabelled partner (Fig. 3.18). Half of 
the reaction was run on a native polyacrylamide gel (Fig. 3.18A), and the other half was 
purified by phenol-chloroform extraction and run on a denaturing polyacrylamide gel 
(Fig. 3.18B). 
 
On a native gel, single-stranded nicks will remain annealed to the complementary 
strand. Therefore, only double-strand breaks generated by either hairpin formation of 
nick-nick cleavage are visible. Substrates that contain a single-strand nick will co-
migrate with uncut substrate. When the 12RSS is labelled, a 10- to 12-fold stimulation 
in cleavage is observed in the presence of a 23RSS (Fig. 3.18A, lane 3) or ESC (lane 
4), and when the 23RSS is labelled, there is a 35-fold stimulation in cleavage in the 
presence of 12RSS and a 17.5-fold stimulation in the presence of ESC (Fig. 3.18A, 
lanes 7 and 8). Addition of a 12RSS to an ESC causes a 7.7-fold stimulation in 
cleavage (Fig. 3.18A, lane 11), but a 23RSS does not greatly stimulate cleavage above 
the level seen at an ESC alone (Fig. 3.18A, lanes 10 and 12). Overall, the level of 
asymmetry in cleavage between an ESC and a 12RSS is 2.6-fold, similar to my 
previous observations, and the asymmetry between a 23RSS and an ESC is 12.7-fold. 
 
On a denaturing gel, single-strand nicks and nick-nick products (if they occur) co-
migrate and denatured hairpins run at a size roughly twice as large as the nick 
products. If the ESC is cleaved by the nick-nick mechanism, then no hairpin products 
will be visible. When a lone 12RSS is incubated with cRAG proteins, 70% of the oligo is 
nicked (Fig. 3.18B, lane 2). Only 1.2% of substrate is cut on a native gel (Fig. 3.18A), 
therefore the nick products seen on the denaturing gel are caused by nicking of the 
oligonucleotide on one strand. This high level of nicking is consistent with the idea that 
RAG proteins can efficiently nick a single RSS in the absence of partner (Eastman and 
Schatz, 1997; Yu and Lieber, 2000). The amount of 12RSS hairpin product increases 
35-fold in the presence of 23RSS or ESC (Fig. 3.18B, lanes 3 and 4, respectively). The 
increase in the percentage of hairpin products is similar to the increase in cleavage on 
the native gel, and the amount of nicked product only changes by twofold, relative to 
RSS alone. These observations are consistent with those made by other groups that in 
the presence of Mg2+, RAG proteins can only make a single-strand nick at a lone RSS, 
and a second RSS of different spacer length is required for efficient hairpin formation 
(Yu and Lieber, 2000). The same effect is observed with a 23RSS (Fig. 3.18B, lanes 5-
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8), indicating that RAG cleavage of RSSs occurs via the standard nick-hairpin 
mechanism in the presence of a suitable partner RSS, as expected, but also with an 
ESC.  
 
 
 
Figure 3.18 – Core RAG proteins cleave ESCs via a nick-hairpin mechanism. Core RAG cleavage 
reactions were performed as in previous experiments, using a labelled 12RSS, 23RSS or ESC 
oligonucleotide and a 10-fold excess of unlabelled partner as indicated. (A) Half the reaction was run on a 
native polyacrylamide gel, which only separates uncut and completely cut substrate. Substrates nicked on 
one strand co-migrate with uncut substrate, and nick-nick products (if formed) co-migrate with hairpin 
products. (B) The other half of the reaction was purified by phenol-chloroform extraction and run on a 
denaturing polyacrylamide gel. The denaturing conditions allow for separation of nicked products and 
hairpin products. HP = hairpins, nt = nucleotides. 
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At an ESC alone, no hairpin product is seen (Fig. 3.18B, lane 10). Either the ESC 
DSBs seen on the native gel (Fig. 3.18A, lane 10) are caused entirely by nick-nick 
cleavage, or the level of hairpinning was too low to be observed above background on 
the denaturing gel. In the presence of a 12RSS, there is an increase in the level of ESC 
hairpin formation that is similar to the level of cleavage seen on the native gel (Fig. 
3.18B, lane 11), indicating that the addition of a 12RSS stimulates cleavage of ESCs 
via the standard nick-hairpin mechanism rather than the nick-nick mechanism. 12RSS 
stimulation of an ESC was not previously observed with cRAG proteins (Fig. 3.11B). 
The reason for this discrepancy is unclear, but it could be that the different cRAG preps 
used in these experiments show slightly different levels of activity. Importantly, 
cleavage of an RSS-ESC pair is asymmetric in both cases.  
 
An increase in ESC hairpin products was not detected in the presence of a 23RSS 
(Fig. 3.18B, lane 12), consistent with the lack of stimulation by a 23RSS on the native 
gel (Fig. 3.18A, lane 12). However, the level of nicking increases 3.7-fold compared to 
ESC alone, with no corresponding increase in ESC cleavage on the native gel (Fig. 
18A, lane 12). This indicates that a 23RSS can stimulate single-strand nicking of an 
ESC, but hairpin formation with a 23RSS partner is blocked.  
 
When using full-length RAG proteins, the ESC did not stimulate cleavage of either RSS 
above an RSS alone (Fig. 3.19A). Similar to the results presented above (Fig. 3.16), 
the cleavage efficiency of an ESC-RSS pair is roughly equivalent, indicating that the 
cleavage is not asymmetric with these full-length RAG proteins. 12/23RSSs stimulate 
cleavage of one another, which correlates with an increase in hairpin products on the 
denaturing gel, as expected (Fig. 3.19B, lanes 3 and 7). There is little to no hairpin 
product formed at an isolated ESC (Fig. 3.19B, lane 10). However, addition of a 
12RSS, but not a 23RSS, results in a slight increase in hairpin formation (Fig. 3.19B, 
lanes 11 and 12). In this instance, the ESC hairpin product does not run at the 
expected size of 68 nucleotides (Fig. 3.19B, lane 11). One possible explanation for this 
is that the ESC hairpin product was not fully denatured, and therefore migrated faster 
than expected. The fact that the increase in this band correlates well with the increase 
in product seen on a native gel suggests that this band does in fact represent ESC 
hairpin products. 
 
 Analys is  o f  RAG c leavage in  an RSS -ESC complex | 110 
 
 
 
 
Figure 3.19 – Full-length RAG proteins cleave ESCs via a nick-hairpin mechanism. Full-length RAG 
cleavage reactions were performed as in previous experiments, using a labelled 12RSS, 23RSS or ESC 
oligonucleotide and a 10-fold excess of unlabelled partner as indicated. (A) Half the reaction was run on a 
native polyacrylamide gel, which only separates uncut and completely cut substrate. Substrates nicked on 
one strand co-migrate with uncut substrate, and nick-nick products (if formed) co-migrate with hairpin 
products. (B) The other half of the reaction was purified by phenol-chloroform extraction and run on a 
denaturing polyacrylamide gel. The denaturing conditions allow for separation of nicked products and 
hairpin products. HP = hairpins, nt = nucleotides. 
 
Although these full-length RAG proteins do not display asymmetric cleavage activity, 
the lack of ESC hairpin formation in the presence of a 23RSS is common to both the 
core and full-length RAG proteins. This suggests that the conformation of a 23RSS-
ESC is somehow more inhibitory to ESC cleavage than the conformation of a 12RSS-
ESC complex. Overall, these results indicate that in my experimental system, ESCs are 
predominantly cleaved via the standard nick-hairpin mechanism when paired with a 
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12RSS, but a low level of nick-nick cleavage of ESCs could occur in the absence of 
partner. 
 
C) Discussion 
 
RAG proteins cleave RSSs and ESCs in an asymmetric manner 
 
Two groups have reported that the RAG proteins can catalyse reintegration of the by-
product of V(D)J recombination, the excised signal circle, back into the genome of B 
and T cells (Vanura et al., 2007, Curry et al., 2007). Furthermore, Curry et al. (2007) 
reported that the presence of the RAG2 C-terminus reduced the level of reintegrated 
products by around 7-fold. Since this is potentially a very harmful reaction, I aimed to 
investigate the biochemistry of this reaction, specifically the inhibitory effect of the 
RAG2 C-terminus. Using purified core RAG proteins, HMGB1 and different 
combinations of labelled and unlabelled oligonucleotide substrates, I made the 
unexpected discovery that whilst addition of an ESC can stimulate cleavage of both 12 
and 23RSSs, the level of cleavage at an ESC under identical conditions is consistently 
lower than at an RSS (i.e. cleavage of an RSS/ESC is asymmetric).  
 
This observation was first made using core RAG proteins in the presence of Mn2+, but 
the reaction conditions had to be optimized since stimulation in Mn2+ was found to be 
non-specific. After achieving cleavage and stimulation in the presence of Mg2+, the 
asymmetry in substrate cleavage was clearly observed with core RAG proteins, but 
was much less pronounced with full-length RAG proteins. 
 
Stimulation of RAG activity is non-specific in the presence of Mn2+ 
 
RAG activity requires a divalent metal cation cofactor, and can utilise either Ca2+, Mn2+ 
or Mg2+, although each one influences RAG recombinase activity in a different way. 
Ca2+ enables RAG proteins to bind RSSs, but precludes cleavage, whereas Mn2+ and 
Mg2+ both allow binding and cleavage (Swanson 2004). However, the consensus in the 
literature is that in the presence of Mn2+, RAG proteins can create a double-strand 
break at a lone RSS (McBlane et al., 1995), whereas in Mg2+ RAG proteins can create 
single-strand nicks at a lone RSS, but hairpin formation can only occur in the context of 
a paired complex between two different length RSSs (van Gent et al., 1996c). Thus, 
cleavage in the presence of Mn2+ is uncoupled, whereas cleavage in the presence of 
Mg2+ is coupled. Since V(D)J recombination follows the 12/23 rule (Tonegawa 1983), 
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and the nuclear concentration of Mg2+ is greater than Mn2+, Mg2+ is considered to be 
the physiologically relevant divalent metal cation.  
 
My initial experiments were performed in the presence of Mn2+, because the level of 
RAG activity in the presence of Mg2+ was too low for detection. It was in the presence 
of Mn2+ that I first observed a very striking asymmetry in RSS-ESC cleavage (Fig. 3.3 
and Fig. 3.4). Since Mn2+ supported stimulation outside of the 12/23 restriction, it was 
replaced with Mg2+. 
 
Efficient hairpin formation in the presence of Mg2+ was only observed when DMSO was 
included in the reaction (Fig. 3.7A). The function of DMSO in this context is unclear. 
DMSO can cause aggregration or oligomerisation of proteins, but it is unlikely that this 
is the case here, since the complexes, or the abundance of certain complexes seen in 
a bandshift assay do not change in the presence of DMSO (see Chapter 4). Therefore 
DMSO does not seem to be affecting the overall oligomeric state of the RAG-RSS 
complex. DMSO is commonly used to lower the melting point of DNA, for example 
when PCR-amplifying GC-rich sequences. The mechanism of RAG-catalysed DNA 
cleavage is thought to involve the local melting of DNA structure since the RAG1 
central domain preferentially binds single-stranded DNA (Peak et al., 2003), and base 
pair mismatches at the heptamer-coding boundary stimulate RAG activity (Cuomo et 
al., 1996; Ramsden et al., 1996; Grundy et al., 2007). Therefore, a possible reason for 
the requirement for DMSO is that in Mg2+, RAG proteins need an extra “helping-hand” 
from DMSO to fully denature the DNA around the cut site. The use of DMSO is, of 
course, not physiological, and since other groups report Mg2+-catalysed cleavage 
without the need for DMSO, it is unclear why DMSO is needed for RAG cleavage in my 
experimental system. It is possible that the active fraction of RAG proteins in my 
preparations is low, and DMSO is required to stimulate cleavage activity to levels that 
can be seen on a gel. 
 
Another factor that required optimisation was the incubation length of the reactions. 
When reactions containing Mg2+ were incubated for as long as reactions containing 
Mn2+, a partner substrate competed for cleavage rather than stimulated cleavage (Fig. 
3.7). A possible explanation is that there is an initial coupled reaction, where RAG 
proteins form a synaptic complex with two substrates, and a “slow” uncoupled reaction, 
where RAG proteins form hairpins at a lone RSS. Stimulation by another substrate is 
only seen at or before 15 minutes of incubation. Beyond this, products formed by 
cleavage of a single RSS begin to outnumber those formed by paired cleavage in a 
synaptic complex. 
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Purified full-length RAG proteins do not catalyse asymmetric cleavage 
 
In order to assess the likelihood that asymmetric cleavage could occur in vivo, it was 
important that I repeated these observations with full-length RAG (flRAG) proteins. The 
first attempt to express and purify flRAG proteins used a vaccinia/HeLa-based system 
(McBlane et al., 1995, Elkin et al., 2005). However, I found that this system did not 
yield soluble flRAG proteins, so expression in HEK-293T cells was adopted instead. 
The major difference between the two approaches that is likely to affect solubility is the 
tagging scheme. flRAG proteins purified from HEK-293T cells were soluble, but unlike 
flRAG proteins expressed using the vaccinia system, they were fused with MBP. 
Although flRAG proteins without the MBP tag have reportedly been purified using the 
vaccinia system, the yield and activity were very low (Elkin et al., 2003). It is possible 
that the vaccinia expression system might have worked in my hands, and produced 
higher yields for other groups, if the flRAG proteins had been fused with MBP. 
Furthermore, recent studies have highlighted that full-length RAG2 mediates 
autoinhibition of RAG cleavage efficiency via the PHD finger. The presence of 
H3K4me3 is thought to relieve this autoinhibition (Shimazaki et al., 2009; Grundy et al., 
2010). Therefore, the lack of H3K4me3 in these experiments, coupled with the low 
yield of flRAG proteins, could account for the low activity levels.  
 
Cleavage was not found to be asymmetric when using full-length RAG proteins. The 
yield and concentration of full-length RAG proteins (Fig. 3.14B) were low compared to 
core RAG proteins (Fig. 3.8). Concentrating the full-length proteins using a spin 
concentrator did not work since a large proportion of full-length RAG proteins were 
seemingly lost through non-specific binding to the concentrator membrane, and pre-
treating the concentrator with BSA did not help. Therefore, relatively low levels of full-
length RAG activity had to be used in cleavage experiments, which could have affected 
the results. It is possible that the non-core regions of the full-length RAG proteins 
somehow affect interactions with ESCs and RSSs. However, in vivo experiments 
presented in Chapter 5 show that ESC-RSS cleavage is indeed asymmetric with full-
length RAG proteins, so these in vitro results do not rule out the possibility of 
asymmetric cleavage and cut-and-run occurring in lymphocytes.  
 
ESC cleavage is blocked at the nicking step 
 
Analysis of the cleavage products on a denaturing gel shows that there is very little 
nicking of the ESC, either alone or in the presence of an RSS (Fig. 3.18B). The fact 
that there is very little nicking at an ESC alone, unlike RSS alone, suggests that 
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cleavage of ESCs is blocked at the nicking step. Since an ESC contains two RSSs 
joined at the heptamer, it is possible that RAG proteins simultaneously bind to both 
sides, thus preventing the RAG complex bound on either side from binding to heptamer 
boundary and catalysing a nick. The lack of nicking at an ESC is consistent with this 
hypothesis, which is addressed in further detail in Chapter 4. 
 
The denaturing gels also show that a low level of hairpinning is observed at an ESC in 
the presence of a 12RSS partner, but not in the presence of a 23RSS, with both core 
and full-length RAG proteins (Fig. 3.18B and Fig. 3.19B). It is unclear why hairpin 
formation is less efficient when using 23RSS partner. It could be that when bound to a 
12RSS and ESC pair, the conformation of RAG proteins is such that a low level of 
hairpin formation is possible, but when paired with a 23RSS, blocking of the heptamer-
heptamer junction is greater and entirely prevents hairpin formation. Interestingly, the 
lack of ESC hairpins with a 23RSS partner is consistent with a study which showed that 
the majority of reintegration events in vivo occur at Vκ 12RSSs and not Jκ 23RSSs 
(Curry et al., 2007). The fact that ESC hairpin formation occurs less efficiently when 
paired with a 23RSS might explain this observation.  
 
The cut-and-run hypothesis 
 
If cleavage within an ESC-RSS complex truly is asymmetric in cells, as I have 
observed in vitro using core RAG proteins, it is possible that the predominant outcome 
of RAG-ESC-RSS interactions in vivo is my proposed mechanism of cut-and-run, and 
not reintegration. Aside from the challenges that the introduction of multiple double 
strand breaks pose to genomic stability, the most significant risk is that they could be a 
potent source of chromosome translocation partners at the antigen receptor loci. The 
most common chromosome translocation resulting from aberrant V(D)J recombination 
is end donation (Section 1.24), where a break at one of the antigen receptor loci is 
joined with a break formed by an unrelated process. However, the source of orphan 
broken RSSs is unclear. It is possible that cut-and-run is a source of these broken 
ends. 
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Chapter 4 
 
Determining the molecular basis of asymmetric ESC-RSS cleavage  
 
A) Introduction 
 
In Chapter 3, I presented data showing that cleavage of an RSS and an ESC is 
asymmetric when bound by core RAG proteins. Extrapolating from this observation, I 
put forward the cut-and-run hypothesis, which states that ESC-RAG complexes are 
able to stimulate multiple double-strand breaks at RSSs within the genome of 
developing B and T cells when these ESCs are present at the same time as RAG 
proteins. The aim of this chapter is to identify the molecular basis of asymmetric 
cleavage by examining RAG-ESC interactions and whether there are any key 
differences between RAG-RSS and RAG-ESC binding.  
 
The majority of information regarding RAG-RSS interactions comes from experiments 
using electrophoretic mobility shift assays (EMSAs) and DNA footprinting. Core RAG1 
alone forms a stable dimer in solution (Bailin et al., 1999; Swanson and Desiderio, 
1999), and can bind to an isolated RSS with an apparent Kd of ~35 nM or ~100 nM, 
depending on the method employed (fluorescence anisotropy or EMSA, respectively; 
Rodgers et al., 1999; Ciubotaru et al., 2003; Zhao et al., 2009). Unlike RAG1, RAG2 
alone has little to no intrinsic DNA binding activity (Difilippantonio et al., 1996; 
Spanopoulou et al., 1996; Hiom and Gellert, 1998; Swanson and Desiderio, 1998; 
Mundy et al., 2002). However, RAG1 and RAG2 can interact in the absence of DNA 
(forming a 1:1 heterotetramer; (Bailin et al., 1999; Swanson and Desiderio, 1999) and 
together, RAG1 and RAG2 bind a single RSS with greater affinity (Kd ~13.5-25 nM) and 
specificity than RAG1 alone (Zhao et al., 2009; Wang et al., 2012). 
 
In the absence of RAG2, the majority of RAG1-DNA interactions occur between the 
RSS nonamer and the nonamer binding domain (NBD) of RAG1 (Yin et al., 2009). 
RAG1-nonamer interactions are a combination of several base-specific interactions 
and extensive nonspecific contacts with the phosphate backbone, which probably 
explains why RAG proteins efficiently bind sequences nonspecifically (Swanson and 
Desiderio, 1998). In the presence of RAG2, these contacts are extended to include the 
entirety of the spacer, the heptamer, and the heptamer-coding sequence boundary 
(Difilippantonio et al., 1996). Therefore, the primary role of RAG2 is to direct the RAG1 
C-terminus (containing the catalytic DDE residues) to the heptamer and heptamer-
coding sequence boundary. Furthermore, the active site of one RAG subunit is 
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contributed in trans to the partner RSS (i.e. each RAG1 subunit cleaves the RSS that is 
not bound by its NBD; Swanson, 2001).  
 
There has been no detailed analysis of RAG-ESC interactions published to date. Since 
an ESC contains two RSSs joined at the heptamer, it is possible the RAG proteins bind 
to both RSSs of the ESC simultaneously, and the competing interactions at the 
heptamer-heptamer junction prevent efficient cleavage of the ESC, leading to 
asymmetric cleavage in an RSS-ESC complex. Here, this hypothesis was tested using 
core RAG proteins and radiolabelled oligonucleotide substrates in electrophoretic 
mobility shift assays (EMSAs), which show that an additional higher molecular weight 
complex forms at an ESC that is not seen at an RSS, consistent with RAG proteins 
simultaneously binding to both RSSs of the ESC. To test whether this is indeed the 
source of asymmetric ESC-RSS cleavage, I carried out in vitro cleavage assays using 
ESC substrates where one RSS of the ESC is mutated to prevent RAG binding. These 
experiments showed that mutation of one of the RSSs restores the level of cleavage in 
an RSS-ESC complex to symmetric levels. Therefore, RAG binding to both sides of the 
ESC appears to be the source of asymmetric RSS-ESC cleavage (i.e. inhibits ESC 
cleavage). 
 
In addition, I tested one of the predictions of the cut-and-run hypothesis, namely that 
when an ESC stimulates RAG cleavage of a genomic RSS, the RSS is then released 
by the RAG complex, but the ESC remains bound by RAG proteins. To test this 
prediction, I performed a series of electrophoretic mobility shift time course assays 
under conditions that allow cleavage. Data from these experiments suggest that as 
predicted, RAG proteins release the cleaved RSS after stimulation by an ESC, but 
remain bound to the ESC. 
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B)  Results 
 
4.1 Analysis of RAG-RSS and RAG-ESC complexes by EMSA 
 
Since an ESC contains two RSSs in a head-to-head configuration, I predicted that the 
RAG proteins can bind to both sides of the ESC simultaneously and that in doing so, 
they prevent cleavage at the heptamer-heptamer junction of the RSSs in an ESC. To 
compare RAG-RSS and RAG-ESC complexes, I carried out EMSAs using the same 
radiolabelled oligonucleotide substrates that were used in the cleavage experiments in 
Chapter 3. Reactions were set up in the same manner except that Ca2+ was used 
instead of Mg2+ to allow binding but prevent cleavage. Thus, only pre-cleavage 
complexes are observed. 
 
When a labelled 12RSS is incubated with HMGB1 and no RAG proteins, a low 
molecular weight HMG-RSS complex is observed (Fig. 4.1A, lane 2), consistent with 
previous reports that HMGB1 can bind RSS-containing DNA in the absence of RAG 
proteins (Swanson, 2002a). When a 12RSS is bound to cRAG proteins alone without 
HMGB1, two major complexes are observed (Fig. 4.1A, lane 3), consistent with 
previously published data (Mundy et al., 2002; Swanson, 2002b). These two 
complexes are generally referred to in the literature as single complex (SC) 1 and SC2 
(Swanson et al., 2009). Work from other laboratories has shown that SC1 contains two 
molecules of RAG1 and one molecule of RAG2, whereas SC2 contains two molecules 
each of RAG1 and RAG2 (Fig. 4.2; Bailin et al., 1999; Swanson, 2002b).  
 
Addition of HMGB1 supershifts both of these complexes to form HSC1 and HSC2 
(HMGB1-containing single RSS complex 1 and 2; Fig. 4.1A, lane 4), consistent with 
previous reports that HMGB1 can incorporate into the RAG-RSS complex (Swanson, 
2002a). The stoichiometry of HMGB1 within this pre-cleavage complex is unclear, but a 
study of the post-cleavage signal end complex (SEC; RAG proteins bound to cleaved 
signal ends) indicates that the ratio of RAG1:RAG2:HMGB1 is 2:2:1 (Fig. 4.2; Grundy 
et al., 2009). 
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Figure 4.1 – cRAG proteins form an additional complex with an ESC. (A) To compare the RAG 
complexes that form with different substrates, a radiolabelled 12RSS, 23RSS or ESC oligonucleotide was 
incubated in the presence of Ca
2+ 
with cRAG proteins, HMGB1 and an unlabelled partner substrate 
(indicated above the gel) for 10 min at 37°C, and run on a 4% polyacrylamide gel. A third complex of 
higher molecular weight is more visible when the labelled substrate is an ESC (indicated by “?”). (B) As for 
(A), but using different substrate combinations, as noted above the gel. SC1/2 = single complex 1/2, 
HSC1/2 = HMGB1 single complex 1/2, PC = paired complex 
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Figure 4.2 – Schematic of RAG-RSS complexes observed in an EMSA. The stoichiometry of subunits 
within each complex is depicted, based on results from other laboratories. In the presence of a single 
substrate, RAG proteins form single complex 1 (SC1) and single complex 2 (SC2). SC1 contains a RAG1 
dimer and a RAG2 monomer which freely reassorts (Swanson 2004). SC2 contains two molecules of 
RAG2 that freely reassort (Swanson et al., 2004). Addition of HMGB1 creates HMGB1-SC1 (HSC1) and 
HSC2. It is thought that a RAG heterotetramer can form on a single substrate, and a second substrate 
incorporates into HSC2 to form a paired complex (PC), which contains exactly the same complement of 
proteins as HSC2. When an ESC is used, an additional complex of higher molecular weight is observed in 
an EMSA, indicating that one or more additional RAG molecules binds to the ESC. The schematics only 
depict the stoichiometry of each component within each complex, and are not intended to accurately 
reflect the overall 3D structure or conformation of the complexes. Yellow oval = RAG1, orange oval = 
RAG2, blue oval = HMGB1, triangles with either 12 or 23 depict 12 or 23RSSs.  
 
Addition of an unlabelled 23RSS to a labelled 12RSS does not cause a detectable shift 
in mobility of either HSC1 or HSC2 (Fig. 4.1B, lane 6). Analysis of the cleavage activity 
of the different RAG-RSS complexes demonstrated that addition of a partner substrate 
stimulates the cleavage activity of HSC2, but not HSC1, by around 4-fold (Swanson, 
2002a). Therefore, it is generally inferred that the second partner RSS incorporates into 
HSC2 to form a paired complex (PC) that co-migrates with HSC2, since no additional 
RAG molecules are recruited (Fig. 4.2). Since HSC1 and HSC2 are observed in Fig. 
4.1, and addition of a partner stimulates cleavage (Fig. 3.9A and B), it is assumed that 
PC formation also occurs in the gels shown in Fig. 4.1. Analysis of full-length RAG-
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RSS complexes was attempted, but unfortunately the concentration of flRAG proteins 
was too low to form distinct complexes (Fig. 4.3), which was the case with three 
different flRAG preparations. 
 
 
 
Figure 4.3 – EMSA using flRAG proteins. To investigate full-length RAG complex formation, EMSAs 
were carried out in an identical manner to Figure 4.1, except that purified flRAG proteins were used 
instead of purified cRAG proteins. A labelled 12RSS oligonucleotide was incubated with increasing 
amounts of unlabelled ESC or 23RSS oligonucleotide.  
 
In an attempt to more clearly demonstrate PC formation, cRAG proteins were 
incubated with a 23RSS oligonucleotide containing biotin and Alexa Fluor 488 labels at 
opposite ends, and either a radiolabelled 12RSS or ESC (Fig. 4.4). Addition of 
monomeric streptavidin should supershift any complex containing biotinylated 23RSS, 
but a supershifted 12RSS complex will only be observed if both substrates are 
contained with the same complex (i.e. if they form a PC). Two supershifted complexes 
are seen when streptavidin is added, concomitant with a decrease in the intensity of 
both HSC1 and HSC2 (Fig. 4.4, bottom panel, lanes 6 and 13). 
 
However, neither of these changes were seen with the radiolabelled 12RSS or ESC 
complexes (Fig. 4.4, top panel). This could indicate that the PC does not form, but 
since RAG cleavage is stimulated by a 12/23RSS pairing under these conditions (Fig. 
3.9A), it is more likely that the supershift is not observed because the PC is relatively 
transient, or is unstable during electrophoresis. However, the biotinylated, 
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fluorescently-labelled 23RSS should be used in a cleavage assay to confirm that these 
additional groups do not adversely affect stimulation. 
 
 
 
Figure 4.4 – A streptavidin supershift assay does not demonstrate paired complex formation. In an 
attempt to more clearly demonstrate paired complex (PC) formation, a biotinylated, Alexa Fluor 488-
labelled 23RSS oligonucleotide was incubated with a radiolabelled 12RSS, cRAG proteins and HMGB1, 
and in lanes 6-7 and 13-14, monomeric streptavidin. Complexes were formed at 37°C for 10 min, and run 
on a 4% polyacrylamide gel. The gel was first scanned using a 488 nm laser (bottom panel) to visualise 
the 488-labelled 23RSS, then dried and exposed to a PhosphorImager screen to visualise the 
radiolabelled 12RSS (top panel). SC1/2 = single complex 1/2, HSC1/2 = HMGB1 single complex 1/2.  
 
Notably, the titration of an unlabelled 23RSS substrate, ranging in concentration from 
equimolar to an 8-fold excess, competes with the labelled substrate for cRAG binding 
(Fig. 4.1B, lanes 3-6). Whilst this initially appears to be at odds with the fact that the 
level of RAG cleavage is greatest at a 10-fold excess of partner (Fig. 3.9), a simple 
explanation for this is that although the proportion of bound molecules is lower, those 
molecules which are bound are cleaved more efficiently because of the 23RSS partner. 
Alternatively, as mentioned above, the PC might be less stable than a single-substrate 
complex. 
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One or two faint complexes of a higher molecular weight than HCS2/PC can be seen in 
many instances (Fig. 4.1). Others have previously noted the presence of complexes 
above the PC in EMSAs (Schatz and Swanson, 2011), but the content or biological 
relevance has not been investigated. In lanes where only standard RSSs are present 
(e.g. Fig. 4.1A, lanes 3 and 4) it is possible that they represent higher-order 
oligomerisation of the RAG-RSS complexes into an octamer, as has been observed in 
atomic force microscopy studies (Shlyakhtenko et al., 2009). However, this complex is 
much more abundant in reactions containing a labelled ESC oligonucleotide (Fig. 4.1A, 
lanes 16-20 and Fig. 4.1B, lanes 14-18). There are two explanations for this 
phenomenon. The first is that RAG heterotetramers are more likely to oligomerise into 
higher-order complexes in the presence of an ESC. Alternatively, the higher molecular 
weight complex might represent RAG proteins bound to both sides of the ESC 
simultaneously, since such a complex would contain more RAG molecules than a 
standard PC (Fig. 4.2). The latter explanation is consistent with the prediction that in an 
ESC-RSS pairing, RAG proteins bind to the RSS and both sides of the ESC 
simultaneously. In this complex, an ESC could stimulate cleavage of the RSS, but the 
presence of RAG proteins bound to the other side of ESC might prevent efficient 
cleavage of the ESC, and therefore could be the basis of asymmetric cleavage. Whilst 
it might be expected that the same complex would be observed with a labelled RSS at 
a similar abundance when paired with an ESC, this is not the case. As discussed 
above, this might be because the ESC-RSS PC is transient or unstable upon 
electrophoresis. 
 
4.2 DNase I footprint analysis of RAG binding 
 
To further examine RAG-ESC interactions and compare these with RAG-RSS 
interactions, DNase I footprinting experiments were performed with either a 
radiolabelled 12RSS or ESC substrate (Fig. 4.5). Analysis of band intensities by 
densitometry suggests that there might be several protected bases in the nonamer 
region of both RSSs in the ESC (Fig. 4.5A, lane 5), which would be consistent with 
DNase I experiments by others which found no protection of the heptamer sequence, 
either with or without RAG2 (Nagawa et al., 1998b). This would also be consistent with 
RAG proteins binding to both RSSs of an ESC simultaneously. However, the strength 
of the footprint here is too weak to reach a definitive conclusion. Furthermore, no 
protection was detected at the RSS (Fig. 4.5A, lane 2). A binding assay under identical 
conditions shows that the majority of the labelled probe is bound by cRAG proteins, but 
they do not form a distinct complex (Fig. 4.5B). This, combined with the relatively high 
nuclease background (Fig. 4.5A, lanes 3 and 6), is likely to have contributed to the 
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weak footprint. Footprint analysis of full-length RAG proteins was not attempted since 
the concentration of purified flRAG proteins was too low to saturate the labelled probe 
in an EMSA (Fig. 4.3). Overall, the quality of the footprinting data precludes any 
accurate interpretation, but the preliminary data are consistent with the hypothesis that 
RAG proteins bind to both RSSs of an ESC simultaneously. 
 
 
 
Figure 4.5 – DNase I footprinting assay of 12RSS and ESC. (A) DNase I footprinting experiments were 
performed to compare RAG-RSS and RAG-ESC contacts, and to further test the hypothesis that RAG 
proteins bind to both sides of the ESC simultaneously. Binding reactions were set up as for the EMSAs, 
and DNase I was added for 1 min. Reactions were purified and separated on a 6% denaturing 
polyacrylamide gel. Bands that showed a difference in band intensity +/- RAG protein, as judged by 
densitometry, are indicated by an asterisk (B) An EMSA using the footprinting probes, to test RAG binding 
under the conditions using for the DNase I footprint. RAG concentration ranges from 20 to 150 nM. 
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4.3 cRAG proteins bind to RSSs and ESCs with similar affinity 
 
It is possible that the RAG proteins cleave ESCs less efficiently than RSSs because 
the affinity of RAG-ESC interactions is lower than RAG-RSS interactions. To test this 
possibility, the affinity of these interactions was estimated by EMSA. Binding assays 
were set up in the same way as before, except that cRAG proteins were titrated 
ranging from 5 to 80 nM and no partner substrate was added. The fraction of bound 
substrate at each RAG concentration was measured by densitometry, and the Kd was 
estimated by plotting the log of RAG concentration against the fraction of substrate 
bound.  
 
Previously, cRAG1 and cRAG2 have been found to bind a single RSS with a Kd of ~25 
nM, as estimated by EMSA (Zhao et al., 2009), and ~13.5 nM in Ca2+ as measured by 
fluorescence anisotropy (Wang et al., 2012). The RAG-ESC binding affinity has not 
previously been assessed. Here, in Ca2+ and in the absence of a partner substrate, the 
cRAG proteins bind with a Kd of 12.8 nM for a 12RSS, 9.5 nM for a 23RSS, and 6.1 nM 
for an ESC (Fig. 4.6). Therefore, any differences in cleavage efficiency and symmetry 
are unlikely to be the result of differences in binding affinity. 
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Figure 4.6 – Core RAG proteins bind to a 12RSS, 23RSS and ESC with a similar affinity. The affinity 
(Kd) of RAG proteins for the three different substrates was compared to see if binding affinity was a factor 
in asymmetric cleavage. 2 nM radiolabelled 12RSS, 23RSS or ESC oligonucleotide was incubated with 
core RAG proteins ranging in concentration from 5-80 nM, 100 nM HMGB1 in the presence of Ca
2+
, on ice 
for 30 min and separated on a 4% polyacrylamide gel at 4°C. Gels were dried and scanned using a 
PhosphorImager. The complex seen below HSC1 could represent a RAG1-RSS complex, if the particular 
RAG prep contained more RAG1 than RAG2. To estimate the dissociation constant (Kd) with different 
substrates, the amount of bound and unbound substrate was measured by densitometry, and the ratio of 
bound substrate:total substrate was plotted against the log RAG concentration. The log[RAG] at which half 
the substrate is bound was calculated using the equation of the line, and then converted to the 
concentration in nM. 
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4.4 Mutating one side of the ESC restores symmetric substrate cleavage 
 
Results from the in vitro binding assays comparing RSS and ESC complexes support 
the hypothesis that RAG proteins bind to both RSSs of the ESC simultaneously. To 
further test this idea, I mutated one of the RSSs in an ESC to see if this simultaneous 
RAG binding is prevented, thus restoring symmetric stimulation and cleavage of ESCs. 
Using the same in vitro reaction conditions established in Chapter 3, mutant ESC 
oligonucleotides with a deleted heptamer or nonamer were incubated with cRAG 
proteins, HMGB1 and an unlabelled partner substrate. Using an ESC where the 
heptamer of the 12RSS is deleted (ESC 12d7), the level of cleavage is low in the 
absence of partner (Fig. 4.7A, lane 2). Assuming that a 12/23 pairing with the intact 
23RSS of the ESC should still be possible, an increasing amount of unlabelled 12RSS 
partner was added. A 12RSS stimulates cleavage by a maximum of 7.5-fold with a 10-
fold excess of 12RSS (Fig. 4.6A, lanes 3-7). In contrast, cleavage of a consensus ESC 
is reduced upon addition of a 12RSS (Fig. 3.10B). Moreover, the mutated ESC 12d7 
stimulates cleavage of a 12RSS 4.5-fold, presumably via synapsis with the intact 
23RSS (Fig. 4.7B). Therefore, consistent with the idea that binding to both RSSs of the 
ESC blocks cleavage, deletion of the ESC 12RSS heptamer appears to have restored 
symmetric RAG-ESC-RSS cleavage. 
 
Similarly, when the heptamer of the 23RSS is deleted (ESC 23d7), ESC cleavage is 
stimulated two-fold by addition of a 23RSS (Fig. 4.7C), and the ESC 23d7 
oligonucleotide stimulates 23RSS cleavage 3.3-fold (Fig. 4.7D). Therefore, deletion of 
the ESC 23RSS heptamer enables the stimulation of ESC cleavage by a 23RSS, which 
was not the case with a consensus ESC (Fig. 3.10D). However, the cleavage efficiency 
in an ESC 23d7-23RSS pairing is still somewhat asymmetric and is less efficient than 
with the ESC12d7-12RSS pair. 
 
Next, the effect of deleting the 23RSS nonamer in an ESC (ESC 23d9) was examined. 
As with the ESC heptamer mutants, ESC 23d9 cleavage was stimulated by a partner 
RSS (2.8-fold, Fig. 4.8A). Control reactions performed at the same time with a 
consensus ESC and 23RSS confirm that cleavage of a consensus ESC is reduced 
rather than stimulated (Fig. 4.8A, lanes 8 and 9). Furthermore, the ESC 23d9 mutant 
stimulates 23RSS cleavage 2.3-fold (Fig. 4.8B), and the overall level of cleavage 
efficiency at both substrates is very similar, indicating that mutation of the ESC 23RSS 
nonamer also restores symmetric cleavage to some extent.  
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Figure 4.7 – Deleting one of the ESC heptamers restores symmetric cleavage. To determine whether 
symmetric cleavage could be restored by disrupting RAG binding to one side of the ESC, the heptamer of 
one RSS of the ESC was deleted. The ESC mutants were paired with an unlabelled substrate that would 
allow a 12/23 pairing between the RSS substrate and the intact RSS of the ESC and used in standard 
cleavage assays. (A) Labelled ESC 12d7 mutant and 12RSS (B) Labelled 12RSS and ESC 12d7 mutant 
(C) Labelled ESC 23d7 mutant and 23RSS (D) Labelled 23RSS and ESC 23d7 mutant.  
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Figure 4.8 – Deleting the nonamer of the 23RSS in an ESC restores symmetric cleavage. (A) To see 
if symmetric cleavage could be restored by disrupting RAG binding to one side of the ESC, the nonamer of 
the ESC 23RSS was deleted. The ESC 23d9 mutant was paired with an unlabelled 23RSS to allow a 
12/23 pairing between the intact 12RSS of the ESC. Wild-type ESC +/- 23RSS was included for 
comparison (lanes 8 and9) (B) As for (A), except the 23RSS is labelled. (C) A 23RSS with a mutated 
nonamer was incubated with a wild-type ESC to verify that mutating the nonamer of an RSS renders it 
unusable by RAG proteins. (D) A 12RSS with a mutated heptamer was incubated with a labelled 23RSS to 
verify that a lone nonamer cannot stimulate cutting at an RSS. Control reactions containing 23RSS +/- 
consensus 12RSS were carried out alongside (lanes 8 and 9).  
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In these experiments it was assumed that mutating either the conserved heptamer or 
nonamer elements of an ESC would render that RSS unusable as a RAG substrate. 
This assumption was tested using a 23RSS oligonucleotide where the nonamer 
sequence was mutated (not deleted, in this case), essentially leaving a heptamer 
sequence. No cleavage of this substrate is detected, and addition of a consensus ESC 
does not stimulate cleavage (Fig. 4.8C), indicating that the RAG proteins cannot cleave 
an RSS heptamer without the nonamer sequence. Similarly, a nonamer sequence 
alone is unable to stimulate cleavage at a 23RSS (Fig. 4.8D, lanes 1-7), whereas a 
consensus 12RSS stimulates cleavage (Fig. 4.8D, lanes 8 and 9). Taken together, 
these results indicate that mutating one RSS of an ESC renders that “side” of the ESC 
unusable and therefore supports the idea that RAG binding to both sides of the ESC 
somehow prevents symmetric cleavage and stimulation. 
 
4.5 Analysis of RAG-ESC mutant complexes 
 
To further test the hypothesis that the RAG proteins bind to both sides of the ESC, 
RAG binding to mutant ESC oligonucleotides was analysed by EMSA. If RAG binding 
to both sides of the ESCs simultaneously is represented by the higher molecular weight 
complex seen in Fig. 4.1, then mutating one of the RSSs should reduce the abundance 
of this complex or entirely prevent its formation. 
 
Indeed, deleting the nonamer of the 23RSS in the ESC reduces the abundance of the 
higher molecular weight complex seen in Fig. 4.1 relative to HSC1 and HSC2/PC, 
consistent with the idea that the uppermost complex represents RAG proteins bound to 
both RSSs simultaneously (Fig. 4.9). Unlike Fig. 4.1, titration of the unlabelled partner 
RSS appears to result in eviction of HMGB1 from the HSC1 complex. This is evidenced 
by the increased abundance of an HMGB1:ESC 23d9 complex at higher 
concentrations of unlabelled partner (Fig. 4.9, lanes 8 and 9), and also by the 
increased migration of the smallest complex, which is roughly equivalent to the size 
difference between HSC1 and SC1 (Fig. 4.1A, compare lanes 3 and 4, and Fig. 4.4, 
compare lanes 3 and 4). It is unclear why addition of an unlabelled 23RSS partner 
would have this effect, but it is unique to the ESC 23d9 substrate. Since HMGB1 binds 
within the 23RSS spacer, deletion of the 23RSS nonamer in the ESC might reduce the 
affinity of the HMGB1:ESC interaction. Addition of a consensus 23RSS is then enough 
to evict HMGB1 from the complex.  
 
Unlike deletion of the nonamer, mutating the heptamer of either RSS in the ESC does 
not reduce the abundance of the higher molecular weight complex (Fig. 4.10). This is 
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perhaps not entirely unexpected, since the most crucial RAG-RSS interactions occur 
between the nonamer and the RAG1 nonamer binding domain (Yin et al., 2009), and 
RAG2 is thought to promote RAG1 binding of the heptamer (Swanson and Desiderio, 
1999; Fugmann and Schatz, 2001; Qiu et al., 2001). Therefore, deleting the nonamer is 
more likely to disrupt RAG binding than deleting the heptamer. However, if RAG 
proteins still bind both sides of the ESC efficiently, why is asymmetric cleavage 
restored upon deletion of the heptamer (Fig. 4.7)? One possible explanation is that 
RAG1 binds the mutated ESC via the intact nonamer, but the lack of a heptamer 
means that RAG contacts do not extend toward the other RSS, which would otherwise 
prevent efficient cleavage and lead to asymmetry. Overall, these data support the 
model that RAG binding simultaneously to both sides of the ESC leads to asymmetric 
cleavage of ESCs. 
 
 
 
Figure 4.9 – Mutation of the 23RSS nonamer in an ESC reduces RAG binding at one side of the 
ESC. To see if deleting the nonamer of the 23RSS in an ESC prevents RAG to both sides of the ESC, an 
ESC 23d9 mutant oligonucleotide was incubated with cRAG proteins, HMGB1, and an unlabelled 23RSS 
and run on a 4% native polyacrylamide gel at 4°C. The higher molecular weight complex seen in Fig. 4.1 
(lanes 16-20) is no longer visible, indicating that deletion of the 23RSS nonamer has prevented RAG 
binding to the 23RSS side of the ESC. HSC1/2 = HMGB1 single complex 1/2, PC = paired complex, SC1 = 
single complex 1 
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Figure 4.10 – Mutation of either heptamer in an ESC does not reduce RAG binding to both sides of 
the ESC. (A) To see if mutating one of the heptamers in an ESC reduces the abundance of the higher 
molecular weight complex, an ESC oligonucleotide where the heptamer of the 12RSS is deleted was 
incubated with a consensus 12RSS oligonucleotide, cRAG proteins and HMGB1, and run on a 4% 
polyacrylamide gel and compared with consensus ESC complex formation. (B) As for A, except either 
labelled consensus ESC or labelled ESC 23d7 mutant were used, paired with a 23RSS. HSC1/2 = HMGB1 
single complex 1, PC = paired complex.  
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4.6 Analysis of postcleavage complex stability 
 
The dangers posed by the cut-and-run reaction critically rely on the fate of the RAG-
DNA complexes following cleavage. If a broken RSS is to trigger genome instability, it 
must first be released by the RAG proteins. To investigate the fate of the broken DNA 
ends, the stability of the RAG-RSS postcleavage complexes was analysed by time 
course assays where half of the reaction was separated on a 4% polyacrylamide gel to 
analyse RAG-substrate complexes, and the other half was separated on a 12% native 
polyacrylamide gel to analyse cleavage products. It should be noted that the labelled 
end of the 12 and 23RSS oligonucleotides is the coding end, and the signal end is 
unlabelled, so the data presented here show the stability of RAG-coding end 
interactions under conditions that facilitate cleavage (i.e. in the presence of Mg2+). In 
the case of the ESC, the 12RSS end is labelled. Therefore, in a pairing with a 23RSS, 
the 23RSS half of the ESC is the “coding” end and the 12RSS is the signal end, and 
vice versa.  
 
In the absence of a partner RSS, HSC1 and HSC2/PC (Fig. 4.2) are seen with a 
labelled 12RSS (Fig. 4.11A, lanes 1-6). Consistent with the data presented in Chapter 
3, cleavage of a 12RSS is stimulated by addition of a 23RSS or ESC partner (Fig. 
4.11A, bottom panel). The increased level of cleavage correlates with a slightly shorter 
half life for both HSC1 and HSC2 compared with 12RSS alone (Fig. 4.11B). The 
shorter half life of both HSC1 and HSC2 indicates that addition of a partner promotes 
the conversion of both complexes to a paired complex, which then releases the coding 
end of the 12RSS following cleavage. The fate of the signal end is unknown, since this 
end is unlabelled. To confirm that cleavage is essential for the observed decrease in 
complex abundance, the same experiment was carried out, but replacing Mg2+ with 
Ca2+ (Fig. 4.12). As in Fig. 4.11A, the abundances of HSC1 and HSC2 decrease with 
increasing cleavage (Fig. 4.12). When Ca2+ is used in place of Mg2+, neither HSC1 nor 
HSC2 dissociates after 180 min (Fig. 4.12), thus confirming that cleavage of the RSS is 
required for the decrease in complex abundance. Furthermore, this is consistent with 
the idea that the RAG proteins release the 12RSS coding end following cleavage. 
 
Similarly, addition of a 12RSS to a 23RSS stimulates cleavage by 3.6-fold (Fig. 4.13A). 
This increase in cleavage correlates with a shorter half life for both complexes (Fig. 
4.13B), indicating that the 23RSS coding end is released by RAG proteins after 
cleavage. Addition of an ESC partner also stimulates 23RSS cleavage, but only by 
~1.6-fold, and as such there is a smaller decrease in the abundance of the HSC1 and 
HSC2 complexes.  
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With a labelled ESC, the higher molecular weight complex previously described (Fig. 
4.1) is no longer observed (Fig. 4.14A, top panel). A possible reason for this 
discrepancy is the use of divalent metal cation. Here, Mg2+ is used to facilitate 
cleavage, so that complex stability could be analysed. In Fig. 4.1, Ca2+ was used to 
preclude cleavage, therefore only precleavage synaptic complexes are observed. It is 
possible that in conditions that facilitate cleavage, the higher molecular weight complex 
is less stable and/or it quickly dissociates into one of the smaller molecular weight 
complexes. Addition of a 12RSS to an ESC results in a slight stimulation in cleavage 
over ESC alone, whereas a 23RSS does not (Fig. 4.14A, bottom panel). In both cases, 
the half life of HSC2 is longer than the half life of HSC1 (Fig. 4.14B). One possible 
interpretation of this observation is that addition of a partner promotes the conversion 
of HSC1 to HSC2 and PC, hence the shorter half life of HSC1. However, ESC 
cleavage is not greatly stimulated by the partner, leading to an accumulation of paired 
complexes, hence the longer half life of HSC2/PC with an ESC compared to a 12 or 
23RSS. Taken together, these data indicate that an ESC-stimulated cleavage of RSS 
results in the release of the coding end, but the RAG proteins remain more stably 
bound to the ESC. 
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Figure 4.11 – RAG proteins release the 12RSS coding end following cleavage (A) Radiolabelled 
12RSS oligonucleotide was incubated with cRAG proteins and HMGB1 in the presence of Mg
2+
 to facilitate 
RAG cleavage, either alone, with a 23RSS, or with an ESC. Reactions were incubated for the indicated 
time, quenched on ice then divided in two. One half was run on a 4% polyacrylamide gel to analyse 
complex stability, and the other half was run on a 12% polyacrylamide gel to analyse cleavage. (B) The 
abundance of each complex was measured by densitometry and plotted against time to estimate complex 
half life.  
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Figure 4.12 – RAG proteins release the 12RSS coding end following cleavage in Mg
2+
, but remain 
bound in Ca
2+
. A bandshift timecourse of 12RSS-ESC complexes was repeated to confirm that RAG 
proteins release the 12RSS coding end following cleavage. Identical reactions were carried out alongside, 
except that Ca
2+
 was used in place of Mg
2+
. In Mg
2+
, the RAG proteins release the 12RSS coding end 
concomitant with an increase in cleavage, but in Ca
2+
, which precludes cleavage, the RAG proteins stay 
bound for over 180 min. 
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Figure 4.13 – RAG proteins release the 23RSS coding end following cleavage (A) A radiolabelled 
23RSS oligonucleotide was incubated with cRAG proteins and HMGB1 in the presence of Mg
2+
 to facilitate 
RAG cleavage, either alone, with a 23RSS, or with an ESC. Reactions were incubated for the indicated 
time, quenched on ice then divided in two. One half was run on a 4% polyacrylamide gel to analyse 
complex stability, and the other half was run on a 12% polyacrylamide gel to analyse cleavage. (B) The 
abundance of each complex was measured by densitometry and plotted against time to estimate complex 
half life.  
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Figure 4.14 – RAG proteins stay bound to ESCs after cleavage (A) Radiolabelled ESC oligonucleotide 
was incubated with cRAG proteins and HMGB1 in the presence of Mg
2+
, to facilitate RAG cleavage, either 
alone, with 23RSS, or with ESC. Reactions were incubated for the indicated time, quenched on ice then 
divided in two. One half was run on a 4% polyacrylamide gel to analyse complex stability, and the other 
half was run on a 12% polyacrylamide gel. (B) The abundance of each complex was measured by 
densitometry and plotted against time to estimate complex half life.  
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C)  Discussion 
 
In this chapter, I investigated the molecular basis of asymmetric RSS/ESC cleavage. A 
plausible hypothesis is that RAG proteins bind to both sides of the ESC simultaneously, 
since it contains two RSSs, and that this simultaneous binding prevents the RAG 
proteins from efficiently cleaving the ESC. EMSA data show that core RAG proteins 
form an additional higher molecular weight complex in the presence of an ESC, 
consistent with this hypothesis. Additionally, estimates of RAG-RSS and RAG-ESC 
binding affinity by EMSA showed that all three substrates (12/23/ESC) are bound with 
roughly the same affinity, ruling out the possibility that asymmetric cleavage is caused 
by differences in binding affinity. Mutating one of the RSSs in an ESC restored 
symmetric cleavage with RSS (albeit with varying levels of efficacy), lending further 
support to the model of simultaneous RAG binding. Finally, the stability of RAG 
postcleavage complexes was examined by a time course EMSA and cleavage assay. 
The results of these assays indicate that the RAG proteins do not remain bound to the 
cleaved coding end of an RSS after stimulation by either an RSS or an ESC, since the 
half life of the RAG-RSS complexes is shorter when there is a higher level of cleavage. 
Furthermore, the RAG proteins appear to remain bound to the uncleaved ESC.  
 
Taken together, the EMSA, DNase I footprinting and ESC mutant cleavage data 
support the simultaneous binding model where the RAG proteins bind to both sides of 
the ESC at the same time, thus preventing symmetric cleavage. However, an 
inconsistency with this model is that the higher-order complex is not seen at an RSS 
substrate in the presence of an ESC. If a RAG1-RAG2 heterotetramer binds to both an 
RSS and an ESC in a paired complex, and also recruits additional RAG molecules via 
the second RSS of the ESC, the larger complex should be seen at the RSS also. As 
mentioned earlier, it is possible that formation of the PC is very transient, and as such 
they are not observed in an EMSA, or that the PC is unstable during electrophoresis. 
Investigating the catalytic activity of each complex using an in-gel cleavage assay 
(Swanson, 2002a) would be invaluable in shedding light on its exact nature.  
 
The stability of RAG postcleavage ESC-RSS and RSS-RSS complexes was analysed 
using an EMSA timecourse. These assays were performed in the absence of any end-
joining machinery and therefore they are not an accurate representation of the fate of 
cleaved substrates in vivo. Nevertheless, they provide insight into the intrinsic stability 
of the different postcleavage complexes when one substrate is an ESC. Performing 
these in vitro reactions in repair-proficient conditions would require either a) the use of 
cell extract, which would inevitably introduce many other unwanted factors, or b) 
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purified proteins from the NHEJ pathway. The entire complement of proteins from the 
NHEJ pathway has indeed been successfully purified and used to recapitulate end-
joing in vitro (Lu et al., 2008), but since this involves the purification of 13 different 
proteins, it is beyond the scope of this project.  
 
Once the RSSs are cleaved by the RAG proteins, the coding ends dissociate in vitro, 
but the signal ends remain tightly bound in a signal end complex (SEC; (Agrawal and 
Schatz, 1997; Wang et al., 2012). The SEC is resistant to nucleases and end joining 
proteins (Jones and Gellert, 2001), indicating that the signal ends cannot be joined to 
form an ESC until the cell cycle-dependent degradation of RAG2. Here, the 
dissociation of the coding end was investigated. The finding that the coding end 
dissociates following cleavage is consistent with previous studies. However, the fate of 
the signal ends was not investigated, but this could be done simply by labelling the 
opposite end of the oligonucleotide. In normal V(D)J recombination, the two coding 
ends would be in close proximity and are swiftly repaired by the NHEJ pathway (Lieber, 
2010). However, in cut-and-run, since the ESC is not cleaved there is only one 
hairpinned coding end and one signal end. In the absence of a second coding end to 
be joined with, the coding end could become available for repair by more error-prone 
pathways such as alternative NHEJ, which would give greater scope for aberrantly 
joining the broken coding end to another chromosome. 
 
One study indicated that the non-core regions of RAG1 and RAG2 promote the 
retention of hairpins following cleavage in vitro (Kumar and Swanson, 2009). It is 
possible that the coding end could be retained for longer following asymmetric 
cleavage by full-length RAG proteins in vitro, therefore it would be useful to investigate 
postcleavage complex stability with full-length RAG proteins. In any case, the most 
dangerous outcome following asymmetric cleavage is that the broken RSS is released 
by the RAG proteins (i.e. the RAG proteins cut-and-run), since potentially 
leukaemogenic chromosome translocations could result if it is repaired incorrectly. 
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Chapter 5 
 
Testing the cut-and-run hypothesis in vivo 
 
A) Introduction  
 
In the first two chapters, I presented evidence that cleavage of RSSs and ESCs by 
purified cRAG proteins in vitro is asymmetric, and that the molecular basis of 
asymmetric cutting is most likely that RAG proteins bind to both RSSs of an ESC at the 
same time, thus preventing efficient cleavage of the ESC. The aim of this chapter is to 
investigate whether or not asymmetric cleavage occurs in vivo, and therefore whether 
cut-and-run is likely to occur in developing B and T cells. 
 
The transfection of nonlymphoid cells with extrachromosomal recombination substrates 
to investigate recombination activity is well established (Lieber et al., 1988; Sadofsky et 
al., 1993; Han et al., 1999; Vanura et al., 2007). In fact, their use predates in vitro 
experiments with short oligonucleotides (Hesse et al., 1987; McBlane et al., 1995). A 
number of these studies have demonstrated that intermolecular V(D)J recombination 
(i.e. recombination between RSSs located on different DNA molecules) is impaired 
relative to recombination between RSSs located on the same DNA molecule (Hesse et 
al., 1987; Tevelev and Schatz, 2000). Further studies showed joining of signal ends in 
trans occurs efficiently, but joining of coding ends is very rare, indicating that 
intermolecular recombination is inhibited at the level of coding joint formation (Han et 
al., 1999). However, binding and cleavage of RSSs in trans is as efficient as RSSs 
located in cis, and stimulation of cleavage adheres to the 12/23 rule (Steen et al., 1996; 
Han et al., 1999). Synapsis of an ESC and a genomic RSS, either cryptic or legitimate, 
is an inherently intermolecular interaction. In the proposed cut-and-run reaction, 
synapsis between an ESC and an RSS results in cleavage of the RSS but not the ESC, 
and does not involve a joining step. Therefore, the plasmid-based assay would be 
suitable for examining whether cleavage an RSS-ESC pair is asymmetric in vivo. 
 
To test if RSS-ESC cleavage is indeed asymmetric in vivo, nonlymphoid cells were 
transfected with RAG expression vectors and different combinations of RAG substrates 
and quantitative PCR (qPCR) was used to assess the level of cleavage. If cut-and-run 
occurs in vivo, then the cleavage of these transfected substrates should be 
asymmetric. Indeed, I find that cleavage of co-transfected 12 and 23RSSs is 
symmetric, but importantly, when an RSS is co-transfected with an ESC, the RSS is 
cleaved but there is essentially no cleavage of the ESC.  
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Whilst ESCs cannot replicate, they appear to be remarkably stable structures in vivo 
that persist until they are diluted out by subsequent cell divisions. Indeed, the stability 
of ESCs has led to their development as a marker for estimating recent thymic activity 
(i.e. T cell production; Hazenberg et al., 2001) and also as a forensic tool to estimate 
the age of an individual (Zubakov et al., 2010). Furthermore, several studies have 
shown that the RAG proteins remain tightly bound to cleaved signal ends (Agrawal and 
Schatz, 1997; Jones and Gellert, 2001), and that signal ends are not joined to form 
ESCs until RAG expression is downregulated (Livak and Schatz, 1996; Jiang et al., 
2004). This could either be because the joining machinery cannot access the tightly-
bound signal ends, or because the RAG proteins re-cleave the ESCs, potentially via 
the nick-nick mechanism (Neiditch et al., 2002). Since a prerequisite of cut-and-run is 
an intact ESC, I also tested the in vivo state of a bona fide ESC from the Igλ locus. 
Using qPCR assays on DNA extracted from mouse pro-B cells, I find that this ESC is 
largely intact in these cells, which is therefore consistent with the cut-and-run 
hypothesis. 
 
B) Results 
 
5.1 Cleavage of extrachromosomal substrates 
 
To test if cleavage of ESC and RSSs is asymmetric in vivo, NIH/3T3 mouse fibroblast 
cells were transfected with four plasmids: an untagged full-length RAG1 expression 
vector (pJH548; Sadofsky et al., 1992), either a full-length or core RAG2 expression 
vector (pEFXC-RAG2 and pEFXC-cRAG2, respectively, both untagged), and two 
substrate plasmids, carrying either a 12RSS (pJβ2.7+), 23RSS (p23+) or an ESC 
(pJδ1+; Fig. 5.1A). The 12RSS and ESC plasmids were already available in the Boyes 
laboratory, but a 23RSS-containing plasmid had to be constructed de novo. This was 
done by cloning a consensus 23RSS sequence (identical to the sequence of the 
oligonucleotide substrate used in Chapters 3 and 4) into pJβ2.7+, replacing the 12RSS 
(see Section 2.43). Although the signal sequences are located on plasmids and not in 
the context of a chromosome, transiently transfected plasmids are chromatinised to 
some degree (Cereghini and Yaniv, 1984; Reeves et al., 1985). Therefore, all substrate 
plasmids contain the strong human cytomegalovirus (CMV) promoter sequence 
upstream of the RSS to enable transcription through the signal sequence , since 
transcription is known to enhance recombination by improving accessibility via several 
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Figure 5.1 – Cleavage of transfected RSS/ESC substrates is asymmetric in vivo. To assess whether 
ESC/RSS cleavage is asymmetric in vivo, NIH/3T3 cells were transfected with a RAG1 expression vector, 
a RAG2 expression vector (either core or full-length, as indicated), and two substrate plasmids. Plasmids 
were extracted after 48 h and the level of cleavage was measured by qPCR to detect the amount of intact 
substrate. (A) Schematic of substrate plasmids used, indicating the primer pairs used to detect cleavage 
(see Section 2.44 for primer details). A primer pair that amplifies across the RSS was used to measure the 
level of intact substrate, and a primer that amplifies a unique region in the backbone of each plasmid was 
used to detect the overall level of substrate for normalisation. (B) Cleavage of cotransfected 12 and 
23RSS substrates is symmetric, whereas cotransfection of 12 or 23RSS substrates with an ESC substrate 
leads to cleavage of the RSS, but not the ESC, indicating that cleavage of extrachromosomal ESC/RSS 
substrates is asymmetric in vivo. Data were normalised to unique regions within each plasmid, and the 
values given are relative to no RAG2 controls. Error bars show the SEM of separate transfections. 12+23, 
n=2; 12+ESC, n=3; 23+ESC, n=2. The data are an amalgamation of work done by Adam Kupinski and 
myself. 
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mechanisms, including the eviction of H2A/H2B dimers from nucleosomes (Bevington 
and Boyes, 2013). Transfected cells were incubated for 48 h, and plasmid DNA was 
recovered via Hirt extraction (Hirt, 1967) and used in a qPCR assay. The level of 
cleavage was measured using a primer pair that amplifies across the RAG cleavage 
site so that only intact substrate is amplified. The data were then normalised by qPCR 
amplification of a sequence unique to each substrate plasmid (Fig. 5.1A).  
 
When cells are transfected with RAG1, RAG2, and 12RSS and 23RSS plasmids, the 
amount of intact 12RSS detected decreases by 26%, and the amount of intact 23RSS 
detected decreases by 34%, relative to samples where RAG2 is not transfected (Fig. 
5.1B), consistent with previously published data (Steen et al., 1996; Han et al., 1999). 
When transfected with a 12RSS and an ESC, 12-18% of the 12RSS is cleaved but no 
cleavage of ESC plasmid is detected (Fig. 5.1B). Similarly, when transfected with 
23RSS and ESC substrates, the 23RSS is cleaved by 10%, but the ESC is not cleaved 
relative to samples lacking RAG2. Therefore, these data indicate that cleavage of two 
RSSs is symmetric, but RSS-ESC cleavage is asymmetric in vivo, consistent with the 
cut-and-run hypothesis. 
 
Since purified full-length RAG proteins did not show asymmetric cleavage of 
oligonucleotide substrates in vitro (Fig. 3.16), the cleavage activity of core and full-
length RAG proteins in vivo was compared. Importantly, cleavage of co-transfected 
12RSS and ESC substrates is asymmetric with both core and full-length RAG proteins 
in vivo (Fig. 5.1B), consistent with full-length RAG proteins catalysing the cut-and-run 
reaction. Results from these qPCR assays indicate that there is absolutely no cleavage 
of the ESC.  
 
The qPCR assay is unable to differentiate between nicked DNA and hairpinned double-
strand break products, since neither will be amplified. Therefore, ligation-mediated 
PCR (LM-PCR) was used to verify that DSBs, and not just nicks, are formed at the 12 
and 23RSS substrates. Here, the linker will only ligate to a DSB, not a single-strand 
nick. As can be seen in Fig. 5.2, an LM-PCR product is formed at the cut 12RSS in the 
presence of both a 23RSS and ESC partner. Furthermore, the product is the same size 
as for control DNA digested with EcoRV. Notably, the uncut ESC does not generate an 
LM-PCR product, but the positive control sample does (ApaLI-cut, and filled in with 
Klenow polymerase), demonstrating a cleaved ESC, if formed, could be detected by 
LM-PCR. Overall, these data indicate that DSBs are formed at the plasmid substrates, 
and it is likely that this is why a decrease in PCR product is seen in Fig. 5.1. 
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Figure 5.2 – LM-PCR of extrachromosomal substrate cleavage products. The plasmid samples from 
Figure 5.1 were used in an LM-PCR assay to verify that the plasmids were fully cleaved to form DSBs, and 
not nicked, since the qPCR assay cannot differentiate between DSBs and nicked DNA. Radioactive LM-
PCR products were run on a 1% agarose gel, dried and visualised using a phosphorimager. The labelled 
substrate is indicated above the gel with an asterisk. R indicates positive control samples that were cut 
with a restriction enzyme. A product of 128 bp is detected only with the 12RSS samples, and not with the 
ESC sample. Positive control samples cut with EcoRV also yield products of the expected size. See 
section 2.47 for LM-PCR primer details. 
 
5.2 An endogenous ESC is intact in mouse pro-B cells  
 
The Igλ locus is the simplest of the seven Ig loci, containing just six V and J gene 
segments, and only one known recombination enhancer, making it an ideal model for 
investigating V(D)J recombination (Haque et al., 2013). Recombination of Igλ is 
activated at the pro-B/pre-B cell transition by a single transcription factor, IRF4, which 
activates recombination by binding to the Igλ enhancer and triggering non-coding 
transcription (Eisenbeis et al., 1993; Muljo and Schlissel, 2003). The Boyes laboratory 
have produced a transgenic mouse line where IRF4 is under the control of the pro-B-
cell-specific λ5/Vpre-B promoter and locus control region (LCR). In the pro-B cells of 
these transgenic mice, IRF4 is expressed at the same level as in pre-B cells. 
Consequently, this single change increases the level of recombination in pro-B-cells to 
pre-B-cell levels, thus demonstrating that IRF4 is the only transcription factor required 
to fully activate recombination of the Igλ locus (Bevington and Boyes, 2013).  
 
This transgenic line (PIP3) provides a convenient model for investigating the in vivo 
state of a bona fide ESC. Approximately 60% of all rearrangements at the Igλ locus 
occur between just two gene segments, namely Vλ1 and JCλ1 (Fig. 5.3; Boudinot et 
al., 1995). Therefore, the most common ESC in pro-B cells is likely to be the Vλ1-JCλ1 
ESC and this provides a good substrate for examining ESC cleavage in vivo. 
Furthermore, the amount of Vλ1-JCλ1 ESC should correlate with the level of Vλ1-JCλ1 
recombination. This can be tested by comparing nontransgenic samples with 
transgenic pro-B cell samples, which should display a ~4-fold increase in 
recombination over nontransgenic samples (Bevington and Boyes, 2013). 
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Conveniently, the sequence of the adjoined RSSs in an ESC creates an ApaLI site. 
Therefore, ApaLI-digested DNA can be used as a negative control. 
 
Samples from nontransgenic (NTG) and transgenic (PIP3) mouse pro B cells were 
prepared by James Scott for unrelated experiments, but he kindly provided me with an 
aliquot of each sample for these analyses. Pro-B cells from the bone marrow of mouse 
femurs were purified by fluorescence-activated cell sorting (FACS) using two pro-B-
cell-specific markers, FITC-CD19 and PE-CD43. DNA purified from double-positive 
cells was analysed by qPCR using primers specific to recombined Vλ1-JCλ1 and the 
Vλ1-JCλ1 ESC (Fig. 5.3A). The data were then normalised to the level of GAPDH in 
each sample. 
 
In the PIP3 transgenic pro-B cells, the level of recombination is 5-fold greater than in 
NTG pro-B cells (Fig. 5.3B), similar to previously published data (Bevington and Boyes, 
2013). The level of recombination decreases with increasing amounts of interleukin 7 
(IL-7) in the growth medium. IL-7 is essential for promoting the proliferation and 
survival of pro-B cells, and to inhibit pro-B to pre-B differentiation (Namen et al., 1988; 
Lu et al., 1999; Milne et al., 2004). However, IL-7 signalling also inhibits recombination 
by downregulating RAG1 and RAG2 expression. This is achieved via activation of the 
phosphoinositide 3 kinase-AKT pathway, which phosphorylates the forkhead box 
protein O (FOXO) proteins that are directly responsible for activating RAG1 and RAG2 
expression (Amin and Schlissel, 2008; Herzog et al., 2008; Clark et al., 2014). 
Therefore, a growth medium concentration of 0.5 µg/ml IL-7 represents the best trade-
off between the survival and proliferation of pro-B cells and the inhibition of 
recombination, as concentrations greater than this inhibit recombination (Fig. 5.3B). 
 
Importantly, there is a good correlation between the levels of ESC and recombination in 
each undigested sample and at each concentration of IL-7, indicating that the ESC is 
intact in these cells (Fig. 5.3B). In samples digested with ApaLI, the level of 
recombination is the same as in undigested samples, since ApaLI does not cut in the 
recombination amplicon. However, the level of ESC is greatly reduced in each sample, 
verifying that the ESC is being amplified specifically in this assay. Together, these data 
suggest that an endogenous ESC is largely intact. 
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Figure 5.3 – An endogenous ESC from the Igλ locus is intact in vivo (A) A simplified schematic of the 
murine Igλ locus. The lambda light chain is the simplest immunoglobulin locus, and ~60% of 
rearrangements occur between gene segments Vλ1 and JCλ1 (Boudinot et al., 1995). The primers used to 
detect the level of Vλ1-JCλ1 recombination and ESC are indicated by the half-head arrows (see Section 
2.48 for specific primers used). Specific detection of recombination required an initial PCR step (outer 
primers), the products of which were then used in nested qPCR (inner primers). (B) To test whether the 
Vλ1-JCλ1 ESC is intact in vivo, DNA was extracted from nontransgenic (NTG) and transgenic (PIP3) 
mouse pro-B cells that overexpress IRF4 to induce early recombination. The number in brackets for each 
PIP3 sample indicates the concentration of IL-7 in the growth medium, in µg/ml. Samples were analysed 
by qPCR using the primer pairs shown in (A), and normalised to GAPDH. The values given are relative to 
NTG, which is set at 1. The level of ESC correlates with the level of recombination. Digestion with ApaLI, 
which cleaves at the ESC heptamer-heptamer junction, greatly reduces the level of ESC. Together, these 
data imply that the Vλ1-JCλ1 ESC is fully intact in vivo. Error bars show the SEM of 2 independent 
experiments. 
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C)  Discussion 
 
Cleavage of extrachromosomal substrates is asymmetric in vivo 
 
In this chapter, I investigated the likelihood that cut-and-run occurs in vivo in two ways. 
Firstly, using transfected extrachromosomal substrates and RAG expression vectors in 
non-lymphoid cells, I found that 12/23 cleavage is symmetric in vivo, whereas 
RSS/ESC cleavage is asymmetric. These findings are supported by the fact that no 
cleaved ESCs could be detected using LM-PCR. Therefore, these results indicate the 
asymmetric cleavage observed in Chapter 3 is not an in vitro artefact that is peculiar to 
purified RAG proteins or short DNA oligonucleotide substrates. The transfected RAG 
constructs do not contain any affinity tags yet still display the same asymmetric 
cleavage activity as the MBP-tagged RAG proteins used in vitro, indicating that the 
large MBP tag is unlikely to have influenced this aspect of RAG activity in the data 
presented in Chapters 3 and 4. Furthermore, the use of plasmid substrates is a more 
accurate reflection of how cut and-run would occur in vivo, on longer, and in the case of 
the ESC, circular DNA molecules.  
 
It is possible that cleavage of the extrachromosomal substrates took place within a 
single complex, rather than a paired complex. To confirm that cleavage of the 
transfected substrates adheres to the 12/23 rule, a lone 12 or 23RSS should be 
transfected, and the level of cleavage compared with the level of cleavage in the 
presence of a suitable partner. In addition, transfection experiments using further ESC 
mutants should be performed analogous to the in vitro experiments described in 
Chapter 4, to see whether asymmetric cleavage in vivo is also a result of RAG binding 
to both sides of the ESC, as it is in vitro. 
 
The possibility that the ESC reintegrates with the RSS plasmid, or indeed into a 
genomic location, was not addressed. It is possible that reintegration occurs to some 
extent, since it is a similar experimental system that was originally used to detect 
reintegration (Vanura et al., 2007). However, the fact that the amount of intact ESC did 
not differ from samples containing no RAG2 (Fig. 5.1) indicates that if any reintegration 
does occur, it occurs only at a very low level. Nevertheless, the level of reintegration 
should be assessed in order to make a direct comparison between the potential 
frequency of cut-and-run and reintegration in vivo. 
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An endogenous ESC detected in murine pro-B cells is intact 
 
Testing whether cut-and-run occurs in B cells is not straightforward, and the possible 
ways in which this could be done are addressed in Chapter 6. To begin to address this 
question, I investigated whether an endogenous ESC is intact in B cells, for two 
reasons: a) an intact ESC is required for cut and run, and b) previous studies indicate 
that signal ends are abundant in developing B and T cells, suggesting that ESCs are 
not intact (Livak and Schatz, 1996; Jiang et al., 2004). Furthermore, the RAG proteins 
remain stably bound to signal ends, which persist until the RAG proteins are 
downregulated (Ramsden and Gellert, 1995; Livak and Schatz, 1996; Jiang et al., 
2004). 
 
I investigated the in vivo state of a bona fide ESC using transgenic and nontransgenic 
mouse pro-B cells. Importantly, in this system, pro-B cells are cultured for 5 days prior 
to recombination taking place. This slowly increases between day 5 and day 7, when 
the cells were isolated for analysis (Bevington and Boyes, 2013). Therefore, the ESC is 
isolated relatively soon after recombination. qPCR analyses indicate that the level of a 
specific ESC correlates well with the corresponding coding joint, suggesting that, in 
contrast to previous studies, the ESC is intact in these cells. However, a limitation of 
the approach taken here is that the level of signal ends was not assayed. If the ESC is 
cleaved/unjoined by the same amount in each sample, this would give the same ratio 
of recombination:ESC in each case. One way of addressing this issue would be to use 
LM-PCR to detect cleaved/unjoined ESC in these pro-B samples, in the same way LM-
PCR was used to detect broken ESCs in the transfection experiments (Fig. 5.2). 
 
Several studies indicate that signal ends can only form ESCs once RAG expression is 
downregulated (Livak and Schatz, 1997; Jiang et al., 2004). This suggests that in the 
pro-B cells used in the present experiments, either a) ESC formation can occur to an 
extent in the presence of RAG proteins, or b) the RAG proteins are downregulated 
following light chain recombination in these cells. There are two phases of B cell 
development at which RAG protein expression is downregulated. The first is following 
successful IgH recombination and expression of the pre-B cell receptor (Grawunder et 
al., 1995). The second is when cell surface IgM is expressed following successful IgL 
recombination, which signals for the downregulation of RAG expression (Wilson et al., 
1994). In addition, RAG2 is degraded via the ubiquitin-proteasome pathway before 
entry into S phase (Jiang et al., 2005). Whether cell-surface IgM is expressed in the 
transgenic cells used in this study has not been determined. It is possible that once the 
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Igλ locus successfully rearranges in these cells, cell-surface IgM is expressed, leading 
to the downregulation of RAG expression and the joining of signal ends to form ESCs.  
 
If ESCs cannot form until the RAG expression is downregulated, what scope is there 
for RAG proteins to catalyse cut-and-run in vivo? There are two conceivable scenarios 
where the RAG proteins and ESCs could co-exist in B and T cells. The first is if the first 
rearrangement of an allele is unproductive. In most cells the first rearrangement of an 
Ig locus is unproductive, and the cell rearranges the second allele (Rajewsky, 1996). 
Therefore, in most lymphocytes, the RAG proteins will coexist with an ESC from the 
first unproductive rearrangement. However, if signal ends cannot be joined to form 
ESCs whilst RAG proteins are still expressed, then this scenario might occur only 
rarely.  
 
During B cell development the IgH locus is rearranged before the IgL loci, and in T cells 
the TCRβ locus rearranges before TCRα (Bassing et al., 2002). Therefore, the second 
scenario where RAG proteins and ESCs (in this case from the IgH/TCRβ locus) could 
coexist is immediately after rearranging the IgH/TCRβ chain, and whilst the IgL/TCRα 
chain is rearranging in the pro-B to pre-B or CD4-/CD8- to CD4+/CD8+ transition. In this 
case, the RAG proteins are downregulated after the IgH/TCRβ rearrangement, and are 
then upregulated for IgL/TCRα rearrangement, which would give the signal ends an 
opportunity to become ESCs. In any case, the data presented in this chapter indicate 
that asymmetric cleavage is not merely an in vitro artefact, and that a bona fide ESC is 
intact in mouse pro-B cells, a prerequisite for cut-and-run. Whether or not the 
production of intact ESCs coincides with RAG expression remains to be seen. 
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Chapter 6 
 
Discussion 
 
6.1 Cut-and-run 
 
An integral part of V(D)J recombination is the excision of intervening DNA between 
recombining gene segments to form an ESC by-product. Sealing the two signal ends in 
an ESC was previously thought to be a way of sequestering the potentially reactive 3’-
OH group from undergoing transposition reactions (Arnal and Roth, 2007). However, it 
was later discovered that transposition is almost completely inhibited by the RAG2 C-
terminus, and happens rarely in vivo (Elkin et al., 2003; Messier et al., 2003; Messier et 
al., 2006). Two reports published around the same time then indicated that ESCs are 
far from inert, and can be rebound by the RAG proteins by virtue of the two RSSs, and 
reintegrated back into the genome at RSSs or cRSSs (Curry et al., 2007; Vanura et al., 
2007). Reintegration of ESCs is potentially a dangerous reaction, specifically if 
reintegration of an ESC occurs adjacent to an oncogene (Fig. 1.11B). Evidence from 
transgenic mice indicated that the RAG2 C-terminus inhibits reintegration 7-fold (Curry 
et al., 2007). Therefore, the initial aim of this project was to investigate the mechanism 
of ESC reintegration and the mechanism by which the RAG2 C-terminus inhibits 
reintegration, with a view to developing inhibitors of RAG-ESC binding to prevent 
reintegration entirely. However, during verification and optimisation of the reaction 
conditions, I discovered that cleavage of an ESC-RSS pair is asymmetric (Chapter 3). 
If cleavage is truly asymmetric in vivo, then in the majority of ESC-RSS pairings the 
ESC will remain uncleaved. Since the RSS appears to be released following cleavage, 
cleavage at the RSS could reoccur until the ESC becomes cleaved, or until the RAG 
proteins are downregulated, thus generating multiple genomic DSBs in developing 
lymphocytes. In turn, these could potentially be substrates for chromosome 
translocations, leading to leukaemia. 
 
In vivo, recombination only occurs between gene segments that are flanked by different 
length RSSs, a requirement known as the 12/23 rule (Tonegawa, 1983). Under 
conditions that recapitulate the 12/23 rule in vitro (specifically, short incubation times 
and the presence of Mg2+ and DMSO), I found that cleavage of an RSS/ESC complex 
is asymmetric (Fig. 3.11). Asymmetry is not a factor of RAG concentration, since 
cleavage is asymmetric at a range of RAG concentrations (Fig. 3.12). Analysis of 
cleavage products by denaturing gel electrophoresis revealed that cleavage of ESCs is 
blocked at the nicking step, rather than the binding or hairpinning step (Fig. 3.18). 
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Furthermore, the asymmetry is more pronounced with a 23RSS than with a 12RSS. A 
low level of hairpinning of ESCs is seen in the presence of a 12RSS, but cleavage of 
ESCs in the presence of a 23RSS also appears to be blocked at the hairpinning step. 
 
Since an ESC contains two RSSs in a head-to-head configuration, a plausible 
hypothesis is that RAG proteins bind to both RSSs of the ESC simultaneously, thus 
blocking efficient binding of the heptamer-heptamer border and preventing efficient 
cleavage. This prediction was borne out by EMSA experiments which showed that the 
RAG proteins form a larger complex with ESCs than with RSSs (Fig. 4.1), and by 
cleavage experiments with mutant ESCs, which showed that deleting either the 
conserved heptamer or nonamer on one side of the ESC restores symmetric cleavage 
by preventing simultaneous binding (Section 4.4).  
 
Since the danger posed by cut-and-run relies on the fate of the broken DNA ends 
following cleavage, the stability of postcleavage complexes was analysed by an EMSA 
timecourse (Section 4.6). These data imply that the coding end of an RSS is released 
by the RAG proteins following cleavage, whereas the ESC is retained. Experiments 
with extrachromosomal substrates showed that asymmetric cleavage of ESCs and 
RSSs also occurs in vivo, and analysis of an endogenous ESC in pro-B cells indicates 
that the ESC is largely intact, a prerequisite for the cut-and-run phenomenon. Together, 
these experiments provide evidence in favour of the cut-and-run hypothesis. 
 
6.2 Asymmetric cleavage 
 
Cleavage of an RSS by the RAG proteins occurs in two steps. First, a nick is 
introduced precisely at the heptamer-coding sequence boundary (McBlane et al., 
1995). Nicking of RSSs can occur independently of synapsis with a suitable partner, 
both in vitro and in vivo (Eastman and Schatz, 1997; Yu and Lieber, 2000). Synapsis 
with a suitable partner RSS is essential for hairpin formation, which proceeds via 
transesterification of the opposite strand. Analysis of the RAG cleavage products on a 
denaturing gel shows that a high level of nicking occurs at both 12 and 23RSSs in the 
absence of a partner substrate, and that addition of a suitable partner stimulates 
hairpin formation, consistent with previous studies (Eastman and Schatz, 1997; Yu and 
Lieber, 2000). 
  
The level of nicking at a lone ESC is much lower than at a lone RSS, indicating that 
ESC cleavage is blocked at the nicking step (Fig. 3.18). Several cases have been 
reported where RAG cleavage is blocked at the nicking step. First, RAG cleavage is 
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blocked at the nicking step when the aromatic residues thought to stabilise a flipped out 
base are mutated (Grundy et al., 2007). Furthermore, DNA is only known to inhibit 
RAG cleavage at the nicking step when certain base pairs of the coding flank sequence 
are replaced with abasic nucleotides (Grundy et al., 2007). Cleavage efficiency can be 
greatly influenced by the flanking coding sequence, but neither RSS in the ESC 
constitutes a bad flank for the other (Ramsden et al., 1996). Given that sequencing of 
the RAG expression vectors showed no mutations, and DNA substrates with abasic 
residues were not used here, the source of blocking at the nicking step must be 
unrelated to the RAG proteins themselves or the specific sequence of the ESC. 
 
A plausible hypothesis is that the RAG proteins bind to both RSSs of the ESC 
simultaneously and compete (unsuccessfully) for binding at the heptamer boundary. 
The low level of nicking seen at the ESC means that binding is not blocked entirely, 
suggesting that there is a degree of “breathing” by the complex (Fig. 3.18). Synapsis 
with a 12RSS partially relieves the block since there is an increase in hairpin formation 
(Fig. 3.18). Synapsis with a 23RSS results in a slight increase in the level of nicking, 
but does not allow for hairpin formation (Fig. 3.18). This lack of hairpinning indicates 
that there is an additional block at the hairpinning step, or that the block at the nicking 
step extends to the hairpin step with a 23RSS. The reason for the block in ESC 
hairpinning when synapsed with a 23RSS is unclear, especially since the molecular 
basis of the 12/23 rule is unknown. In some cases, 23RSS cleavage is stimulated less 
well by an ESC than by a 12RSS (i.e. asymmetric cleavage is greater with a 23RSS). 
This is consistent with a study which found that reintegration occurs in vivo at Vκ 
12RSSs but not Jκ 23RSSs (Curry et al., 2007). One possibility is that the 23/ESC 
complex is less stable, but this is not supported by the bandshift timecourse assays, 
since a 23-ESC complex is as stable as a 23-12 complex (Fig. 4.13 and 4.14). Another 
possible explanation is that in an ESC-23RSS pairing, RAG proteins do not undergo 
the necessary conformational change to catalyse efficient hairpin formation by aligning 
a flipped out base with aromatic residues of the RAG1 active site. 
 
The blocking hypothesis could be further tested by introducing a spacer of several bp 
between the two heptamers of the ESC. The prediction here would be that the higher 
molecular weight complex would still be abundant with this ESC, but that symmetric 
cleavage would be restored. A possible scenario that could explain the lack of ESC 
hairpin formation when paired with a 23RSS (Fig. 3.18) is that the second “bystander” 
RSS in the ESC somehow influences hairpinning. It might be that when the 23RSS of 
an ESC is paired with a 12RSS, the 12RSS bystander in the ESC allows hairpinning, 
but when an ESC is paired with a 23RSS, the 23RSS bystander somehow blocks 
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hairpinning. This could be tested by pairing a 12-12 ESC with a 23RSS and a 23-23 
ESC with a 12RSS partner. 
 
6.3 RAG binding to both RSSs of an ESC prevents efficient cleavage 
 
EMSAs showed that an extra complex of higher molecular weight is more abundant 
with a labelled ESC than a labelled RSS (Fig. 4.1), consistent with the hypothesis that 
the RAG proteins bind to both RSSs of the ESC simultaneously. If the source of 
asymmetry is double occupancy, then the ESC-RSS paired complex (PC) has to 
contain an RSS partner and the RAG proteins bound to both RSSs of the ESC. Whilst 
the presence of a higher molecular weight complex is consistent with double 
occupancy/simultaneous binding, the protein/DNA content and cleavage activity of this 
complex is unknown. This could be addressed in two ways. First, to deduce the protein 
stoichiometry of the upper complex, differential tagging of the RAG1 and RAG2 
proteins combined with supershift EMSA could be performed. Secondly, the cleavage 
activity of the additional ESC complex could be analysed using an in-gel cleavage 
assay (Swanson, 2002a). In this assay, complexes are formed in Ca2+ (to prevent 
substrate cleavage) and separated on a gel. Discrete complexes are excised from the 
gel and incubated in Mg2+-containing buffer to instigate substrate cleavage and the 
products are separated on a second gel. This would show whether or not the upper 
complex is competent for asymmetric cleavage. 
 
If the doubly-occupied ESC is involved in asymmetric cleavage, then it would be 
expected to form the same higher molecular weight complex when paired with a 
labelled 12 or 23RSS (i.e. the ESC would supershift a labelled RSS), but this was not 
observed (Fig. 4.1). However, the formation of a PC could not be detected with a 
standard 12/23RSS pair. Detection of the PC is confounded by the fact that HSC2 and 
PC have the same protein content and therefore co-migrate. I attempted to 
demonstrate PC formation by streptavidin supershift in Chapter 4 (Fig. 4.4) but was 
unsuccessful, possibly because the PC is only transient, or it is unstable under the 
electrophoresis conditions used. If either or both of these are true, the PC could be 
captured by cross-linking then used in a supershift EMSA. In this case, pairing of the 
doubly-occupied ESC with a labelled 12/23 RSS would be expected to give a higher 
molecular weight complex. 
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6.4 The fate of broken ends following asymmetric cleavage 
 
Time course analysis of complex stability in vitro indicates that the RAG proteins 
release the coding end of an RSS after cleavage (Section 4.6). In these experiments, 
only the coding end was labelled, therefore they should be repeated with 
oligonucleotides where the signal end is labelled to deduce its fate. The stability of 
postcleavage complexes could also be analysed using single molecule total internal 
reflection fluorescence microscopy (smTIRFm). Use of smTIRFm would enable 
analysis of individual complexes, as opposed to EMSAs, where a heterogeneous 
population of molecules is simultaneously examined. In the smTIRF approach, RAG 
proteins would be immobilised on a cover slip and bound to an RSS-containing 
oligonucleotide labelled with a FRET pair, such that cleavage of the oligonucleotide 
would result in loss of the FRET signal (Wang et al., 2012). In the presence of calcium, 
an ESC labelled with a third fluorophore would be added to assemble RSS-ESC 
complexes, and complexes containing all three fluorophores would be analysed. Then, 
magnesium would be added to trigger cleavage and loss of the FRET signal would be 
used to follow dissociation of the cleaved RSS. The dissociation of the coding end, 
signal end and ESC would then be monitored by virtue of their different fluorophores. 
 
6.5 Full length RAG proteins 
 
A considerable amount of time and effort was expended in expressing and purifying 
flRAG proteins. Unfortunately, once successfully expressed and purified from HEK-
293T cells, they were not concentrated enough for binding studies, and data from 
cleavage assays indicated that ESC-RSS cleavage was not asymmetric (observed with 
three individual preparations). One possible reason why the in vitro cleavage activity of 
flRAG proteins is inconsistent with that of the cRAG proteins is that the flRAG proteins 
were not concentrated enough to occupy both RSSs of the ESC. The fact that flRAG 
proteins were not concentrated enough to saturate the probe in an EMSA is consistent 
with this. However, cleavage of transfected substrates in nonlymphoid mammalian cells 
shows that both full-length and core RAG proteins display asymmetric cleavage of ESC 
and RSS substrates in vivo.  
 
A comparison of core and full-length RAG proteins is crucial because the RAG2 C-
terminus has been shown to inhibit reintegration 7-fold (Curry et al., 2007). Since 
reintegration and cut-and-run both involve binding an ESC, it is also possible that the 
RAG2 C-terminus also inhibits cut-and-run. The mechanism by which the RAG2 C-
terminus inhibits reintegration is unknown. The PHD finger of the RAG2 C-terminus 
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directs the RAG recombinase to actively transcribed regions by binding to H3K4me3 
(Matthews et al., 2007; Ramon-Maiques et al., 2007), and can bind to H3K4me3 at any 
location in the genome in the absence of RAG1. However, RAG1 and RAG2 binding 
only coincides at RSSs that contain H3K4me3 (Ji et al., 2010). Therefore, it is possible 
that the RAG2 C-terminus inhibits reintegration by directing the RAG proteins away 
from ESCs, which might lose their H3K4me3 after excision from the genome. However, 
the ESC plasmid substrate used in the in vivo cleavage assay contained the CMV 
promoter upstream of the signal joint, to enable transcription (Fig. 5.1). Therefore, the 
ESC likely contained H3K4me3, but was cleaved asymmetrically by flRAG proteins 
regardless. Preliminary data from the Boyes laboratory suggest that the RAG2 C-
terminus inhibits the end-joining step of reintegration. However, since cut-and run does 
not involve joining ESC ends with genomic ends (and it releases the RSS ends), it is 
unlikely that the C-terminus would inhibit cut-and-run in the same way. 
 
6.6 Does cut-and run occur in B and T cells? 
 
Definitive proof that cut-and-run occurs in vivo is inherently difficult to obtain. Unlike 
chromosome translocations and reintegration, which result in detectable DNA 
rearrangements and insertions, cut-and-run would leave no trace other than a broken 
RSS. In addition, there would be nothing specific about the broken RSS to indicate that 
it was caused by synapsis with an ESC, since the mechanism by which the RSS is 
cleaved is the same as standard V(D)J recombination. Furthermore, if the cleaved RSS 
was subsequently used in a chromosome translocation, there would be no indication 
that the breakpoint was specifically caused by an ESC. Nevertheless, there are several 
ways in which the likelihood of cut-and-run could be assessed. 
 
Extrachromosomal substrate assays indicate that cleavage of RSSs and ESCs is 
asymmetric in vivo, and therefore is not an in vitro artefact (Fig. 5.1). In these 
experiments RAG levels are likely to be very high since RAG expression is under the 
control of the strong EF-1α promoter. To verify that asymmetric cutting occurs at 
physiological levels of RAG proteins, the same plasmid substrates used in Chapter 5 
would be used to transfect a cell line that endogenously expresses the RAG proteins. 
One such cell line is the human ETV6-RUNX1 positive leukaemic cell line, REH 
(Uphoff et al., 1997; Wagner et al., 2004). Since the level of cleavage will be lower in 
these cells than in transfected NIH/3T3 cells, one of the substrate plasmids would 
contain a green fluorescent protein transfection marker. This would allow for FACS 
purification of successfully transfected cells, which in turn should improve the detection 
of substrate cleavage. Analysis of cleavage would be done using a qPCR assay in the 
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same way as in Chapter 5. 
 
In order for ESCs to pose a threat, they must be present in a lymphocyte at the same 
time as the RAG proteins. Previous studies indicate that signal ends are tightly bound 
by RAG proteins, and are unlikely to form ESCs until the RAG proteins are 
downregulated (Livak and Schatz, 1996; Zhu et al., 1996; Agrawal and Schatz, 1997; 
Jiang et al., 2004). Analysis of a single endogenous ESC in mouse pro-B cells 
indicates that at least some degree of ESC formation occurs (Fig. 5.3), but whether 
formation of the ESC coincides with RAG expression was not investigated. As 
discussed in Chapter 5, there are two instances where RAG expression could coincide 
with ESC formation. The first is following unproductive rearrangement of the first 
Ig/TCR allele, and the second is following rearrangement of the IgH/TCRβ locus, whilst 
the IgL/TCRα locus is rearranging. RAG binding of the Vλ1JCλ1 ESC, which is formed 
in ~60% of cells that undergo IgL rearrangement, could be tested by ChIP with an anti-
RAG1 antibody followed by qPCR analysis of the recovered DNA with primers specific 
to the head-to-head RSSs. If RAG expression and ESC formation coincide, and ESCs 
are bound by RAG proteins, intact ESCs should be pulled down with RAG1. If ESCs 
and RAG expression do not coincide, only signal ends will be pulled down. 
 
A transgenic mouse line recently developed in the Boyes laboratory could be used to 
further test this. These mice express IRF4 fused to the estrogen receptor (ER) to form 
IRF4-ER. This fusion protein is under the control of the λ5/VpreB promoter and LCR, 
(as for the mice described in Chapter 5), therefore it is only expressed in pro-B cells 
(Sabbattini et al., 2001). Notably, increased levels of IRF4 in pro-B cells is all that is 
required to full activate IgL recombination (Bevington and Boyes, 2013). Activity of 
IRF4-ER is induced by the addition of tamoxifen to the growth medium, which then 
triggers early Igλ recombination in pro-B cells. The ability to control the onset of Igλ 
recombination allows for temporal analyses. IgL recombination could be induced in B 
cells from these mice, and then the Vλ1-Jλ1 signal ends could be tracked by LM-PCR 
at intervals to deduce when joining of signal ends occurs. This could be combined with 
qPCR/western blot analysis of RAG expression following induction to see if there is any 
overlap between RAG expression and ESC formation. 
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6.7 Do ESCs form synaptic complexes with genomic RSSs? 
 
In addition to the asymmetric cleavage of ESCs, and the coexpression of RAG proteins 
and ESCs, the ESC has to form a complex with a genomic RSS for cut-and-run to 
occur. Evidence from a study investigating reintegration of an ESC at genomic loci 
indicates that this is likely to be the case (Curry et al., 2007). To gain a comprehensive 
map of the genomic sites that are bound by ESCs, a combination of ChIP-Seq and a 
transcription activator-like effector (TALE) designed to recognise an ESC could be 
used. TALEs can be designed to bind any sequence of interest (Scott et al., 2014). 
Therefore, an expression vector for HA-tagged TALE that binds next to the head-to-
head RSSs in an ESC could be cotransfected into mammalian cells with the ESC. 
TALE-ChIP-Seq could then be used to deduce the genomic binding locations of the 
ESC. If ESCs do indeed undergo cut-and-run reactions, the binding sites would be 
expected to map to RSSs and cRSSs. 
 
In a second approach to determine whether ESCs bind to genomic RSSs and trigger 
DBSs, the incidence of γH2AX foci could be examined. Within one minute of a 
chromosomal DSB forming, the histone variant H2AX is phosphorylated at Ser139, 
creating γH2AX (Rogakou et al., 1998). γH2AX foci spread for several Mb around the 
site of the DSB (Rogakou et al., 1999) and are crucial in signalling the formation of 
DSBs. RAG-induced DSBs at genomic RSSs are no different, leading to rapid 
formation of γH2AX foci (Chen et al., 2000). Therefore, it would be possible to see 
whether ESCs trigger DSBs in the genome by transfecting cells with an ESC plasmid, 
and measuring the incidence of γH2AX foci relative to untransfected cells. There are 
multiple methods for detecting γH2AX, but immunofluorescence is the best established 
technique (Nakamura et al., 2006). 
 
The incidence of γH2AX foci caused by ESCs could be tested in three different ways. 
First, nonlymphoid mammalian cells such as COS-7 cells could be transfected with an 
ESC and RAG expression vectors, and the resulting γH2AX foci compared with 
untransfected cells. This would give the highest chance of detecting ESC-induced 
DSBs since the RAG proteins would be highly expressed, but the ESC would only be 
able to synapse with cryptic RSSs since the Ig loci are inactive in these cells. The 
second way of testing ESC-induced DSBs would be to transfect the lymphoid REH cell 
line with an ESC, but no RAG expression vectors. This would allow for break analysis 
in a more relevant cell line where the Ig loci are accessible, and where RAG proteins 
are expressed at physiological level.  
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The third approach makes use of the IRF4-ER-expressing mice described above. To 
gain insight into the physiological level of cut-and-run resulting from V(D)J 
recombination, γH2AX foci could be measured following induction of Igλ recombination 
and compared with uninduced cells at intervals following induction of recombination. 
Since most Igλ recombination occurs between Vλ1 and JCλ1, increases in γH2AX due 
to V(D)J recombination-induced breaks will be small. Therefore, a large increase in 
γH2AX foci might indicate ESC-induced breaks. The site of γH2AX foci could then be 
mapped by ChIP-seq and compared with site of ESC binding (above) to determine 
whether any of the DSBs were likely to be ESC-induced. Together, data from 
experiments that test if a) RAG and ESC expression coincides, b) if the ESC is bound 
by RAG proteins at genomic RSSs, and c) if the presence of the ESC increases the 
incidence of γH2AX foci at RSSs, would enable a comprehensive assessment of 
whether cut-and-run truly occurs in vivo. 
 
6.8 Implications of cut-and-run 
 
a) Cut-and-run could be a major way of causing orphan DNA breaks during V(D)J 
recombination. 
Chromosome translocations caused by aberrant recombinase activity in the production 
of antibodies and T cell receptors are a hallmark of many leukaemias and lymphomas 
(Kuppers, 2005). In this thesis, I have identified a new way in which aberrant RAG 
activity could produce orphan DSBs that have the potential to participate in 
carcinogenic chromosome translocations. It is possible that many of the DSBs resulting 
from cut-and-run are efficiently repaired via NHEJ. Nevertheless, the high frequency of 
chromosome translocations in many lymphoid cancers proves that many DSBs, 
regardless of their origin, are capable of escaping the cell’s repair machinery. 
Therefore, cut-and-run could be a potent source of translocation partners at the Ig/TCR 
loci.  
 
One of the most common forms of translocation caused by V(D)J recombination is end 
donation (Roth, 2003; Kuppers, 2005). In end donation, a broken RSS formed by RAG 
cleavage is joined with a DSB formed by an unrelated process, such as ionizing 
radiation. It is unclear how end donation occurs, since RSS cleavage should take place 
within the context of a paired complex. Whilst it is true that the coding ends are bound 
less tightly than signal ends in vitro, this weaker association might be necessary for 
efficient resolution of coding ends via the NHEJ pathway. This is supported by certain 
RAG mutants that are competent for cleavage but deficient for joining, possibly by 
binding too tightly to the coding ends (Roth, 2003). Since cut-and-run occurs at a single 
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RSS during each cutting cycle, it is possible that cut-and-run is a potent source of 
“single” broken RSSs that can undergo an end donation-type translocation. 
 
The mechanism by which broken RSSs are transferred to the NHEJ machinery is 
poorly understood. Mutational analyses of the RAG proteins revealed several joining-
deficient mutants, indicating that the RAG proteins play a critical scaffolding role to 
facilitate end-joining (Qiu et al., 2001; Yarnell Schultz et al., 2001; Huye et al., 2002). 
Moreover, the acidic hinge of the RAG2 C-terminus helps to shepherd the DSBs 
toward the classical NHEJ pathway, and away from the error-prone alternative NHEJ 
pathway (Coussens et al., 2013; Gigi et al., 2014). It is unclear how asymmetric 
cleavage might affect the end-joining process. Since only one coding end and one 
signal end is produced following asymmetric cleavage, instead of two of each, this 
might negatively influence the end-joining. If the RAG proteins released the coding end 
but remain bound to the signal end as previous studies suggest, only the coding end 
will be immediately available for joining. This coding end might be bound by the 
nonhomologous end joining machinery, and in the absence of a suitable partner it is 
perhaps more likely to undergo translocation. Alternatively, the coding end might be 
transferred to the alternative NHEJ pathway, or perhaps not transferred to any end-
joining machinery. More thorough analyses of the postcleavage complex following 
asymmetric cleavage, as described above, are needed to address these issues.  
 
A specific example where cut-and-run could play a significant role is in leukaemia 
patients bearing the ETV6/RUNX1 (TEL/AML1) translocation, the most common 
translocation found in childhood acute lymphocytic leukaemia (ALL; Pui et al., 2004). 
This translocation often arises in utero, but it cannot trigger malignancy in the absence 
of other aberrations. Instead, the ETV6/RUNX1 translocation partially stalls B cell 
progression at a stage where the RAG proteins are still expressed (Tsuzuki et al., 
2004), thus providing an extended window of opportunity for secondary recombination 
reactions. The majority of these aberrant recombination reactions occur at cryptic 
RSSs adjacent to transcriptionally active B cell development genes, thereby stalling B-
cell progression even further, which can eventually result in full malignant 
transformation (Papaemmanuil et al., 2014). In patients where full malignant 
transformation has occurred, 27% of the chromosome aberrations contain an RSS or 
cRSS at only one side of translocation (Papaemmanuil et al., 2014), consistent with 
cut-and-run providing broken RSSs for end donation. If cut-and-run is the cause of 
these breaks, then their location would correspond with ESC binding in the 
experiments described above. Moreover, slowly proliferating pro-B cells deriving from 
the original transformed cell are continuously produced, meaning that a cell population 
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with the potential to become transformed is constantly present. Therefore, inhibitors 
that prevent the recombination by-product from triggering genome instability could be 
very useful in preventing progression from the pre-leukaemic state in these patients.  
 
b) Cut-and-run may have a protective role in preventing reintegration 
An alternative interpretation of this work is that rather than disrupting genomic stability 
and contributing to lymphoid transformation, cut-and-run actually plays a protective role 
in preventing reintegration. As described in the introduction, reintegration has the 
potential to upregulate oncogene expression if reintegration occurs at an adjacent 
cryptic RSS. Reintegration of an ESC is likely to be a largely irreversible process, since 
the introduction of non-templated base pairs at the hybrid joint is likely to render that 
RSS useless (Fig. 1.8). 
 
Whilst cut-and-run creates DSBs that could participate in chromosome translocations, 
these DSBs have the potential to be repaired correctly by the cell. From this 
perspective, cut-and-run may represent the lesser of two evils. Since cut-and-run is 
more likely to occur than reintegration, by virtue of asymmetric cleavage, cut-and-run 
might actually work together with the inhibitory effect of the RAG2 C-terminus to 
prevent the potentially more damaging reintegration reaction. 
 
6.9 Conclusions 
 
Aberrant RAG activity is a hallmark of lymphoid cancers. Whilst investigating the 
mechanism of reintegration of the ESC by-product, I found that cleavage of ESC is 
actually remarkably inefficient compared with RSS cleavage. Since reintegration 
requires opening of the ESC, a more likely outcome from ESC-RSS synapsis is that the 
RSS is cleaved, but the ESC remains intact. This leaves the ESC free to stimulate 
multiple DSBs within the genome of developing B and T lymphocytes, thus posing a 
major threat to genomic stability in a reaction called cut-and-run. 
 
Asymmetric cleavage of an ESC-RSS pair is most likely the result of RAG binding to 
both sides of the ESC simultaneously, and initial experiments indicate that cut-and-run 
could occur in vivo. This has significant implications for the generation of lymphoid 
cancers. In particular, it could be a potent source of broken RSSs that undergo 
chromosome translocations, and might play a large role in the progression of 
leukaemias that bear the ETV6/RUNX1 translocation. 
 
| 161 
 
References 
 
Abarrategui, I. & Krangel, M.S. (2006). Regulation of T cell receptor-alpha gene recombination 
by transcription. Nat Immunol 7, 1109-1115. 
 
Abarrategui, I. & Krangel, M.S. (2007). Noncoding transcription controls downstream promoters 
to regulate T-cell receptor alpha recombination. Embo J 26, 4380-4390. 
 
Adams, J.M., Harris, A.W., Pinkert, C.A., Corcoran, L.M., Alexander, W.S., Cory, S., Palmiter, 
R.D., & Brinster, R.L. (1985). The c-myc oncogene driven by immunoglobulin enhancers 
induces lymphoid malignancy in transgenic mice. Nature 318, 533-538. 
 
Agrawal, A., Eastman, Q.M., & Schatz, D.G. (1998). Transposition mediated by RAG1 and 
RAG2 and its implications for the evolution of the immune system. Nature 394, 744-751. 
 
Agrawal, A. & Schatz, D.G. (1997). RAG1 and RAG2 form a stable postcleavage synaptic 
complex with DNA containing signal ends in V(D)J recombination. Cell 89, 43-53. 
 
Aidinis, V., Dias, D.C., Gomez, C.A., Bhattacharyya, D., Spanopoulou, E., & Santagata, S. 
(2000). Definition of minimal domains of interaction within the recombination-activating genes 1 
and 2 recombinase complex. J Immunol 164, 5826-5832. 
 
Akamatsu, Y., Monroe, R., Dudley, D.D., Elkin, S.K., Gartner, F., Talukder, S.R., Takahama, Y., 
Alt, F.W., Bassing, C.H., & Oettinger, M.A. (2003). Deletion of the RAG2 C terminus leads to 
impaired lymphoid development in mice. Proc Natl Acad Sci USA 100, 1209-1214. 
 
Akamatsu, Y. & Oettinger, M.A. (1998). Distinct roles of RAG1 and RAG2 in binding the V(D)J 
recombination signal sequences. Mol Cell Biol 18, 4670-4678. 
 
Alberts, B., Johnson, A., Lewis, J., Raff, M., Robert, K., & Walter, P., Molecular Biology of the 
Cell, Available at http://www.ncbi.nlm.nih.gov/books/NBK21070/, (2002). 
 
Alt, F.W., Yancopoulos, G.D., Blackwell, T.K., Wood, C., Thomas, E., Boss, M., Coffman, R., 
Rosenberg, N., Tonegawa, S., & Baltimore, D. (1984). Ordered rearrangement of 
immunoglobulin heavy chain variable region segments. Embo J 3, 1209-1219. 
 
Amin, R.H. & Schlissel, M.S. (2008). Foxo1 directly regulates the transcription of recombination-
activating genes during B cell development. Nat Immunol 9, 613-622. 
 
Arbuckle, J.L., Fauss, L.A., Simpson, R., Ptaszek, L.M., & Rodgers, K.K. (2001). Identification of 
two topologically independent domains in RAG1 and their role in macromolecular interactions 
relevant to V(D)J recombination. J Biol Chem 276, 37093-37101. 
 
Arnal, S.M., Holub, A.J., Salus, S.S., & Roth, D.B. (2010). Non-consensus heptamer sequences 
destabilize the RAG post-cleavage complex, making ends available to alternative DNA repair 
pathways. Nucleic Acids Res 38, 2944-2954. 
 
Arnal, S.M. & Roth, D.B. (2007). Excised V(D)J recombination byproducts threaten genomic 
integrity. Trends Immunol 28, 289-292. 
 
Bailin, T., Mo, X., & Sadofsky, M.J. (1999). A RAG1 and RAG2 tetramer complex is active in 
cleavage in V(D)J recombination. Mol Cell Biol 19, 4664-4671. 
 
Bakhshi, A., Wright, J.J., Graninger, W., Seto, M., Owens, J., Cossman, J., Jensen, J.P., 
Goldman, P., & Korsmeyer, S.J. (1987). Mechanism of the t(14;18) chromosomal translocation: 
structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 84, 
2396-2400. 
 
Bassing, C.H., Swat, W., & Alt, F.W. (2002). The mechanism and regulation of chromosomal 
V(D)J recombination. Cell 109 Suppl, S45-55. 
 
References  | 162 
 
 
Baumann, M., Mamais, A., McBlane, F., Xiao, H., & Boyes, J. (2003). Regulation of V(D)J 
recombination by nucleosome positioning at recombination signal sequences. EMBO J 22, 
5197-5207. 
 
Bellon, S.F., Rodgers, K.K., Schatz, D.G., Coleman, J.E., & Steitz, T.A. (1997). Crystal structure 
of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc 
binuclear cluster. Nat Struct Biol 4, 586-591. 
 
Belotserkovskaya, R., Oh, S., Bondarenko, V.A., Orphanides, G., Studitsky, V.M., & Reinberg, 
D. (2003). FACT facilitates transcription-dependent nucleosome alteration. Science 301, 1090-
1093. 
 
Bergeron, S., Anderson, D.K., & Swanson, P.C. (2006). RAG and HMGB1 proteins: purification 
and biochemical analysis of recombination signal complexes. Methods Enzymol 408, 511-528. 
 
Bergeron, S., Madathiparambil, T., & Swanson, P.C. (2005). Both high mobility group (HMG)-
boxes and the acidic tail of HMGB1 regulate recombination-activating gene (RAG)-mediated 
recombination signal synapsis and cleavage in vitro. J Biol Chem 280, 31314-31324. 
 
Bernstein, B.E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D.K., Huebert, D.J., 
McMahon, S., Karlsson, E.K., Kulbokas, E.J., 3rd, Gingeras, T.R. et al. (2005). Genomic maps 
and comparative analysis of histone modifications in human and mouse. Cell 120, 169-181. 
 
Bevington, S. & Boyes, J. (2013). Transcription-coupled eviction of histones H2A/H2B governs 
V(D)J recombination. EMBO J. 
 
Bischerour, J., Lu, C., Roth, D.B., & Chalmers, R. (2009). Base flipping in V(D)J recombination: 
insights into the mechanism of hairpin formation, the 12/23 rule, and the coordination of double-
strand breaks. Mol Cell Biol 29, 5889-5899. 
 
Blackwell, T.K., Moore, M.W., Yancopoulos, G.D., Suh, H., Lutzker, S., Selsing, E., & Alt, F.W. 
(1986). Recombination between immunoglobulin variable region gene segments is enhanced by 
transcription. Nature 324, 585-589. 
 
Boehm, T., Baer, R., Lavenir, I., Forster, A., Waters, J.J., Nacheva, E., & Rabbitts, T.H. (1988). 
The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor C delta 
locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J 
7, 385-394. 
 
Born, W.K., Reardon, C.L., & O'Brien, R.L. (2006). The function of gammadelta T cells in innate 
immunity. Curr Opin Immunol 18, 31-38. 
 
Boudinot, P., Rueff-Juy, D., Drapier, A.M., Cazenave, P.A., & Sanchez, P. (1995). Various V-J 
rearrangement efficiencies shape the mouse lambda B cell repertoire. Eur J Immunol 25, 2499-
2505. 
 
Brandle, D., Muller, C., Rulicke, T., Hengartner, H., & Pircher, H. (1992). Engagement of the T-
cell receptor during positive selection in the thymus down-regulates RAG-1 expression. Proc 
Natl Acad Sci USA 89, 9529-9533. 
 
Brandt, V.L. & Roth, D.B. (2009). Recent insights into the formation of RAG-induced 
chromosomal translocations. Adv Exp Med Biol 650, 32-45. 
 
Bredemeyer, A.L., Sharma, G.G., Huang, C.Y., Helmink, B.A., Walker, L.M., Khor, K.C., 
Nuskey, B., Sullivan, K.E., Pandita, T.K., Bassing, C.H. et al. (2006). ATM stabilizes DNA 
double-strand-break complexes during V(D)J recombination. Nature 442, 466-470. 
 
Bujacz, G., Alexandratos, J., Wlodawer, A., Merkel, G., Andrake, M., Katz, R.A., & Skalka, A.M. 
(1997). Binding of different divalent cations to the active site of avian sarcoma virus integrase 
and their effects on enzymatic activity. J Biol Chem 272, 18161-18168. 
 
References  | 163 
 
 
Calin, G.A. & Croce, C.M. (2007). Chromosomal rearrangements and microRNAs: a new cancer 
link with clinical implications. J Clin Invest 117, 2059-2066. 
 
Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., 
Rattan, S., Bullrich, F., Negrini, M. et al. (2004). Human microRNA genes are frequently located 
at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101, 2999-
3004. 
 
Callebaut, I. & Mornon, J.P. (1998). The V(D)J recombination activating protein RAG2 consists 
of a six-bladed propeller and a PHD fingerlike domain, as revealed by sequence analysis. Cell 
Mol Life Sci 54, 880-891. 
 
Calogero, S., Grassi, F., Aguzzi, A., Voigtlander, T., Ferrier, P., Ferrari, S., & Bianchi, M.E. 
(1999). The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal 
hypoglycaemia in newborn mice. Nat Genet 22, 276-280. 
 
Casali, P., Pal, Z., Xu, Z., & Zan, H. (2006). DNA repair in antibody somatic hypermutation. 
Trends Immunol 27, 313-321. 
 
Cereghini, S. & Yaniv, M. (1984). Assembly of transfected DNA into chromatin: structural 
changes in the origin-promoter-enhancer region upon replication. EMBO J 3, 1243-1253. 
 
Chaumeil, J., Micsinai, M., Ntziachristos, P., Roth, D.B., Aifantis, I., Kluger, Y., Deriano, L., & 
Skok, J.A. (2013). The RAG2 C-terminus and ATM protect genome integrity by controlling 
antigen receptor gene cleavage. Nat Commun 4, 2231. 
 
Chen, H.T., Bhandoola, A., Difilippantonio, M.J., Zhu, J., Brown, M.J., Tai, X., Rogakou, E.P., 
Brotz, T.M., Bonner, W.M., Ried, T. et al. (2000). Response to RAG-mediated VDJ cleavage by 
NBS1 and gamma-H2AX. Science 290, 1962-1965. 
 
Cheroutre, H. & Husain, M.M. (2013). CD4 CTL: living up to the challenge. Semin Immunol 25, 
273-281. 
 
Chowdhury, D. & Sen, R. (2004). Regulation of immunoglobulin heavy-chain gene 
rearrangements. Immunol Rev 200, 182-196. 
 
Ciubotaru, M., Ptaszek, L.M., Baker, G.A., Baker, S.N., Bright, F.V., & Schatz, D.G. (2003). 
RAG1-DNA binding in V(D)J recombination. Specificity and DNA-induced conformational 
changes revealed by fluorescence and CD spectroscopy. J Biol Chem 278, 5584-5596. 
 
Ciubotaru, M., Trexler, A.J., Spiridon, L.N., Surleac, M.D., Rhoades, E., Petrescu, A.J., & 
Schatz, D.G. (2013). RAG and HMGB1 create a large bend in the 23RSS in the V(D)J 
recombination synaptic complexes. Nucleic Acids Res 41, 2437-2454. 
 
Clark, M.R., Mandal, M., Ochiai, K., & Singh, H. (2014). Orchestrating B cell lymphopoiesis 
through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol 14, 69-80. 
 
Corneo, B., Wendland, R.L., Deriano, L., Cui, X., Klein, I.A., Wong, S.Y., Arnal, S., Holub, A.J., 
Weller, G.R., Pancake, B.A. et al. (2007). Rag mutations reveal robust alternative end joining. 
Nature 449, 483-486. 
 
Coussens, M.A., Wendland, R.L., Deriano, L., Lindsay, C.R., Arnal, S.M., & Roth, D.B. (2013). 
RAG2's acidic hinge restricts repair-pathway choice and promotes genomic stability. Cell Rep 4, 
870-878. 
 
Cui, X. & Meek, K. (2007). Linking double-stranded DNA breaks to the recombination activating 
gene complex directs repair to the nonhomologous end-joining pathway. Proc Natl Acad Sci 
USA 104, 17046-17051. 
 
Cuomo, C.A., Mundy, C.L., & Oettinger, M.A. (1996). DNA sequence and structure 
requirements for cleavage of V(D)J recombination signal sequences. Mol Cell Biol 16, 5683-
5690. 
References  | 164 
 
 
 
Cuomo, C.A. & Oettinger, M.A. (1994). Analysis of regions of RAG-2 important for V(D)J 
recombination. Nucleic Acids Res 22, 1810-1814. 
 
Curry, J.D., Geier, J.K., & Schlissel, M.S. (2005). Single-strand recombination signal sequence 
nicks in vivo: evidence for a capture model of synapsis. Nat Immunol 6, 1272-1279. 
 
Curry, J.D., Schulz, D., Guidos, C.J., Danska, J.S., Nutter, L., Nussenzweig, A., & Schlissel, 
M.S. (2007). Chromosomal reinsertion of broken RSS ends during T cell development. J Exp 
Med 204, 2293-2303. 
 
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R.C., & Croce, C.M. (1982). 
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt 
lymphoma cells. Proc Natl Acad Sci USA 79, 7824-7827. 
 
Davies, D.R., Goryshin, I.Y., Reznikoff, W.S., & Rayment, I. (2000). Three-dimensional structure 
of the Tn5 synaptic complex transposition intermediate. Science 289, 77-85. 
 
De Silva, N.S., Simonetti, G., Heise, N., & Klein, U. (2012). The diverse roles of IRF4 in late 
germinal center B-cell differentiation. Immunol Rev 247, 73-92. 
 
Degner, S.C., Verma-Gaur, J., Wong, T.P., Bossen, C., Iverson, G.M., Torkamani, A., 
Vettermann, C., Lin, Y.C., Ju, Z., Schulz, D. et al. (2011). CCCTC-binding factor (CTCF) and 
cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B 
cells. Proc Natl Acad Sci USA 108, 9566-9571. 
 
Deriano, L., Chaumeil, J., Coussens, M., Multani, A., Chou, Y., Alekseyenko, A.V., Chang, S., 
Skok, J.A., & Roth, D.B. (2011). The RAG2 C terminus suppresses genomic instability and 
lymphomagenesis. Nature 471, 119-123. 
 
Deriano, L. & Roth, D.B. (2013). Modernizing the nonhomologous end-joining repertoire: 
alternative and classical NHEJ share the stage. Annu Rev Genet 47, 433-455. 
 
Di Noia, J.M. & Neuberger, M.S. (2007). Molecular mechanisms of antibody somatic 
hypermutation. Annu Rev Biochem 76, 1-22. 
 
Difilippantonio, M.J., McMahan, C.J., Eastman, Q.M., Spanopoulou, E., & Schatz, D.G. (1996). 
RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination. 
Cell 87, 253-262. 
 
Drejer-Teel, A.H., Fugmann, S.D., & Schatz, D.G. (2007). The beyond 12/23 restriction is 
imposed at the nicking and pairing steps of DNA cleavage during V(D)J recombination. Mol Cell 
Biol 27, 6288-6299. 
 
Duber, S., Engel, H., Rolink, A., Kretschmer, K., & Weiss, S. (2003). Germline transcripts of 
immunoglobulin light chain variable regions are structurally diverse and differentially expressed. 
Mol Immunol 40, 509-516. 
 
Duquette, M.L., Pham, P., Goodman, M.F., & Maizels, N. (2005). AID binds to transcription-
induced structures in c-MYC that map to regions associated with translocation and 
hypermutation. Oncogene 24, 5791-5798. 
 
Earl, P.L., Moss, B., Wyatt, L.S., & Carroll, M.W. (2001). Generation of recombinant vaccinia 
viruses. Curr Protoc Protein Sci Chapter 5, Unit5 13. 
 
Eastman, Q.M. & Schatz, D.G. (1997). Nicking is asynchronous and stimulated by synapsis in 
12/23 rule-regulated V(D)J cleavage. Nucleic Acids Res 25, 4370-4378. 
 
Eisenbeis, C.F., Singh, H., & Storb, U. (1993). PU.1 is a component of a multiprotein complex 
which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol Cell Biol 
13, 6452-6461. 
 
References  | 165 
 
 
Elkin, S.K., Ivanov, D., Ewalt, M., Ferguson, C.G., Hyberts, S.G., Sun, Z.Y., Prestwich, G.D., 
Yuan, J., Wagner, G., Oettinger, M.A. et al. (2005). A PHD finger motif in the C terminus of 
RAG2 modulates recombination activity. J Biol Chem 280, 28701-28710. 
 
Elkin, S.K., Matthews, A.G., & Oettinger, M.A. (2003). The C-terminal portion of RAG2 protects 
against transposition in vitro. EMBO J 22, 1931-1938. 
 
Ellington, A. & Pollard, J.D., Jr. (2001). Purification of oligonucleotides using denaturing 
polyacrylamide gel electrophoresis. Curr Protoc Mol Biol Chapter 2, Unit2 12. 
 
Elliott, B., Richardson, C., & Jasin, M. (2005). Chromosomal translocation mechanisms at 
intronic alu elements in mammalian cells. Mol Cell 17, 885-894. 
 
Elroy-Stein, O. & Moss, B. (2001). Gene expression using the vaccinia virus/T7 RNA 
polymerase hybrid system. Curr Protoc Mol Biol Chapter 16, Unit16 19. 
 
Engel, H., Rolink, A., & Weiss, S. (1999). B cells are programmed to activate kappa and lambda 
for rearrangement at consecutive developmental stages. Eur J Immunol 29, 2167-2176. 
 
Espinoza, C.R. & Feeney, A.J. (2005). The extent of histone acetylation correlates with the 
differential rearrangement frequency of individual VH genes in pro-B cells. J Immunol 175, 
6668-6675. 
 
Featherstone, K., Wood, A.L., Bowen, A.J., & Corcoran, A.E. (2010). The mouse 
immunoglobulin heavy chain V-D intergenic sequence contains insulators that may regulate 
ordered V(D)J recombination. J Biol Chem 285, 9327-9338. 
 
Ferrando, A.A., Neuberg, D.S., Staunton, J., Loh, M.L., Huard, C., Raimondi, S.C., Behm, F.G., 
Pui, C.H., Downing, J.R., Gilliland, D.G. et al. (2002). Gene expression signatures define novel 
oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87. 
 
Fitzsimmons, S.P., Bernstein, R.M., Max, E.E., Skok, J.A., & Shapiro, M.A. (2007). Dynamic 
changes in accessibility, nuclear positioning, recombination, and transcription at the Ig kappa 
locus. J Immunol 179, 5264-5273. 
 
Franchini, D.M., Benoukraf, T., Jaeger, S., Ferrier, P., & Payet-Bornet, D. (2009). Initiation of 
V(D)J recombination by Dbeta-associated recombination signal sequences: a critical control 
point in TCRbeta gene assembly. PLoS ONE 4, e4575. 
 
Fugmann, S.D., Lee, A.I., Shockett, P.E., Villey, I.J., & Schatz, D.G. (2000a). The RAG proteins 
and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol 18, 495-527. 
 
Fugmann, S.D. & Schatz, D.G. (2001). Identification of basic residues in RAG2 critical for DNA 
binding by the RAG1-RAG2 complex. Mol Cell 8, 899-910. 
 
Fugmann, S.D., Villey, I.J., Ptaszek, L.M., & Schatz, D.G. (2000b). Identification of two catalytic 
residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex. Mol 
Cell 5, 97-107. 
 
Fuxa, M., Skok, J., Souabni, A., Salvagiotto, G., Roldan, E., & Busslinger, M. (2004). Pax5 
induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain 
gene. Genes Dev 18, 411-422. 
 
Gay, D., Saunders, T., Camper, S., & Weigert, M. (1993). Receptor editing: an approach by 
autoreactive B cells to escape tolerance. J Exp Med 177, 999-1008. 
 
Geier, J.K. & Schlissel, M.S. (2006). Pre-BCR signals and the control of Ig gene 
rearrangements. Semin Immunol 18, 31-39. 
 
Gellert, M. (2002). V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev 
Biochem 71, 101-132. 
 
References  | 166 
 
 
Gigi, V., Lewis, S., Shestova, O., Mijuskovic, M., Deriano, L., Meng, W., Luning Prak, E.T., & 
Roth, D.B. (2014). RAG2 mutants alter DSB repair pathway choice in vivo and illuminate the 
nature of 'alternative NHEJ'. Nucleic Acids Res 42, 6352-6364. 
 
Golding, A., Chandler, S., Ballestar, E., Wolffe, A.P., & Schlissel, M.S. (1999). Nucleosome 
structure completely inhibits in vitro cleavage by the V(D)J recombinase. Embo J 18, 3712-
3723. 
 
Goldmit, M., Ji, Y., Skok, J., Roldan, E., Jung, S., Cedar, H., & Bergman, Y. (2005). Epigenetic 
ontogeny of the Igk locus during B cell development. Nat Immunol 6, 198-203. 
 
Gordon, S.J., Saleque, S., & Birshtein, B.K. (2003). Yin Yang 1 is a lipopolysaccharide-inducible 
activator of the murine 3' Igh enhancer, hs3. J Immunol 170, 5549-5557. 
 
Gorman, J.R. & Alt, F.W. (1998). Regulation of immunoglobulin light chain isotype expression. 
Adv Immunol 69, 113-181. 
 
Gorman, J.R., van der Stoep, N., Monroe, R., Cogne, M., Davidson, L., & Alt, F.W. (1996). The 
Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes. 
Immunity 5, 241-252. 
 
Gottlieb, T.M. & Jackson, S.P. (1993). The DNA-dependent protein kinase: requirement for DNA 
ends and association with Ku antigen. Cell 72, 131-142. 
 
Grawunder, U., Leu, T.M., Schatz, D.G., Werner, A., Rolink, A.G., Melchers, F., & Winkler, T.H. 
(1995). Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional 
immunoglobulin heavy chain rearrangement. Immunity 3, 601-608. 
 
Grazini, U., Zanardi, F., Citterio, E., Casola, S., Goding, C.R., & McBlane, F. (2010). The RING 
domain of RAG1 ubiquitylates histone H3: a novel activity in chromatin-mediated regulation of 
V(D)J joining. Mol Cell 37, 282-293. 
 
Grundy, G.J., Hesse, J.E., & Gellert, M. (2007). Requirements for DNA hairpin formation by 
RAG1/2. Proc Natl Acad Sci USA 104, 3078-3083. 
 
Grundy, G.J., Ramon-Maiques, S., Dimitriadis, E.K., Kotova, S., Biertumpfel, C., Heymann, J.B., 
Steven, A.C., Gellert, M., & Yang, W. (2009). Initial Stages of V(D)J Recombination: The 
Organization of RAG1/2 and RSS DNA in the Postcleavage Complex. Mol Cell 35, 217-227. 
 
Grundy, G.J., Yang, W., & Gellert, M. (2010). Autoinhibition of DNA cleavage mediated by 
RAG1 and RAG2 is overcome by an epigenetic signal in V(D)J recombination. Proc Natl Acad 
Sci USA 107, 22487-22492. 
 
Gu, Y., Seidl, K.J., Rathbun, G.A., Zhu, C., Manis, J.P., van der Stoep, N., Davidson, L., Cheng, 
H.L., Sekiguchi, J.M., Frank, K. et al. (1997). Growth retardation and leaky SCID phenotype of 
Ku70-deficient mice. Immunity 7, 653-665. 
 
Guo, C., Gerasimova, T., Hao, H., Ivanova, I., Chakraborty, T., Selimyan, R., Oltz, E.M., & Sen, 
R. (2011a). Two forms of loops generate the chromatin conformation of the immunoglobulin 
heavy-chain gene locus. Cell 147, 332-343. 
 
Guo, C., Yoon, H.S., Franklin, A., Jain, S., Ebert, A., Cheng, H.L., Hansen, E., Despo, O., 
Bossen, C., Vettermann, C. et al. (2011b). CTCF-binding elements mediate control of V(D)J 
recombination. Nature 477, 424-430. 
 
Han, J.O., Steen, S.B., & Roth, D.B. (1999). Intermolecular V(D)J recombination is prohibited 
specifically at the joining step. Mol Cell 3, 331-338. 
 
Haque, S.F., Bevington, S.L., & Boyes, J. (2013). The E Enhancer is Essential for V(D)J 
Recombination of the Murine Immunoglobulin Lambda Light Chain Locus. Biochem Biophys 
Res Commun. 
 
References  | 167 
 
 
Hazenberg, M.D., Verschuren, M.C., Hamann, D., Miedema, F., & van Dongen, J.J. (2001). T 
cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical 
approach, and guidelines for interpretation. J Mol Med (Berl) 79, 631-640. 
 
Herzog, S., Hug, E., Meixlsperger, S., Paik, J.H., DePinho, R.A., Reth, M., & Jumaa, H. (2008). 
SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo 
pathway. Nat Immunol 9, 623-631. 
 
Hesse, J.E., Lieber, M.R., Gellert, M., & Mizuuchi, K. (1987). Extrachromosomal DNA 
substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining 
signals. Cell 49, 775-783. 
 
Hesslein, D.G., Pflugh, D.L., Chowdhury, D., Bothwell, A.L., Sen, R., & Schatz, D.G. (2003). 
Pax5 is required for recombination of transcribed, acetylated, 5' IgH V gene segments. Genes 
Dev 17, 37-42. 
 
Hiom, K. & Gellert, M. (1998). Assembly of a 12/23 paired signal complex: a critical control point 
in V(D)J recombination. Mol Cell 1, 1011-1019. 
 
Hiom, K., Melek, M., & Gellert, M. (1998). DNA transposition by the RAG1 and RAG2 proteins: a 
possible source of oncogenic translocations. Cell 94, 463-470. 
 
Hirt, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol 
Biol 26, 365-369. 
 
Holtmeier, W. & Kabelitz, D. (2005). gammadelta T cells link innate and adaptive immune 
responses. Chem Immunol Allergy 86, 151-183. 
 
Huang, J. & Muegge, K. (2001). Control of chromatin accessibility for V(D)J recombination by 
interleukin-7. J Leukoc Biol 69, 907-911. 
 
Huye, L.E., Purugganan, M.M., Jiang, M.M., & Roth, D.B. (2002). Mutational analysis of all 
conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient 
mutants in the V(D)J recombinase. Mol Cell Biol 22, 3460-3473. 
 
Ichihara, Y., Matsuoka, H., & Kurosawa, Y. (1988). Organization of human immunoglobulin 
heavy chain diversity gene loci. EMBO J 7, 4141-4150. 
 
Inlay, M., Alt, F.W., Baltimore, D., & Xu, Y. (2002). Essential roles of the kappa light chain 
intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nat Immunol 3, 
463-468. 
 
Jackson, A.M. & Krangel, M.S. (2006). Turning T-cell receptor beta recombination on and off: 
more questions than answers. Immunol Rev 209, 129-141. 
 
Jager, U., Bocskor, S., Le, T., Mitterbauer, G., Bolz, I., Chott, A., Kneba, M., Mannhalter, C., & 
Nadel, B. (2000). Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide 
insertions: novel insights into the mechanism of t(14;18) translocation. Blood 95, 3520-3529. 
 
Ji, Y., Resch, W., Corbett, E., Yamane, A., Casellas, R., & Schatz, D.G. (2010). The in vivo 
pattern of binding of RAG1 and RAG2 to antigen receptor loci. Cell 141, 419-431. 
 
Jiang, H., Chang, F.C., Ross, A.E., Lee, J., Nakayama, K., & Desiderio, S. (2005). Ubiquitylation 
of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol Cell 18, 
699-709. 
 
Jiang, H., Ross, A.E., & Desiderio, S. (2004). Cell cycle-dependent accumulation in vivo of 
transposition-competent complexes between recombination signal ends and full-length RAG 
proteins. J Biol Chem 279, 8478-8486. 
 
Johansen, F.E., Braathen, R., & Brandtzaeg, P. (2000). Role of J chain in secretory 
immunoglobulin formation. Scand J Immunol 52, 240-248. 
References  | 168 
 
 
 
Johnson, K., Angelin-Duclos, C., Park, S., & Calame, K.L. (2003). Changes in histone 
acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ 
recombination during B-cell ontogeny and development. Mol Cell Biol 23, 2438-2450. 
 
Johnson, K., Hashimshony, T., Sawai, C.M., Pongubala, J.M., Skok, J.A., Aifantis, I., & Singh, 
H. (2008). Regulation of immunoglobulin light-chain recombination by the transcription factor 
IRF-4 and the attenuation of interleukin-7 signaling. Immunity 28, 335-345. 
 
Jones, J.M., Bhattacharyya, A., Simkus, C., Vallieres, B., Veenstra, T.D., & Zhou, M. (2011). 
The RAG1 V(D)J recombinase/ubiquitin ligase promotes ubiquitylation of acetylated, 
phosphorylated histone 3.3. Immunol Lett 136, 156-162. 
 
Jones, J.M. & Gellert, M. (2001). Intermediates in V(D)J recombination: a stable RAG1/2 
complex sequesters cleaved RSS ends. Proc Natl Acad Sci USA 98, 12926-12931. 
 
Jones, J.M. & Gellert, M. (2002). Ordered assembly of the V(D)J synaptic complex ensures 
accurate recombination. EMBO J 21, 4162-4171. 
 
Jones, J.M. & Gellert, M. (2003). Autoubiquitylation of the V(D)J recombinase protein RAG1. 
Proc Natl Acad Sci USA 100, 15446-15451. 
 
Jones, J.M. & Simkus, C. (2009). The roles of the RAG1 and RAG2 "non-core" regions in V(D)J 
recombination and lymphocyte development. Arch Immunol Ther Exp (Warsz) 57, 105-116. 
 
Kaplan, M.H. (2013). Th9 cells: differentiation and disease. Immunol Rev 252, 104-115. 
 
Kassmeier, M.D., Mondal, K., Palmer, V.L., Raval, P., Kumar, S., Perry, G.A., Anderson, D.K., 
Ciborowski, P., Jackson, S., Xiong, Y. et al. (2012). VprBP binds full-length RAG1 and is 
required for B-cell development and V(D)J recombination fidelity. EMBO J 31, 945-958. 
 
Kelsoe, G. (1996). The germinal center: a crucible for lymphocyte selection. Semin Immunol 8, 
179-184. 
 
Kibbe, W.A. (2007). OligoCalc: an online oligonucleotide properties calculator. Nucleic Acids 
Res 35, W43-46. 
 
Kim, D.R., Dai, Y., Mundy, C.L., Yang, W., & Oettinger, M.A. (1999). Mutations of acidic 
residues in RAG1 define the active site of the V(D)J recombinase. Genes Dev 13, 3070-3080. 
 
Kirch, S.A., Sudarsanam, P., & Oettinger, M.A. (1996). Regions of RAG1 protein critical for 
V(D)J recombination. Eur J Immunol 26, 886-891. 
 
Kirsch, I.R., Morton, C.C., Nakahara, K., & Leder, P. (1982). Human immunoglobulin heavy 
chain genes map to a region of translocations in malignant B lymphocytes. Science 216, 301-
303. 
 
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V.K. (2009). IL-17 and Th17 Cells. Annu Rev 
Immunol 27, 485-517. 
 
Kosak, S.T., Skok, J.A., Medina, K.L., Riblet, R., Le Beau, M.M., Fisher, A.G., & Singh, H. 
(2002). Subnuclear compartmentalization of immunoglobulin loci during lymphocyte 
development. Science 296, 158-162. 
 
Kovalchuk, A.L., Kim, J.S., Park, S.S., Coleman, A.E., Ward, J.M., Morse, H.C., 3rd, Kishimoto, 
T., Potter, M., & Janz, S. (2002). IL-6 transgenic mouse model for extraosseous plasmacytoma. 
Proc Natl Acad Sci USA 99, 1509-1514. 
 
Kramerov, D.A. & Vassetzky, N.S. (2005). Short retroposons in eukaryotic genomes. Int Rev 
Cytol 247, 165-221. 
 
References  | 169 
 
 
Kriatchko, A.N., Anderson, D.K., & Swanson, P.C. (2006). Identification and characterization of 
a gain-of-function RAG-1 mutant. Mol Cell Biol 26, 4712-4728. 
 
Kridel, R., Sehn, L.H., & Gascoyne, R.D. (2012). Pathogenesis of follicular lymphoma. J Clin 
Invest 122, 3424-3431. 
 
Kumar, S. & Swanson, P.C. (2009). Full-length RAG1 promotes contact with coding and 
intersignal sequences in RAG protein complexes bound to recombination signals paired in cis. 
Nucleic Acids Res 37, 2211-2226. 
 
Kuppers, R. (2005). Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5, 251-
262. 
 
Kuppers, R. & Dalla-Favera, R. (2001). Mechanisms of chromosomal translocations in B cell 
lymphomas. Oncogene 20, 5580-5594. 
 
Kurahashi, H., Inagaki, H., Ohye, T., Kogo, H., Kato, T., & Emanuel, B.S. (2006). Palindrome-
mediated chromosomal translocations in humans. DNA Repair (Amst) 5, 1136-1145. 
 
Kwon, J., Imbalzano, A.N., Matthews, A., & Oettinger, M.A. (1998). Accessibility of nucleosomal 
DNA to V(D)J cleavage is modulated by RSS positioning and HMG1. Mol Cell 2, 829-839. 
 
Landree, M.A., Wibbenmeyer, J.A., & Roth, D.B. (1999). Mutational analysis of RAG1 and 
RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J 
recombination. Genes Dev 13, 3059-3069. 
 
Lee, G.S., Neiditch, M.B., Salus, S.S., & Roth, D.B. (2004). RAG proteins shepherd double-
strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates 
homologous recombination. Cell 117, 171-184. 
 
Lennon, G.G. & Perry, R.P. (1985). C mu-containing transcripts initiate heterogeneously within 
the IgH enhancer region and contain a novel 5'-nontranslatable exon. Nature 318, 475-478. 
 
Lewis, S.M. (1994). The mechanism of V(D)J joining: lessons from molecular, immunological, 
and comparative analyses. Adv Immunol 56, 27-150. 
 
Lewis, S.M., Agard, E., Suh, S., & Czyzyk, L. (1997). Cryptic signals and the fidelity of V(D)J 
joining. Mol Cell Biol 17, 3125-3136. 
 
Li, Z., Dordai, D.I., Lee, J., & Desiderio, S. (1996). A conserved degradation signal regulates 
RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. 
Immunity 5, 575-589. 
 
Li, Z., Woo, C.J., Iglesias-Ussel, M.D., Ronai, D., & Scharff, M.D. (2004). The generation of 
antibody diversity through somatic hypermutation and class switch recombination. Genes Dev 
18, 1-11. 
 
Lieber, M.R. (2010). The mechanism of double-strand DNA break repair by the nonhomologous 
DNA end-joining pathway. Annu Rev Biochem 79, 181-211. 
 
Lieber, M.R., Hesse, J.E., Mizuuchi, K., & Gellert, M. (1988). Studies of V(D)J recombination 
with extrachromosomal substrates. Curr Top Microbiol Immunol 137, 94-99. 
 
Little, A.J., Corbett, E., Ortega, F., & Schatz, D.G. (2013). Cooperative recruitment of HMGB1 
during V(D)J recombination through interactions with RAG1 and DNA. Nucleic Acids Res 41, 
3289-3301. 
 
Liu, H., Schmidt-Supprian, M., Shi, Y., Hobeika, E., Barteneva, N., Jumaa, H., Pelanda, R., 
Reth, M., Skok, J., Rajewsky, K. et al. (2007a). Yin Yang 1 is a critical regulator of B-cell 
development. Genes Dev 21, 1179-1189. 
 
References  | 170 
 
 
Liu, Y., Subrahmanyam, R., Chakraborty, T., Sen, R., & Desiderio, S. (2007b). A plant 
homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for 
efficient antigen-receptor-gene rearrangement. Immunity 27, 561-571. 
 
Livak, F. & Schatz, D.G. (1996). T-cell receptor alpha locus V(D)J recombination by-products 
are abundant in thymocytes and mature T cells. Mol Cell Biol 16, 609-618. 
 
Livak, F. & Schatz, D.G. (1997). Identification of V(D)J recombination coding end intermediates 
in normal thymocytes. J Mol Biol 267, 1-9. 
 
Lu, C.P., Sandoval, H., Brandt, V.L., Rice, P.A., & Roth, D.B. (2006). Amino acid residues in 
Rag1 crucial for DNA hairpin formation. Nat Struct Mol Biol 13, 1010-1015. 
 
Lu, H., Shimazaki, N., Raval, P., Gu, J., Watanabe, G., Schwarz, K., Swanson, P.C., & Lieber, 
M.R. (2008). A biochemically defined system for coding joint formation in V(D)J recombination. 
Mol Cell 31, 485-497. 
 
Lu, L., Chaudhury, P., & Osmond, D.G. (1999). Regulation of cell survival during B 
lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice 
with altered expression of IL-7 and recombinase-activating gene-2. J Immunol 162, 1931-1940. 
 
Ma, C.S. & Deenick, E.K. (2014). Human T follicular helper (Tfh) cells and disease. Immunol 
Cell Biol 92, 64-71. 
 
Ma, Y., Pannicke, U., Schwarz, K., & Lieber, M.R. (2002). Hairpin opening and overhang 
processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end 
joining and V(D)J recombination. Cell 108, 781-794. 
 
MacLennan, I.C. (2005). Germinal centers still hold secrets. Immunity 22, 656-657. 
 
Maes, J., O'Neill, L.P., Cavelier, P., Turner, B.M., Rougeon, F., & Goodhardt, M. (2001). 
Chromatin remodeling at the Ig loci prior to V(D)J recombination. J Immunol 167, 866-874. 
 
Malarkey, C.S. & Churchill, M.E. (2012). The high mobility group box: the ultimate utility player 
of a cell. Trends Biochem Sci 37, 553-562. 
 
Marculescu, R., Le, T., Simon, P., Jaeger, U., & Nadel, B. (2002). V(D)J-mediated 
translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic 
sites. J Exp Med 195, 85-98. 
 
Mathieu, N., Hempel, W.M., Spicuglia, S., Verthuy, C., & Ferrier, P. (2000). Chromatin 
remodeling by the T cell receptor (TCR)-beta gene enhancer during early T cell development: 
Implications for the control of TCR-beta locus recombination. J Exp Med 192, 625-636. 
 
Matthews, A.G., Kuo, A.J., Ramon-Maiques, S., Han, S., Champagne, K.S., Ivanov, D., 
Gallardo, M., Carney, D., Cheung, P., Ciccone, D.N. et al. (2007). RAG2 PHD finger couples 
histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 450, 1106-1110. 
 
McBlane, F. & Boyes, J. (2000). Stimulation of V(D)J recombination by histone acetylation. Curr 
Biol 10, 483-486. 
 
McBlane, J.F., van Gent, D.C., Ramsden, D.A., Romeo, C., Cuomo, C.A., Gellert, M., & 
Oettinger, M.A. (1995). Cleavage at a V(D)J recombination signal requires only RAG1 and 
RAG2 proteins and occurs in two steps. Cell 83, 387-395. 
 
McMurry, M.T. & Krangel, M.S. (2000). A role for histone acetylation in the developmental 
regulation of VDJ recombination [see comments]. Science 287, 495-498. 
 
Melek, M., Jones, J.M., O'Dea, M.H., Pais, G., Burke, T.R., Jr., Pommier, Y., Neamati, N., & 
Gellert, M. (2002). Effect of HIV integrase inhibitors on the RAG1/2 recombinase. Proc Natl 
Acad Sci USA 99, 134-137. 
 
References  | 171 
 
 
Messier, T.L., O'Neill, J.P., & Finette, B.A. (2006). V(D)J recombinase mediated inter-
chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human 
T cells. Hum Mutat 27, 829. 
 
Messier, T.L., O'Neill, J.P., Hou, S.M., Nicklas, J.A., & Finette, B.A. (2003). In vivo transposition 
mediated by V(D)J recombinase in human T lymphocytes. EMBO J 22, 1381-1388. 
 
Mestecky, J., Zikan, J., & Butler, W.T. (1971). Immunoglobulin M and secretory immunoglobulin 
A: presence of a common polypeptide chain different from light chains. Science 171, 1163-
1165. 
 
Milne, C.D., Fleming, H.E., & Paige, C.J. (2004). IL-7 does not prevent pro-B/pre-B cell 
maturation to the immature/sIgM(+) stage. Eur J Immunol 34, 2647-2655. 
 
Mizushima, S. & Nagata, S. (1990). pEF-BOS, a powerful mammalian expression vector. 
Nucleic Acids Res 18, 5322. 
 
Mo, X., Bailin, T., & Sadofsky, M.J. (1999). RAG1 and RAG2 cooperate in specific binding to the 
recombination signal sequence in vitro. J Biol Chem 274, 7025-7031. 
 
Morshead, K.B., Ciccone, D.N., Taverna, S.D., Allis, C.D., & Oettinger, M.A. (2003). Antigen 
receptor loci poised for V(D)J rearrangement are broadly associated with BRG1 and flanked by 
peaks of histone H3 dimethylated at lysine 4. Proc Natl Acad Sci USA 100, 11577-11582. 
 
Moss, B., Elroy-Stein, O., Mizukami, T., Alexander, W.A., & Fuerst, T.R. (1990). Product review. 
New mammalian expression vectors. Nature 348, 91-92. 
 
Mucida, D., Husain, M.M., Muroi, S., van Wijk, F., Shinnakasu, R., Naoe, Y., Reis, B.S., Huang, 
Y., Lambolez, F., Docherty, M. et al. (2013). Transcriptional reprogramming of mature CD4(+) 
helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat Immunol 
14, 281-289. 
 
Muljo, S.A. & Schlissel, M.S. (2003). A small molecule Abl kinase inhibitor induces 
differentiation of Abelson virus-transformed pre-B cell lines. Nat Immunol 4, 31-37. 
 
Mundy, C.L., Patenge, N., Matthews, A.G., & Oettinger, M.A. (2002). Assembly of the 
RAG1/RAG2 synaptic complex. Mol Cell Biol 22, 69-77. 
 
Murphy, K.M., Travers, P., & Walport, M., in NCBI bookshelf (Garland Pub., London, 2007). 
 
Nagawa, F., Hirose, S., Nishizumi, H., Nishihara, T., & Sakano, H. (2004). Joining mutants of 
RAG1 and RAG2 that demonstrate impaired interactions with the coding-end DNA. J Biol Chem 
279, 38360-38368. 
 
Nagawa, F., Ishiguro, K., Tsuboi, A., Yoshida, T., Ishikawa, A., Takemori, T., Otsuka, A.J., & 
Sakano, H. (1998a). Footprint analysis of the RAG protein recombination signal sequence 
complex for V(D)J type recombination. Mol Cell Biol 18, 655-663. 
 
Nagawa, F., Ishiguro, K., Tsuboi, A., Yoshida, T., Ishikawa, A., Takemori, T., Otsuka, A.J., & 
Sakano, H. (1998b). Footprint analysis of the RAG protein recombination signal sequence 
complex for V(D)J type recombination. Mol Cell Biol 18, 655-663. 
 
Nagawa, F., Kodama, M., Nishihara, T., Ishiguro, K., & Sakano, H. (2002). Footprint analysis of 
recombination signal sequences in the 12/23 synaptic complex of V(D)J recombination. Mol Cell 
Biol 22, 7217-7225. 
 
Nakamura, A., Sedelnikova, O.A., Redon, C., Pilch, D.R., Sinogeeva, N.I., Shroff, R., Lichten, 
M., & Bonner, W.M. (2006). Techniques for gamma-H2AX detection. Methods Enzymol 409, 
236-250. 
 
Nambiar, M. & Raghavan, S.C. (2012). Mechanism of fragility at BCL2 gene minor breakpoint 
cluster region during t(14;18) chromosomal translocation. J Biol Chem 287, 8688-8701. 
References  | 172 
 
 
 
Namen, A.E., Lupton, S., Hjerrild, K., Wignall, J., Mochizuki, D.Y., Schmierer, A., Mosley, B., 
March, C.J., Urdal, D., & Gillis, S. (1988). Stimulation of B-cell progenitors by cloned murine 
interleukin-7. Nature 333, 571-573. 
 
Neiditch, M.B., Lee, G.S., Huye, L.E., Brandt, V.L., & Roth, D.B. (2002). The V(D)J recombinase 
efficiently cleaves and transposes signal joints. Mol Cell 9, 871-878. 
 
Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R. (1993). Regulation 
of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. 
Science 261, 82-86. 
 
Ng, H.H., Robert, F., Young, R.A., & Struhl, K. (2003). Targeted recruitment of Set1 histone 
methylase by elongating Pol II provides a localized mark and memory of recent transcriptional 
activity. Mol Cell 11, 709-719. 
 
Niedziela-Majka, A., Rymarczyk, G., Kochman, M., & Ozyhar, A. (1998). GST-Induced 
dimerization of DNA-binding domains alters characteristics of their interaction with DNA. Protein 
Expr Purif 14, 208-220. 
 
Nightingale, K.P., Baumann, M., Eberharter, A., Mamais, A., Becker, P.B., & Boyes, J. (2007). 
Acetylation increases access of remodelling complexes to their nucleosome targets to enhance 
initiation of V(D)J recombination. Nucleic Acids Res 35, 6311-6321. 
 
Nishihara, T., Nagawa, F., Imai, T., & Sakano, H. (2008). RAG-heptamer interaction in the 
synaptic complex is a crucial biochemical checkpoint for the 12/23 recombination rule. J Biol 
Chem 283, 4877-4885. 
 
Nussenzweig, A. & Nussenzweig, M.C. (2010). Origin of chromosomal translocations in 
lymphoid cancer. Cell 141, 27-38. 
 
Nutt, S.L., Heavey, B., Rolink, A.G., & Busslinger, M. (1999). Commitment to the B-lymphoid 
lineage depends on the transcription factor Pax5. Nature 401, 556-562. 
 
Oettinger, M.A., Schatz, D.G., Gorka, C., & Baltimore, D. (1990). RAG-1 and RAG-2, adjacent 
genes that synergistically activate V(D)J recombination. Science 248, 1517-1523. 
 
Orphanides, G., Wu, W.H., Lane, W.S., Hampsey, M., & Reinberg, D. (1999). The chromatin-
specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. 
Nature 400, 284-288. 
 
Papaemmanuil, E., Rapado, I., Li, Y., Potter, N.E., Wedge, D.C., Tubio, J., Alexandrov, L.B., 
Van Loo, P., Cooke, S.L., Marshall, J. et al. (2014). RAG-mediated recombination is the 
predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. 
Nat Genet 46, 116-125. 
 
Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., Chaganti, R.S., 
Klein, U., Kuppers, R., Rajewsky, K. et al. (1998). BCL-6 mutations in normal germinal center B 
cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 95, 
11816-11821. 
 
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Kuppers, R., & 
Dalla-Favera, R. (2001). Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell 
lymphomas. Nature 412, 341-346. 
 
Peak, M.M., Arbuckle, J.L., & Rodgers, K.K. (2003). The central domain of core RAG1 
preferentially recognizes single-stranded recombination signal sequence heptamer. J Biol Chem 
278, 18235-18240. 
 
Peled, J.U., Kuang, F.L., Iglesias-Ussel, M.D., Roa, S., Kalis, S.L., Goodman, M.F., & Scharff, 
M.D. (2008a). The biochemistry of somatic hypermutation. Annu Rev Immunol 26, 481-511. 
 
References  | 173 
 
 
Peled, J.U., Kuang, F.L., Iglesias-Ussel, M.D., Roa, S., Kalis, S.L., Goodman, M.F., & Scharff, 
M.D. (2008b). The biochemistry of somatic hypermutation. Annual Review of Immunology 26, 
481-511. 
 
Perkins, E.J., Kee, B.L., & Ramsden, D.A. (2004). Histone 3 lysine 4 methylation during the pre-
B to immature B-cell transition. Nucleic Acids Res 32, 1942-1947. 
 
Pijlman, G.P., van den Born, E., Martens, D.E., & Vlak, J.M. (2001). Autographa californica 
baculoviruses with large genomic deletions are rapidly generated in infected insect cells. 
Virology 283, 132-138. 
 
Pijlman, G.P., van Schijndel, J.E., & Vlak, J.M. (2003). Spontaneous excision of BAC vector 
sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells. J 
Gen Virol 84, 2669-2678. 
 
Pokholok, D.K., Harbison, C.T., Levine, S., Cole, M., Hannett, N.M., Lee, T.I., Bell, G.W., 
Walker, K., Rolfe, P.A., Herbolsheimer, E. et al. (2005). Genome-wide map of nucleosome 
acetylation and methylation in yeast. Cell 122, 517-527. 
 
Poltoratsky, V., Goodman, M.F., & Scharff, M.D. (2000). Error-prone candidates vie for somatic 
mutation. J Exp Med 192, F27-30. 
 
Potter, M. & Wiener, F. (1992). Plasmacytomagenesis in mice: model of neoplastic development 
dependent upon chromosomal translocations. Carcinogenesis 13, 1681-1697. 
 
Pui, C.H., Relling, M.V., & Downing, J.R. (2004). Acute lymphoblastic leukemia. N Engl J Med 
350, 1535-1548. 
 
Pui, J.C., Allman, D., Xu, L., DeRocco, S., Karnell, F.G., Bakkour, S., Lee, J.Y., Kadesch, T., 
Hardy, R.R., Aster, J.C. et al. (1999). Notch1 expression in early lymphopoiesis influences B 
versus T lineage determination. Immunity 11, 299-308. 
 
Qiu, J.X., Kale, S.B., Yarnell Schultz, H., & Roth, D.B. (2001). Separation-of-function mutants 
reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination. Mol 
Cell 7, 77-87. 
 
Rabkin, C.S. & Janz, S. (2008). Mechanisms and consequences of chromosomal translocation. 
Cancer Epidemiol Biomarkers Prev 17, 1849-1851. 
 
Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H.R., & Aguet, M. 
(1999). Deficient T cell fate specification in mice with an induced inactivation of Notch1. 
Immunity 10, 547-558. 
 
Raghavan, S.C., Houston, S., Hegde, B.G., Langen, R., Haworth, I.S., & Lieber, M.R. (2004a). 
Stability and strand asymmetry in the non-B DNA structure at the bcl-2 major breakpoint region. 
J Biol Chem 279, 46213-46225. 
 
Raghavan, S.C., Kirsch, I.R., & Lieber, M.R. (2001). Analysis of the V(D)J recombination 
efficiency at lymphoid chromosomal translocation breakpoints. J Biol Chem 276, 29126-29133. 
 
Raghavan, S.C., Swanson, P.C., Ma, Y., & Lieber, M.R. (2005). Double-strand break formation 
by the RAG complex at the bcl-2 major breakpoint region and at other non-B DNA structures in 
vitro. Mol Cell Biol 25, 5904-5919. 
 
Raghavan, S.C., Swanson, P.C., Wu, X., Hsieh, C.L., & Lieber, M.R. (2004b). A non-B-DNA 
structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 428, 88-
93. 
 
Rajewsky, K. (1996). Clonal selection and learning in the antibody system. Nature 381, 751-
758. 
 
References  | 174 
 
 
Ramiro, A.R., Jankovic, M., Callen, E., Difilippantonio, S., Chen, H.T., McBride, K.M., 
Eisenreich, T.R., Chen, J., Dickins, R.A., Lowe, S.W. et al. (2006). Role of genomic instability 
and p53 in AID-induced c-myc-Igh translocations. Nature 440, 105-109. 
 
Ramon-Maiques, S., Kuo, A.J., Carney, D., Matthews, A.G., Oettinger, M.A., Gozani, O., & 
Yang, W. (2007). The plant homeodomain finger of RAG2 recognizes histone H3 methylated at 
both lysine-4 and arginine-2. Proc Natl Acad Sci USA 104, 18993-18998. 
 
Ramsden, D.A. & Gellert, M. (1995). Formation and resolution of double-strand break 
intermediates in V(D)J rearrangement. Genes Dev 9, 2409-2420. 
 
Ramsden, D.A., McBlane, J.F., van Gent, D.C., & Gellert, M. (1996). Distinct DNA sequence 
and structure requirements for the two steps of V(D)J recombination signal cleavage. EMBO J 
15, 3197-3206. 
 
Ramsden, D.A., van Gent, D.C., & Gellert, M. (1997). Specificity in V(D)J recombination: new 
lessons from biochemistry and genetics. Curr Opin Immunol 9, 114-120. 
 
Reeves, R., Gorman, C.M., & Howard, B. (1985). Minichromosome assembly of non-integrated 
plasmid DNA transfected into mammalian cells. Nucleic Acids Res 13, 3599-3615. 
 
Rivera, R.R., Stuiver, M.H., Steenbergen, R., & Murre, C. (1993). Ets proteins: new factors that 
regulate immunoglobulin heavy-chain gene expression. Mol Cell Biol 13, 7163-7169. 
 
Robbiani, D.F., Bothmer, A., Callen, E., Reina-San-Martin, B., Dorsett, Y., Difilippantonio, S., 
Bolland, D.J., Chen, H.T., Corcoran, A.E., Nussenzweig, A. et al. (2008). AID is required for the 
chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135, 1028-1038. 
 
Robbiani, D.F. & Nussenzweig, M.C. (2013). Chromosome translocation, B cell lymphoma, and 
activation-induced cytidine deaminase. Annu Rev Pathol 8, 79-103. 
 
Rodgers, K.K., Bu, Z., Fleming, K.G., Schatz, D.G., Engelman, D.M., & Coleman, J.E. (1996). A 
zinc-binding domain involved in the dimerization of RAG1. J Mol Biol 260, 70-84. 
 
Rodgers, K.K., Villey, I.J., Ptaszek, L., Corbett, E., Schatz, D.G., & Coleman, J.E. (1999). A 
dimer of the lymphoid protein RAG1 recognizes the recombination signal sequence and the 
complex stably incorporates the high mobility group protein HMG2. Nucleic Acids Res 27, 2938-
2946. 
 
Rogakou, E.P., Boon, C., Redon, C., & Bonner, W.M. (1999). Megabase chromatin domains 
involved in DNA double-strand breaks in vivo. J Cell Biol 146, 905-916. 
 
Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., & Bonner, W.M. (1998). DNA double-
stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273, 5858-
5868. 
 
Roldan, E., Fuxa, M., Chong, W., Martinez, D., Novatchkova, M., Busslinger, M., & Skok, J.A. 
(2005). Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the 
immunoglobulin heavy-chain gene. Nat Immunol 6, 31-41. 
 
Roth, D.B. (2003). Restraining the V(D)J recombinase. Nat Rev Immunol 3, 656-666. 
 
Roth, D.B. & Roth, S.Y. (2000). Unequal access: regulating V(D)J recombination through 
chromatin remodeling. Cell 103, 699-702. 
 
Sabbattini, P., Lundgren, M., Georgiou, A., Chow, C., Warnes, G., & Dillon, N. (2001). Binding 
of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not 
require heterochromatin formation. EMBO J 20, 2812-2822. 
 
Sadofsky, M.J., Hesse, J.E., & Gellert, M. (1994). Definition of a core region of RAG-2 that is 
functional in V(D)J recombination. Nucleic Acids Res 22, 1805-1809. 
 
References  | 175 
 
 
Sadofsky, M.J., Hesse, J.E., McBlane, J.F., & Gellert, M. (1993). Expression and V(D)J 
recombination activity of mutated RAG-1 proteins. Nucleic Acids Res 21, 5644-5650. 
 
Sakamoto, S., Wakae, K., Anzai, Y., Murai, K., Tamaki, N., Miyazaki, M., Miyazaki, K., 
Romanow, W.J., Ikawa, T., Kitamura, D. et al. (2012). E2A and CBP/p300 act in synergy to 
promote chromatin accessibility of the immunoglobulin kappa locus. J Immunol 188, 5547-5560. 
 
Santagata, S., Aidinis, V., & Spanopoulou, E. (1998). The effect of Me
2+
 cofactors at the initial 
stages of V(D)J recombination. J Biol Chem 273, 16325-16331. 
 
Sawchuk, D.J., Weis-Garcia, F., Malik, S., Besmer, E., Bustin, M., Nussenzweig, M.C., & 
Cortes, P. (1997). V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 
12/23 substrates by whole cell extract and DNA-bending proteins. J Exp Med 185, 2025-2032. 
 
Sayegh, C.E., Jhunjhunwala, S., Riblet, R., & Murre, C. (2005). Visualization of looping 
involving the immunoglobulin heavy-chain locus in developing B cells. Genes Dev 19, 322-327. 
 
Schatz, D.G. & Ji, Y. (2011). Recombination centres and the orchestration of V(D)J 
recombination. Nat Rev Immunol 11, 251-263. 
 
Schatz, D.G. & Swanson, P.C. (2011). V(D)J recombination: mechanisms of initiation. Annu Rev 
Genet 45, 167-202. 
 
Schlissel, M.S. (2004). Regulation of activation and recombination of the murine Igkappa locus. 
Immunol Rev 200, 215-223. 
 
Schlissel, M.S. & Baltimore, D. (1989). Activation of immunoglobulin kappa gene rearrangement 
correlates with induction of germline kappa gene transcription. Cell 58, 1001-1007. 
 
Sciammas, R. & Davis, M.M. (2004). Modular nature of Blimp-1 in the regulation of gene 
expression during B cell maturation. J Immunol 172, 5427-5440. 
 
Scott, J.N., Kupinski, A.P., & Boyes, J. (2014). Targeted genome regulation and modification 
using transcription activator-like effectors. FEBS J. 
 
Shaffer, A.L., Emre, N.C., Lamy, L., Ngo, V.N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., 
Zhao, H. et al. (2008). IRF4 addiction in multiple myeloma. Nature 454, 226-231. 
 
Shaffer, A.L., Lin, K.I., Kuo, T.C., Yu, X., Hurt, E.M., Rosenwald, A., Giltnane, J.M., Yang, L., 
Zhao, H., Calame, K. et al. (2002). Blimp-1 orchestrates plasma cell differentiation by 
extinguishing the mature B cell gene expression program. Immunity 17, 51-62. 
 
Shaffer, A.L., Shapiro-Shelef, M., Iwakoshi, N.N., Lee, A.H., Qian, S.B., Zhao, H., Yu, X., Yang, 
L., Tan, B.K., Rosenwald, A. et al. (2004). XBP1, downstream of Blimp-1, expands the secretory 
apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. 
Immunity 21, 81-93. 
 
Shapiro-Shelef, M., Lin, K.I., McHeyzer-Williams, L.J., Liao, J., McHeyzer-Williams, M.G., & 
Calame, K. (2003). Blimp-1 is required for the formation of immunoglobulin secreting plasma 
cells and pre-plasma memory B cells. Immunity 19, 607-620. 
 
Shimazaki, N., Askary, A., Swanson, P.C., & Lieber, M.R. (2012). Mechanistic basis for RAG 
discrimination between recombination sites and the off-target sites of human lymphomas. Mol 
Cell Biol 32, 365-375. 
 
Shimazaki, N., Tsai, A.G., & Lieber, M.R. (2009). H3K4me3 stimulates the V(D)J RAG complex 
for both nicking and hairpinning in trans in addition to tethering in cis: implications for 
translocations. Mol Cell 34, 535-544. 
 
Shlyakhtenko, L.S., Gilmore, J., Kriatchko, A.N., Kumar, S., Swanson, P.C., & Lyubchenko, Y.L. 
(2009). Molecular mechanism underlying RAG1/RAG2 synaptic complex formation. J Biol Chem 
284, 20956-20965. 
References  | 176 
 
 
 
Shurtleff, S.A., Buijs, A., Behm, F.G., Rubnitz, J.E., Raimondi, S.C., Hancock, M.L., Chan, G.C., 
Pui, C.H., Grosveld, G., & Downing, J.R. (1995). TEL/AML1 fusion resulting from a cryptic 
t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients 
with an excellent prognosis. Leukemia 9, 1985-1989. 
 
Sikes, M.L., Meade, A., Tripathi, R., Krangel, M.S., & Oltz, E.M. (2002). Regulation of V(D)J 
recombination: a dominant role for promoter positioning in gene segment accessibility. Proc Natl 
Acad Sci U S A 99, 12309-12314. 
 
Silver, D.P., Spanopoulou, E., Mulligan, R.C., & Baltimore, D. (1993). Dispensable sequence 
motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination. Proc Natl Acad Sci 
USA 90, 6100-6104. 
 
Simkus, C., Anand, P., Bhattacharyya, A., & Jones, J.M. (2007). Biochemical and folding 
defects in a RAG1 variant associated with Omenn syndrome. J Immunol 179, 8332-8340. 
 
Simkus, C., Makiya, M., & Jones, J.M. (2009). Karyopherin alpha 1 is a putative substrate of the 
RAG1 ubiquitin ligase. Mol Immunol 46, 1319-1325. 
 
Skok, J.A., Gisler, R., Novatchkova, M., Farmer, D., de Laat, W., & Busslinger, M. (2007). 
Reversible contraction by looping of the Tcra and Tcrb loci in rearranging thymocytes. Nat 
Immunol 8, 378-387. 
 
Sobacchi, C., Marrella, V., Rucci, F., Vezzoni, P., & Villa, A. (2006). RAG-dependent primary 
immunodeficiencies. Hum Mutat 27, 1174-1184. 
 
Spanopoulou, E., Cortes, P., Shih, C., Huang, C.M., Silver, D.P., Svec, P., & Baltimore, D. 
(1995). Localization, interaction, and RNA binding properties of the V(D)J recombination-
activating proteins RAG1 and RAG2. Immunity 3, 715-726. 
 
Spanopoulou, E., Zaitseva, F., Wang, F.H., Santagata, S., Baltimore, D., & Panayotou, G. 
(1996). The homeodomain region of Rag-1 reveals the parallel mechanisms of bacterial and 
V(D)J recombination. Cell 87, 263-276. 
 
Stavnezer, J. (1996). Immunoglobulin class switching. Curr Opin Immunol 8, 199-205. 
 
Stavnezer, J., Guikema, J.E., & Schrader, C.E. (2008). Mechanism and regulation of class 
switch recombination. Annu Rev Immunol 26, 261-292. 
 
Steen, S.B., Gomelsky, L., & Roth, D.B. (1996). The 12/23 rule is enforced at the cleavage step 
of V(D)J recombination in vivo. Genes Cells 1, 543-553. 
 
Stros, M. (1998). DNA bending by the chromosomal protein HMG1 and its high mobility group 
box domains. Effect of flanking sequences. J Biol Chem 273, 10355-10361. 
 
Swanson, P.C. (2001). The DDE motif in RAG-1 is contributed in trans to a single active site 
that catalyzes the nicking and transesterification steps of V(D)J recombination. Mol Cell Biol 21, 
449-458. 
 
Swanson, P.C. (2002a). Fine structure and activity of discrete RAG-HMG complexes on V(D)J 
recombination signals. Mol Cell Biol 22, 1340-1351. 
 
Swanson, P.C. (2002b). A RAG-1/RAG-2 tetramer supports 12/23-regulated synapsis, 
cleavage, and transposition of V(D)J recombination signals. Mol Cell Biol 22, 7790-7801. 
 
Swanson, P.C. (2004). The bounty of RAGs: recombination signal complexes and reaction 
outcomes. Immunol Rev 200, 90-114. 
 
Swanson, P.C. & Desiderio, S. (1998). V(D)J recombination signal recognition: distinct, 
overlapping DNA-protein contacts in complexes containing RAG1 with and without RAG2. 
Immunity 9, 115-125. 
References  | 177 
 
 
 
Swanson, P.C. & Desiderio, S. (1999). RAG-2 promotes heptamer occupancy by RAG-1 in the 
assembly of a V(D)J initiation complex. Mol Cell Biol 19, 3674-3683. 
 
Swanson, P.C., Kumar, S., & Raval, P. (2009). Early steps of V(D)J rearrangement: insights 
from biochemical studies of RAG-RSS complexes. Adv Exp Med Biol 650, 1-15. 
 
Tabor, S. & Richardson, C.C. (1989). Effect of manganese ions on the incorporation of 
dideoxynucleotides by bacteriophage T7 DNA polymerase and Escherichia coli DNA 
polymerase I. Proc Natl Acad Sci USA 86, 4076-4080. 
 
Takeda, S., Zou, Y.R., Bluethmann, H., Kitamura, D., Muller, U., & Rajewsky, K. (1993). 
Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene 
rearrangement in cis but not lambda chain gene rearrangement in trans. Embo J 12, 2329-
2336. 
 
Teitell, M.A. & Pandolfi, P.P. (2009). Molecular genetics of acute lymphoblastic leukemia. Annu 
Rev Pathol 4, 175-198. 
 
Teng, G. & Papavasiliou, F.N. (2007). Immunoglobulin somatic hypermutation. Annu Rev Genet 
41, 107-120. 
 
Tevelev, A. & Schatz, D.G. (2000). Intermolecular V(D)J recombination. J Biol Chem 275, 8341-
8348. 
 
Tiegs, S.L., Russell, D.M., & Nemazee, D. (1993). Receptor editing in self-reactive bone marrow 
B cells. J Exp Med 177, 1009-1020. 
 
Tonegawa, S. (1983). Somatic generation of antibody diversity. Nature 302, 575-581. 
 
Torrano, V., Procter, J., Cardus, P., Greaves, M., & Ford, A.M. (2011). ETV6-RUNX1 promotes 
survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor. Blood 118, 
4910-4918. 
 
Tripathi, R., Jackson, A., & Krangel, M.S. (2002). A change in the structure of Vbeta chromatin 
associated with TCR beta allelic exclusion. J Immunol 168, 2316-2324. 
 
Tsai, A.G. & Lieber, M.R. (2010). Mechanisms of chromosomal rearrangement in the human 
genome. BMC Genomics 11 Suppl 1, S1. 
 
Tsuzuki, S., Seto, M., Greaves, M., & Enver, T. (2004). Modeling first-hit functions of the 
t(12;21) TEL-AML1 translocation in mice. Proc Natl Acad Sci USA 101, 8443-8448. 
 
Tycko, B. & Sklar, J. (1990). Chromosomal translocations in lymphoid neoplasia: a reappraisal 
of the recombinase model. Cancer Cells 2, 1-8. 
 
Unniraman, S., Zhou, S., & Schatz, D.G. (2004). Identification of an AID-independent pathway 
for chromosomal translocations between the Igh switch region and Myc. Nat Immunol 5, 1117-
1123. 
 
Uphoff, C.C., MacLeod, R.A., Denkmann, S.A., Golub, T.R., Borkhardt, A., Janssen, J.W., & 
Drexler, H.G. (1997). Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in 
human early B-lineage leukemia cell lines. Leukemia 11, 441-447. 
 
van Gent, D.C., Hiom, K., Paull, T.T., & Gellert, M. (1997). Stimulation of V(D)J cleavage by 
high mobility group proteins. EMBO J 16, 2665-2670. 
 
van Gent, D.C., McBlane, J.F., Ramsden, D.A., Sadofsky, M.J., Hesse, J.E., & Gellert, M. 
(1996a). Initiation of V(D)J recombinations in a cell-free system by RAG1 and RAG2 proteins. 
Curr Top Microbiol Immunol 217, 1-10. 
 
References  | 178 
 
 
van Gent, D.C., Mizuuchi, K., & Gellert, M. (1996b). Similarities between initiation of V(D)J 
recombination and retroviral integration. Science 271, 1592-1594. 
 
van Gent, D.C., Ramsden, D.A., & Gellert, M. (1996c). The RAG1 and RAG2 proteins establish 
the 12/23 rule in V(D)J recombination. Cell 85, 107-113. 
 
Vanasse, G.J., Concannon, P., & Willerford, D.M. (1999). Regulated genomic instability and 
neoplasia in the lymphoid lineage. Blood 94, 3997-4010. 
 
Vanura, K., Montpellier, B., Le, T., Spicuglia, S., Navarro, J.M., Cabaud, O., Roulland, S., 
Vachez, E., Prinz, I., Ferrier, P. et al. (2007). In vivo reinsertion of excised episomes by the 
V(D)J recombinase: a potential threat to genomic stability. PLoS Biol 5, e43. 
 
Vignali, D.A., Collison, L.W., & Workman, C.J. (2008). How regulatory T cells work. Nat Rev 
Immunol 8, 523-532. 
 
Wagner, H.J., Scott, R.S., Buchwald, D., & Sixbey, J.W. (2004). Peripheral blood lymphocytes 
express recombination-activating genes 1 and 2 during Epstein-Barr virus-induced infectious 
mononucleosis. J Infect Dis 190, 979-984. 
 
Wang, G., Dhar, K., Swanson, P.C., Levitus, M., & Chang, Y. (2012). Real-time monitoring of 
RAG-catalyzed DNA cleavage unveils dynamic changes in coding end association with the 
coding end complex. Nucleic Acids Res 40, 6082-6096. 
 
Wang, X., Xiao, G., Zhang, Y., Wen, X., Gao, X., Okada, S., & Liu, X. (2008). Regulation of Tcrb 
recombination ordering by c-Fos-dependent RAG deposition. Nat Immunol 9, 794-801. 
 
Weir, H.M., Kraulis, P.J., Hill, C.S., Raine, A.R., Laue, E.D., & Thomas, J.O. (1993). Structure of 
the HMG box motif in the B-domain of HMG1. EMBO J 12, 1311-1319. 
 
Welzel, N., Le, T., Marculescu, R., Mitterbauer, G., Chott, A., Pott, C., Kneba, M., Du, M.Q., 
Kusec, R., Drach, J. et al. (2001). Templated nucleotide addition and immunoglobulin JH-gene 
utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of 
mantle cell lymphoma. Cancer Res 61, 1629-1636. 
 
West, K.L., Singha, N.C., De Ioannes, P., Lacomis, L., Erdjument-Bromage, H., Tempst, P., & 
Cortes, P. (2005). A direct interaction between the RAG2 C terminus and the core histones is 
required for efficient V(D)J recombination. Immunity 23, 203-212. 
 
West, R.B. & Lieber, M.R. (1998). The RAG-HMG1 complex enforces the 12/23 rule of V(D)J 
recombination specifically at the double-hairpin formation step. Mol Cell Biol 18, 6408-6415. 
 
Wilson, A., Held, W., & MacDonald, H.R. (1994). Two waves of recombinase gene expression in 
developing thymocytes. J Exp Med 179, 1355-1360. 
 
Workman, J.L. (2006). Nucleosome displacement in transcription. Genes Dev 20, 2009-2017. 
 
Xu, C.R. & Feeney, A.J. (2009). The epigenetic profile of Ig genes is dynamically regulated 
during B cell differentiation and is modulated by pre-B cell receptor signaling. J Immunol 182, 
1362-1369. 
 
Xu, Y., Davidson, L., Alt, F.W., & Baltimore, D. (1996). Deletion of the Ig kappa light chain 
intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa 
rearrangement. Immunity 4, 377-385. 
 
Yamane, H. & Paul, W.E. (2013). Early signaling events that underlie fate decisions of naive 
CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev 252, 12-23. 
 
Yancopoulos, G.D. & Alt, F.W. (1985). Developmentally controlled and tissue-specific 
expression of unrearranged VH gene segments. Cell 40, 271-281. 
 
References  | 179 
 
 
Yarnell Schultz, H., Landree, M.A., Qiu, J.X., Kale, S.B., & Roth, D.B. (2001). Joining-deficient 
RAG1 mutants block V(D)J recombination in vivo and hairpin opening in vitro. Mol Cell 7, 65-75. 
 
Ye, S.K., Agata, Y., Lee, H.C., Kurooka, H., Kitamura, T., Shimizu, A., Honjo, T., & Ikuta, K. 
(2001). The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and 
histone acetylation. Immunity 15, 813-823. 
 
Yin, F.F., Bailey, S., Innis, C.A., Ciubotaru, M., Kamtekar, S., Steitz, T.A., & Schatz, D.G. 
(2009). Structure of the RAG1 nonamer binding domain with DNA reveals a dimer that mediates 
DNA synapsis. Nat Struct Mol Biol 16, 499-508. 
 
Yoshida, T., Tsuboi, A., Ishiguro, K., Nagawa, F., & Sakano, H. (2000). The DNA-bending 
protein, HMG1, is required for correct cleavage of 23 bp recombination signal sequences by 
recombination activating gene proteins in vitro. Int Immunol 12, 721-729. 
 
Yu, K. & Lieber, M.R. (1999). Mechanistic basis for coding end sequence effects in the initiation 
of V(D)J recombination. Mol Cell Biol 19, 8094-8102. 
 
Yu, K. & Lieber, M.R. (2000). The nicking step in V(D)J recombination is independent of 
synapsis: implications for the immune repertoire. Mol Cell Biol 20, 7914-7921. 
 
Zachau, H.G. (1993). The immunoglobulin kappa locus-or-what has been learned from looking 
closely at one-tenth of a percent of the human genome. Gene 135, 167-173. 
 
Zhang, L., Reynolds, T.L., Shan, X., & Desiderio, S. (2011). Coupling of V(D)J recombination to 
the cell cycle suppresses genomic instability and lymphoid tumorigenesis. Immunity 34, 163-
174. 
 
Zhao, S., Gwyn, L.M., De, P., & Rodgers, K.K. (2009). A non-sequence-specific DNA binding 
mode of RAG1 is inhibited by RAG2. J Mol Biol 387, 744-758. 
 
Zhu, C., Bogue, M.A., & Roth, D.B. (1996). Thymocyte differentiation in gamma-irradiated 
severe-combined immunodeficient mice: characterization of intermediates and products of 
V(D)J recombination at the T cell receptor alpha locus. Eur J Immunol 26, 2859-2865. 
 
Zubakov, D., Liu, F., van Zelm, M.C., Vermeulen, J., Oostra, B.A., van Duijn, C.M., Driessen, 
G.J., van Dongen, J.J., Kayser, M., & Langerak, A.W. (2010). Estimating human age from T-cell 
DNA rearrangements. Curr Biol 20, R970-971. 
 
 
 
